Skip to Main Content
CWRU Links


2012 Member Publications

This is a list of publications authored by Cancer Center members. Cancer Center members are highlighted in BOLD text. 

Publications are listed in alphabetical order by first author. 

Abdel-Wahab M, Mahmoud O, Merrick G, Hsu IC, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ Jr, Yamada Y. ACR Appropriateness Criteria(®) external-beam radiation therapy treatment planning for clinically localized prostate cancer. J Am Coll Radiol 9:233-238, 2012.


Abraham J, Chua YX, Glover JM, Tyner JW, Loriaux MM, Kilcoyne A, Giles FJ, Nelon LD, Carew JS, Ouyang Y, Michalek JE, Pal R, Druker BJ, Rubin BP, Keller C. An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcoma. Biochem Biophys Res Commun 426:363-368, 2012. PMCID: PMC3463776


Achkar JP, Klei L, de Bakker PI, Bellone G, Rebert N, Scott R, Lu Y, Regueiro M, Brzezinski A, Kamboh MI, Fiocchi C, Devlin B, Trucco M, Ringquist S, Roeder K, Duerr RH. Amino acid position 11 of HLA-DRβ1 is a major determinant of chromosome 6p association with ulcerative colitis. Genes Immun 13:245-252, 2012. PMCID: PMC3341846


Adams MD, Veigl MLWang Z, Molyneux N, Sun SGuda K, Yu X, Markowitz SDWillis J. Global mutational profiling of formalin-fixed human colon cancers from a pathology archive. Mod Pathol 25:1599-1608, 2012.


Adelstein DJ, Koyfman SA, El-Naggar AK, Hanna EY. Biology and management of salivary gland cancers. Semin Radiat Oncol 22:245-253, 2012.


Adelstein DJ, Rodriguez CP, Rybicki LA, Ives DI, Rice TW. A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction. Invest New Drugs 30:1684-1689, 2012.


Adelstein DJ. Clinical trial design in head and neck cancer: what has the oncologist learned? Lancet Oncol 13:e318-e323, 2012.


Agnes RS, Broome AM, Wang J, Verma A, Lavik K, Basilion JP. An optical probe for noninvasive molecular imaging of orthotopic brain tumors overexpressing epidermal growth factor receptor. Mol Cancer Ther 11:2202-2211, 2012.


Agyeman A, Mazumdar T, Houghton JA. Regulation of DNA damage following termination of hedgehog (HH) survival signaling at the level of the GLI genes in human colon cancer. Oncotarget 3:851-865, 2012. PMCID: PMC3478462


Ahluwalia MS, Wallace PK, Peereboom DM. Flow cytometry as a diagnostic tool in lymphomatous or leukemic meningitis: ready for prime time? Cancer 118:1747-1753, 2012.


Ahmad MF, Kaushal PS, Wan Q, Wijerathna SR, An X, Huang M, Dealwis CG. Role of arginine 293 and glutamine 288 in communication between catalytic and allosteric sites in yeast ribonucleotide reductase. J Mol Biol 419:315-329, 2012.


Ahmad MF, Wan Q, Jha S, Motea E, Berdis ADealwis C. Evaluating the therapeutic potential of a non-natural nucleotide that inhibits human ribonucleotide reductase. Mol Cancer Ther 11:2077-2086, 2012. PMCID: PMC3569060


Ahmed HU, Akin O, Coleman JA, Crane S, Emberton M, Goldenberg L, Hricak H, Kattan MW, Kurhanewicz J, Moore CM, Parker C, Polascik TJ, Scardino P, van As N, Villers A; on behalf of the Transatlantic Consensus Group on Active Surveillance and Focal Therapy for Prostate Cancer. Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer. BJU Int 109:1636-1647, 2012.


Akhtar-Zaidi B, Cowper-Sal-lari R, Corradin O, Saiakhova A, Bartels CF, Balasubramanian D, Myeroff L, Lutterbaugh J, Jarrar A, Kalady MF, Willis J, Moore JH, Tesar PJLaframboise TMarkowitz S, Lupien M, Scacheri PC. Epigenomic enhancer profiling defines a signature of colon cancer. Science 336:736-739, 2012.


Alaiti MA, Ishikawa M, Masuda H, Simon DI, Jain MK, Asahara T, Costa MA. Up-regulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD34+ cells enhances cell-mediated angiogenesis. J Cell Mol Med 16:2413-2421, 2012.


Alberti MO, Roth JC, Ismail M, Tsuruta Y, Abraham E, Pereboeva L, Gerson SL, Curiel DT. Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation. PLoS One 7:e37812, 2012. PMCID: PMC3356302


Alcazar O, Achberger S, Aldrich W, Hu Z, Negrotto S, Saunthararajah YTriozzi P. Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo. Int J Cancer 131:18-29, 2012. PMCID: PMC3454528


Alexander RE, Hu Y, Kum JB, Montironi R, Lopez-Beltran A, Maclennan GT, Idrees MT, Emerson RE, Ulbright TM, Grignon DG, Eble JN, Cheng L. p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma. Mod Pathol 25:1526-1533, 2012.


Alexander RE, Lopez-Beltran A, Montironi R, MacLennan GT, Post KM, Bilbo SA, Jones TD, Huang W, Rao Q, Sen JD, Meehan K, Cornwell A, Miravalle L, Cheng L. KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas. Histopathology 61:1036-1042, 2012.


Aljabali AA, Barclay JE, Steinmetz NF, Lomonossoff GP, Evans DJ. Controlled immobilisation of active enzymes on the cowpea mosaic virus capsid. Nanoscale 4:5640-5645, 2012.


Allen EM, Mieyal JJ. Protein-thiol oxidation and cell death: regulatory role of glutaredoxins. Antioxid Redox Signal 17:1748-1763, 2012. PMCID: PMC3474186


Altuntas CZ, Jaini R, Kesaraju P, Jane-Wit D, Johnson JM, Covey K, Flask CA, Dutertre M, Picard JY, Tuohy VK. Autoimmune mediated regulation of ovarian tumor growth. Gynecol Oncol 124:98-104, 2012. PMCID: PMC3258506


Anand S, Ortel BJ, Pereira SP, Hasan T, Maytin EV. Biomodulatory approaches to photodynamic therapy for solid tumors. Cancer Lett 326:8-16, 2012. PMCID: PMC3459352


Andersen T, Melvik JE, Gåserød O, Alsberg E, Christensen BE. Ionically gelled alginate foams: physical properties controlled by operational and macromolecular parameters. Biomacromolecules 13:3703-3710, 2012.


Aneja S, Aneja S, Bordeaux JS. Association of increased dermatologist density with lower melanoma mortality. Arch Dermatol 148:174-178, 2012.


Aneja S, Brimhall AK, Kast DR, Aneja S, Carlson D, Cooper KD, Bordeaux JS. Improvement in patient performance of skin self-examinations after intervention with interactive education and telecommunication reminders: a randomized controlled study. Arch Dermatol 148:1266-1272, 2012.


Ang SK, LeGrand SB, Walsh D, Davis MP, Lagman RL. Physician home visits by palliative medicine fellow. Am J Hosp Palliat Care 29:112-115, 2012.


Ankerst DP, Boeck A, Freedland SJ, Thompson IM, Cronin AM, Roobol MJ, Hugosson J, Jones JS, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schröder FH, Lilja H, Vickers AJ. Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. World J Urol 30:181-187, 2012.


Apisarnthanarax N, Wood GS, Stevens SR, Carlson S, Chan DV, Liu L, Szabo SK, Fu P, Gilliam AC, Gerson SL, Remick SC, Cooper KD. Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type. Arch Dermatol 148:613-620, 2012. PMCID: PMC3519426


Arif A, Chatterjee P, Moodt RA, Fox PL. Heterotrimeric GAIT complex drives transcript-selective translation inhibition in murine macrophages. Mol Cell Biol 32:5046-5055, 2012. PMCID: PMC3510535


Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, Schouten HC, Finke J, Ball ED, Aljurf MD, Cutler CS, Rowe JM, Antin JH, Isola LM, Di Bartolomeo P, Camitta BM, Miller AM, Cairo MS, Stockerl-Goldstein K, Sierra J, Savoie ML, Halter J, Stiff PJ, Nabhan C, Jakubowski AA, Bunjes DW, Petersdorf EW, Devine SM, Maziarz RT, Bornhauser M, Lewis VA, Marks DI, Bredeson CN, Soiffer RJ, Weisdorf DJ. Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biol Blood Marrow Transplant 18:280-288, 2012. PMCID: PMC3224672


Armstrong AJ, Hurd WW, Elguero S, Barker NM, Zanotti KM. Diagnosis and management of endometrial hyperplasia. J Minim Invasive Gynecol 19:562-571, 2012.


Aron M, Gill IS, Campbell SC. A nonischemic approach to partial nephrectomy is optimal. Yes. J Urol 187:387-388, 2012.


Aronow M, Sun Y, Saunthararajah Y, Biscotti C, Tubbs R, Triozzi P, Singh A. Monosomy 3 by FISH in uveal melanoma: variability in techniques and results. Surv Ophthalmol 57:463-473, 2012.


Ashida S, Orloff MS, Bebek G, Zhang L, Zheng P, Peehl DM, Eng C. Integrated analysis reveals critical genomic regions in prostate tumor microenvironment associated with clinicopathologic phenotypes. Clin Cancer Res 18:1578-1587, 2012.


Aspy CB, Hamm RM, Schauf KJ, Mold JW, Flocke S. Interpreting the psychometric properties of the components of primary care instrument in an elderly population. J Family Community Med 19:119-124, 2012. PMCID: PMC3410175


Augoff K, McCue B, Plow EFSossey-Alaoui K. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer 11:5, 2012. PMCID: PMC3298503


Auletta JJ, Deans RJ, Bartholomew AM. Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. Blood 119:1801-1809, 2012. PMCID: PMC3293637


Avallone AN, Avallone MA, Share S, Rubin BP. Epithelioid hemangioma-a rare scrotal tumor of childhood. Urology 80:707-709, 2012.


Avva J, Weis MC, Sramkoski RM, Sreenath SNJacobberger JW. Dynamic expression profiles from static cytometry data: component fitting and conversion to relative, "same scale" values. PLoS One 7:e38275, 2012. PMCID: PMC3395670

Babsky AM, Ju S, Bennett S, George B, McLennan G, Bansal N. Effect of implantation site and growth of hepatocellular carcinoma on apparent diffusion coefficient of water and sodium MRI. NMR Biomed 25:312-321, 2012.


Bacher U, Klyuchnikov E, Le-Rademacher J, Carreras J, Armand P, Bishop MR, Bredeson CN, Cairo MS, Fenske TS, Freytes CO, Gale RP, Gibson J, Isola LM, Inwards DJ, Laport GG, Lazarus HM, Maziarz RT, Wiernik PH, Schouten HC, Slavin S, Smith SM, Vose JM, Waller EK, Hari PN; Lymphoma Working Committee of the CIBMTR. Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity? Blood 120:4256-4262, 2012. PMCID: PMC3501720


Bader HL, Wang LW, Ho JC, Tran T, Holden P, Fitzgerald J, Atit RP, Reinhardt DP, Apte SS. A disintegrin-like and metalloprotease domain containing thrombospondin type 1 motif-like 5 (ADAMTSL5) is a novel fibrillin-1-, fibrillin-2-, and heparin-binding member of the ADAMTS superfamily containing a netrin-like module. Matrix Biol 31:398-411, 2012. PMCID: PMC3546522


Bai L, Lennon DP, Caplan AI, Dechant A, Hecker J, Kranso J, Zaremba A, Miller RH. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 15:862-870, 2012. PMCID: PMC3427471


Baker AR, Qiu F, Randhawa AK, Horne DJ, Adams MD, Shey M, Barnholtz-Sloan J, Mayanja-Kizza H, Kaplan G, Hanekom WA, Boom WH, Hawn TR, Stein CM; Tuberculosis Research Unit (TBRU) and South African Tuberculosis Vaccine Initiative Team (SATVI). Genetic variation in TLR genes in Ugandan and South African populations and comparison with HapMap data. PLoS One 7:e47597, 2012. PMCID: PMC3480404


Balagamwala EH, Angelov L, Koyfman SA, Suh JH, Reddy CA, Djemil T, Hunter GK, Xia PChao ST. Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma. J Neurosurg Spine 17:556-564, 2012.


Balagamwala EH, Chao STSuh JH. Principles of radiobiology of stereotactic radiosurgery and clinical applications in the central nervous system. Technol Cancer Res Treat 11:3-13, 2012.


Balagamwala EH, Suh JHBarnett GH, Khan MK, Neyman G, Cai RS, Vogelbaum MA, Novak E, Chao ST. The importance of the conformality, heterogeneity, and gradient indices in evaluating gamma knife radiosurgery treatment plans for intracranial meningiomas. Int J Radiat Oncol Biol Phys 83:1406-1413, 2012.


Balanis N, Carlin CR. Mutual cross-talk between fibronectin integrins and the EGF receptor: molecular basis and biological significance. Cell Logist 2:46-51, 2012. PMCID: PMC3355975


Balasubramanian D, Akhtar-Zaidi B, Song L, Bartels CF, Veigl M, Beard L, Myeroff L, Guda K, Lutterbaugh J, Willis J, Crawford GE, Markowitz SD,Scacheri PC. H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island containing start sites. Genome Med 4:47, 2012. PMCID: PMC3506913


Balasubramanian P, Lang JC, Jatana KR, Miller B, Ozer E, Old M, Schuller DE, Agrawal A, Teknos TN, Summers TA Jr, Lustberg MB, Zborowski M, Chalmers JJ. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck. PLoS One 7:e42048, 2012. PMCID: PMC3406036


Ballen KK, Klein JP, Pedersen TL, Bhatla D, Duerst R, Kurtzberg J, Lazarus HM, Lemaistre CF, McCarthy P, Mehta P, Palmer J, Setterholm M, Wingard JR, Joffe S, Parsons SK, Switzer GE, Lee SJ, Rizzo JD, Majhail NS. Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. Biol Blood Marrow Transplant 18:903-912, 2012.


Ballen KK, Woolfrey AE, Zhu X, Ahn KW, Wirk B, Arora M, George B, Savani BN, Bolwell B, Porter DL, Copelan E, Hale G, Schouten HC, Lewis I, Cahn JY, Halter J, Cortes J, Kalaycio ME, Antin J, Aljurf MD, Carabasi MH, Hamadani M, McCarthy P, Pavletic S, Gupta V, Deeg HJ, Maziarz RT, Horowitz MM, Saber W. Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. Biol Blood Marrow Transplant 18:1446-1454, 2012. PMCID: PMC3499973


Bandyopadhyay S, Harris DP, Adams GN, Lause GE, McHugh A, Tillmaand EG, Money A, Willard BFox PL, Dicorleto PE. HOXA9 methylation by PRMT5 is essential for endothelial cell expression of leukocyte adhesion molecules. Mol Cell Biol 32:1202-1213, 2012. PMCID: PMC3302442


Baquero MT, Hanna JA, Neumeister V, Cheng H, Molinaro AM, Harris LN, Rimm DL. Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer. Cancer 118:4660-4669, 2012. PMCID: PMC3391341


Baranek C, Dittrich M, Parthasarathy S, Bonnon CG, Britanova O, Lanshakov D, Boukhtouche F, Sommer JE, Colmenares C, Tarabykin V, Atanasoski S. Protooncogene Ski cooperates with the chromatin-remodeling factor Satb2 in specifying callosal neurons. Proc Natl Acad Sci U S A 109:3546-3551, 2012. PMCID: PMC3295291


Bardowell SA, Duan F, Manor D, Swanson JE, Parker RS. Disruption of mouse cytochrome p450 4f14 (Cyp4f14 gene) causes severe perturbations in vitamin E metabolism. J Biol Chem 287:26077-26086, 2012. PMCID: PMC3406691


Bark CM, Traboulsi RS, Honda K, Starnes AM, Jacobs MR, Rodriguez B. Disseminated mycobacterium chelonae infection in a patient receiving an epidermal growth factor receptor inhibitor for advanced head and neck cancer. J Clin Microbiol 50:194-195, 2012. PMCID: PMC3256709


Barlin JN, Yu C, Hill EK, Zivanovic O, Kolev V, Levine DA, Sonoda Y, Abu-Rustum NR, Huh J, Barakat RR, Kattan MW, Chi DS. Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer. Gynecol Oncol 125:25-30, 2012.


Barnholtz-Sloan JS, Yu C, Sloan AE, Vengoechea J, Wang M, Dignam JJ, Vogelbaum MA, Sperduto PW, Mehta MP, Machtay M, Kattan MW. A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro Oncol 14:910-918, 2012. PMCID: PMC3379797


Barrett LE, Granot Z, Coker C, Iavarone A, Hambardzumyan D, Holland EC, Nam HS, Benezra R. Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell 21:11-24, 2012.


Barron VA, Lou H. Alternative splicing of the neurofibromatosis type I pre-mRNA. Biosci Rep 32:131-138, 2012.


Bastian PJ, Boorjian SA, Bossi A, Briganti A, Heidenreich A, Freedland SJ, Montorsi F, Roach M 3rd, Schröder F, van Poppel H, Stief CG, Stephenson AJ, Zelefsky MJ. High-risk prostate cancer: from definition to contemporary management. Eur Urol 61:1096-1106, 2012.


Bates DO, Catalano PJ, Symonds KE, Varey AH, Ramani P, O'Dwyer PJ, Giantonio BJ, Meropol NJ, Benson AB, Harper SJ. Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab. Clin Cancer Res 18:6384-6391, 2012.


Bebek G, Bennett KL, Funchain P, Campbell R, Seth R, Scharpf J, Burkey B, Eng C. Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma. Hum Mol Genet 21:1557-1565, 2012. PMCID: PMC3298279


Bebek G, Koyutürk M, Price ND, Chance MR. Network biology methods integrating biological data for translational science. Brief Bioinform 13:446-459, 2012. PMCID: PMC3404396


Beck TL, Singhal PK, Ehrenberg HM, Rose PG, Lele SB, Krivak TC, McBee WC Jr. Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment. Gynecol Oncol 125:141-144, 2012.


Beckham TH, Lu P, Cheng JC, Zhao D, Turner LS, Zhang X, Hoffman S, Armeson KE, Liu A, Marrison T, Hannun YA, Liu X. Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B. Int J Cancer 131:2034-2043, 2012. PMCID: PMC3384773


Bejanyan N, Bolwell BJ, Lazaryan A, Rybicki L, Tench S, Duong H, Andresen S, Sobecks RDean RPohlman BKalaycio M, Copelan EA. Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT). Biol Blood Marrow Transplant 18:874-880, 2012.


Bejanyan N, Tiu RV, Raza A, Jankowska A, Kalaycio MAdvani A, Chan J, Saunthararajah Y, Mooney L, Maciejewski JPSekeres MA. A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF). Cancer 118:3968-3976, 2012.


Belinson JL, Du H, Yang B, Wu R, Belinson SE, Qu X, Pretorius RG, Yi X, Castle PE. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. Int J Cancer 130:1855-1860, 2012.


Benezra M, Hambardzumyan D, Penate-Medina O, Veach DR, Pillarsetty N, Smith-Jones P, Phillips E, Ozawa T, Zanzonico PB, Longo V, Holland EC, Larson SM, Bradbury MS. Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a PDGFB-driven murine glioblastoma model. Neoplasia 14:1132-1143, 2012. PMCID: PMC3540940


Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, …Chak A, et al. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 143:336-346, 2012.


Bentley AA, Merkulov SM, Peng Y, Rozmarynowycz R, Qi X, Pusztai-Carey M, Merrick WC, Yee VCMcCrae KR, Komar AA. Chimeric glutathione S-transferases containing inserts of kininogen peptides: potential novel protein therapeutics. J Biol Chem 287:22142-22150, 2012. PMCID: PMC3381172


Berglund RK, Tangen CM, Powell IJ, Lowe BA, Haas GP, Carroll PR, Canby-Hagino ED, Devere White R, Hemstreet GP 3rd, Crawford ED, Thompson IM Jr, Klein EA. Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109. Urology 79:633-637, 2012.


Berglund RK, Zaytoun O, Thousand R, Stephans K, Tendulkar R, Klein EA, Jones JS. Early infectious complications with transponder placement for external beam radiation therapy for prostate cancer. BJU Int 110:834-838, 2012.


Bernardo GM, Keri RA. FOXA1: a transcription factor with parallel functions in development and cancer. Biosci Rep 32:113-130, 2012.


Berry DC, Croniger CM, Ghyselinck NB, Noy N. Transthyretin blocks retinol uptake and cell signaling by the holo-retinol-binding protein receptor STRA6. Mol Cell Biol 32:3851-3859, 2012. PMCID: PMC3457529


Berry DC, DeSantis D, Soltanian H, Croniger CM, Noy N. Retinoic acid upregulates preadipocyte genes to block adipogenesis and suppress diet-induced obesity. Diabetes 61:1112-1121, 2012. PMCID: PMC3331760


Berry DC, Noy N. Signaling by vitamin A and retinol-binding protein in regulation of insulin responses and lipid homeostasis. Biochim Biophys Acta 1821:168-176, 2012. PMCID: PMC3204314 Berry DC, O'Byrne SM, Vreeland AC, Blaner WS, Noy N. Cross talk between signaling and vitamin A transport by the retinol-binding protein receptor STRA6. Mol Cell Biol 32:3164-3175, 2012. PMCID: PMC3434520


Bevilacqua JL, Kattan MW, Changhong Y, Koifman S, Mattos IE, Koifman RJ, Bergmann A. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Ann Surg Oncol 19:2580-2589, 2012.


Bhaskaran N, Shukla S, Kanwal R, Srivastava JK, Gupta S. Induction of heme oxygenase-1 by chamomile protects murine macrophages against oxidative stress. Life Sci 90:1027-1033, 2012. PMCID: PMC3389181


Bhaskaran N, Srivastava JK, Shukla S, Gupta S. Chamomile confers protection against hydrogen peroxide-induced toxicity through activation of Nrf2-mediated defense response. Phytother Res 90:1027-1033, 2012. PMCID: PMC3389181


Blake-Gumbs L, Chen Z, Thompson CLBerger NA, Tucker TC, Li L. Adult BMI change and risk of colon cancer in postmenopausal women. J Obes 2012:857510, 2012. PMCID: PMC3400390


Bolesta E, Pfannenstiel LW, Demelash A, Lesniewski ML, Tobin M, Schlanger SE, Nallar SC, Papadimitriou JC, Kalvakolanu DV, Gastman BR. Inhibition of Mcl-1 promotes senescence in cancer cells: implications for preventing tumor growth and chemotherapy resistance. Mol Cell Biol 32:1879-1892, 2012. PMCID: PMC3347419


Borden ECDowlati A. Phase I trials of targeted anticancer drugs: a need to refocus. Nat Rev Drug Discov 11:889-890, 2012.


Bose P, Perkins EB, Honeycut C, Wellons MD, Stefan T, Jacobberger JW, Kontopodis E, Beumer JH, Egorin MJ, Imamura CK, Douglas Figg W Sr, Karp JE, Koc ON, Cooper BW, Luger SM, Colevas AD, Roberts JD, Grant S. Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl(+) hematological malignancies. Cancer Chemother Pharmacol 69:1657-1667, 2012. PMCID: PMC3365614


Bostrom MA, Kao WH, Li M, Abboud HE, Adler SG, Iyengar SK, Kimmel PL, Hanson RL, Nicholas SB, Rasooly RS, Sedor JR, Coresh J, Kohn OF, Leehey DJ, Thornley-Brown D, Bottinger EP, Lipkowitz MS, Meoni LA, Klag MJ, Lu L, Hicks PJ, Langefeld CD, Parekh RS, Bowden DW, Freedman BI; Family Investigation of Nephropathy and Diabetes (FIND) Research Group. Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy. Am J Kidney Dis 59:210-221, 2012. PMCID: PMC3259209


Brady A, Gibson S, Rybicki L, Hsi ESaunthararajah YSekeres MATiu RCopelan E, Kalaycio MSobecks R, Bates J, Advani AS. Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemia. Eur J Haematol 89:288-293, 2012.


Brady-Kalnay SM. Molecular mechanisms of cancer cell-cell interactions: cell-cell adhesion-dependent signaling in the tumor microenvironment. Cell Adh Migr 6:344-345, 2012. PMCID: PMC3478256


Brell JM, Krishnamurthi SS, Rath L, Bokar JASavvides PGibbons JCooney MMMeropol NJ, Ivy P, Dowlati A. Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors. Cancer Chemother Pharmacol 70:547-553, 2012.


Brennan CW, Daly BJ, Dawson NV, Higgins PA, Jones KR, Madigan E, Van Der Meulen J. The oncology acuity tool: a reliable, valid method for measuring patient acuity for nurse assignment decisions. J Nurs Meas 20:155-185, 2012.


Buchbinder D, Nugent DJ, Brazauskas R, Wang Z, Aljurf MD, Cairo MS, Chow R, Duncan C, Eldjerou LK, Gupta V, Hale GA, Halter J, Hayes-Lattin BM, Hsu JW, Jacobsohn DA, Kamble RT, Kasow KA, Lazarus HM, Mehta P, Myers KC, Parsons SK, Passweg JR, Pidala J, Reddy V, Sales-Bonfim CM, Savani BN, Seber A, Sorror ML, Steinberg A, Wood WA, Wall DA, Winiarski JH, Yu LC, Majhail NS. Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 18:1776-1784, 2012. PMCID: PMC3496823


Bucur O, Stancu AL, Khosravi-Far R, Almasan A. Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications. Cell Death Dis 3:e263, 2012. PMCID: PMC3288344


Budd GT. Circulating tumor cells in biliary cancer: first step or false step? J Gastrointest Oncol 3:82-83, 2012. PMCID: PMC3397654


Bulgar AD, Weeks LD, Miao Y, Yang S, Xu Y, Guo C, Markowitz SOleinick NGerson SLLiu L. Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair. Cell Death Dis 3:e252, 2012. PMCID: PMC3270269


Bunting KD, Qu CK, Tomasson MH. Molecular-targeted therapies for hematologic malignancies. Adv Hematol 2012:606423, 2012. PMCID: PMC3254001


Burris HA 3rd, Dowlati A, Moss RA, Infante JR, Jones SF, Spigel DR, Levinson KT, Lindquist D, Gainer SD, Dar MM, Suttle AB, Ball HA, Tan AR. Phase I study of pazopanib in combination with paclitaxel and carboplatin given every 21 days in patients with advanced solid tumors. Mol Cancer Ther 11:1820-1828, 2012.


Burrows AC, Prokop J, Summers MK. Skp1-Cul1-F-box ubiquitin ligase (SCFβTrCP)-mediated destruction of the ubiquitin-specific protease USP37 during G2-phase promotes mitotic entry. J Biol Chem 287:39021-39029, 2012. PMCID: PMC3493943


Busaidy NL, Farooki A, Dowlati A, Perentesis JP, Dancey JE, Doyle LA, Brell JM, Siu LL. Management of metabolic effects associated with anticancer agents targeting the PI3K-Akt-mTOR pathway. J Clin Oncol 30:2919-2928, 2012. PMCID: PMC3410405

Calderon MR, Verway M, An BS, DiFeo A, Bismar TA, Ann DK, Martignetti JA, Shalom-Barak T, White JH. Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene. J Biol Chem 287:8662-8674, 2012. PMCID: PMC3308733


Campbell SC. A nonischemic approach to partial nephrectomy is optimal. No. J Urol 187:388-390, 2012.


Cantrell LA, Havrilesky L, Moore DT, O'Malley D, Liotta M, Secord AA, Nagel CI, Cohn DE, Fader AN, Wallace AH, Rose P, Gehrig PA. A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma. Gynecol Oncol 127:22-26, 2012.


Carneiro BA, Ramanathan RK, Fakih MG, Krishnamurthi SS, Lembersky BC, Stoller RG, Lancaster SL, Pinkerton RA, Crandall TL, Schmotzer AR, Potter DM, Bahary N. Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer. Clin Colorectal Cancer 11:53-59, 2012.


Castle PE, de Sanjosé S, Qiao YL, Belinson JL, Lazcano-Ponce E, Kinney W. Introduction of human papillomavirus DNA screening in the world: 15 years of experience. Vaccine 30(Suppl 5):F117-F122, 2012.


Chak A, Chen Y, Vengoechea J, Canto MI, Elston R, Falk GW, Grady WM, Guda K, Kinnard M, Markowitz S, Mittal S, Prasad G, Shaheen N, Willis JE,Barnholtz-Sloan JS. Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 21:376-383, 2012. PMCID: PMC3275661


Chakrabarti A, Ghosh PK, Banerjee S, Gaughan C, Silverman RH. RNase L triggers autophagy in response to viral infections. J Virol 86:11311-11321, 2012. PMCID: PMC3457150


Chakrabarti A, Gupta K, Sharma JP, Yang J, Agarwal A, Glick A, Zhang Y, Agarwal M, Agarwal MK, Wald DN. ATP depletion triggers acute myeloid leukemia differentiation through an ATR/Chk1 protein-dependent and p53 protein-independent pathway. J Biol Chem 287:23635-23643, 2012. PMCID: PMC3390638


Chan DV, Aneja S, Honda K, Carlson S, Yao M, Katcher J, Cooper KD. Radiation therapy in the management of unilesional primary cutaneous T-cell lymphomas. Br J Dermatol 166:1134-1137, 2012.


Chan ES, Patel AR, Hansel DE, Larchian WA, Heston WD. Sunitinib malate provides activity against murine bladder tumor growth and invasion in a preclinical orthotopic model. Urology 80:736.e1-736.e5, 2012.


Chang KJ, Reid T, Senzer N, Swisher S, Pinto H, Hanna N, Chak A, Soetikno R. Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer. Gastrointest Endosc 75:1139-1146.e2, 2012.


Chao J, Synold TW, Morgan RJ Jr, Kunos C, Longmate J, Lenz HJ, Lim D, Shibata S, Chung V, Stoller RG, Belani CP, Gandara DR, McNamara M, Gitlitz BJ, Lau DH, Ramalingam SS, Davies A, Espinoza-Delgado I, Newman EM, Yen Y. A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium study. Cancer Chemother Pharmacol 69:835-843, 2012. PMCID: PMC3288125


Chao ST, Koyfman SA, Woody N, Angelov L, Soeder SL, Reddy CA, Rybicki LA, Djemil T, Suh JH. Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases. Int J Radiat Oncol Biol Phys 82:1738-1743, 2012.


Chao ST, Thakkar VV, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, Rasmussen P, Reuther AM, Jamison B, Neyman G, Suh JH. Prospective study of the short-term adverse effects of gamma knife radiosurgery. Technol Cancer Res Treat 11:117-122, 2012.


Chen BR, Hale DC, Ciolek PJ, Runge KW. Generation and analysis of a barcode-tagged insertion mutant library in the fission yeast Schizosaccharomyces pombe. BMC Genomics 13:161, 2012. PMCID: PMC3418178


Chen BR, Runge KW. Genetic approaches to aging in budding and fission yeasts: new connections and new opportunities. Subcell Biochem 57:291-314, 2012.


Chen J, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP. Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Coll Cardiol 60:2504-2512, 2012.


Chen WC, Katcher J, Nunez C, Tirgan AM, Ellis RJ. Radioactive seed migration after transperineal interstitial prostate brachytherapy and associated development of small-cell lung cancer. Brachytherapy 11:354-358, 2012.


Chen WC, Kim J, Kim E, Silverman P, Overmoyer B, Cooper BW, Anthony S, Shenk RLeeming R, Hanks SH, Lyons JA. A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast cancer. Int J Radiat Oncol Biol Phys 82:14-20, 2012.


Chen Y, Li J. Generation of synthetic data and experimental designs in evaluating interactions for association studies. J Bioinform Comput Biol 10:1240005, 2012.


Cheng L, Alexander RE, Maclennan GT, Cummings OW, Montironi R, Lopez-Beltran A, Cramer HM, Davidson DD, Zhang S. Molecular pathology of lung cancer: key to personalized medicine. Mod Pathol 25:347-369, 2012.


Cheng L, Maclennan GT, Lopez-Beltran A. Histologic grading of urothelial carcinoma: a reappraisal. Hum Pathol 43:2097-2108, 2012.


Cheng X, Kao HY. Microarray analysis revealing common and distinct functions of promyelocytic leukemia protein (PML) and tumor necrosis factor alpha (TNFα) signaling in endothelial cells. BMC Genomics 13:453, 2012. PMCID: PMC3542097


Cheng X, Kao HY. Post-translational modifications of PML: consequences and implications. Front Oncol 2:210, 2012. PMCID: PMC3539660


Cheng X, Liu Y, Chu H, Kao HY. Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα). J Biol Chem 287:23356-23367, 2012. PMCID: PMC3390613


Cheriyath V, Kuhns MA, Jacobs BS, Evangelista P, Elson P, Downs-Kelly E, Tubbs R, Borden EC. G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer. Oncogene 31:2222-2236, 2012.


Chiang CW, Liu CT, Lettre G, Lange LA, Jorgensen NW, Keating BJ, Vedantam S, Nock NL, Franceschini N, Reiner AP, Demerath EW, Boerwinkle E, Rotter JI, Wilson JG, North KE, Papanicolaou GJ, Cupples LA; Genetic Investigation of ANthropometric Traits Consortium, Murabito JM, Hirschhorn JN. Ultraconserved elements in the human genome: association and transmission analyses of highly constrained single-nucleotide polymorphisms. Genetics 192:253-266, 2012. PMCID: PMC3430540


Chim H, Miller E, Gliniak C, Alsberg E. Stromal-cell-derived factor (SDF) 1-alpha in combination with BMP-2 and TGF-β1 induces site-directed cell homing and osteogenic and chondrogenic differentiation for tissue engineering without the requirement for cell seeding. Cell Tissue Res 350:89-94, 2012.


Chin BB, Hjelmeland ARich J, Song H, Lascola C, Storms R, McLendon R, Reiman R, Greer KL, Metzler SD, McDougald D, Dai D, Vaidyanathan G. Synthesis and preliminary evaluation of n.c.a. iodoquine: a novel radiotracer with high uptake in cells with high ALDH1 expression. Curr Radiopharm 5:47-58, 2012.


Choe J, Kulasekere R, Oddo D, Anthony S, Shin T, Murray M, Kunos CA. Helical tomotherapy versus conventional radiation to deliver abdominopelvic radiation. Technol Cancer Res Treat 11:49-56, 2012.


Choi AH, Barnholtz-Sloan JSKim JA. Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis. Ann Oncol 23:2449-2457, 2012. PMCID: PMC3425369


Choi I, Kattan MW, Wells BJ, Yu C. A hybrid approach to survival model building using integration of clinical and molecular information in censored data. IEEE/ACM Trans Comput Biol Bioinform 9:1091-1105, 2012.


Choi JS, Berdis AJ. Nucleoside transporters: biological insights and therapeutic applications. Future Med Chem 4:1461-1478, 2012.


Choi SW, Stiff P, Cooke K, Ferrara JL, Braun T, Kitko C, Reddy P, Yanik G, Mineishi S, Paczesny S, Hanauer D, Pawarode A, Peres E, Rodriguez T, Smith S, Levine JE. TNF-inhibition with Etanercept for graft-versus-host disease prevention in high-risk HCT: Lower TNFR1 levels correlate with better outcomes. Biol Blood Marrow Transplant 18:1525-1532, 2012. PMCID: PMC3443302


Chopra K, Gastman BR, Manson PN. Stereolithographic modeling in reconstructive surgery of the craniofacial skeleton after tumor resection. Plast Reconstr Surg 129:743e-745e, 2012.


Ciezki JP, Hsu IC, Abdel-Wahab M, Arterbery VE, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G; American College of Radiology Appropriateness Criteria. American College of Radiology Appropriateness Criteria®–locally advanced (high-risk) prostate cancer. Clin Oncol (R Coll Radiol) 24:43-51, 2012.


Ciezki JP, Reddy CA, Kupelian PA, Klein EA. Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis. Urology 80:367-373, 2012.


Cimbro R, Vassena L, Arthos J, Cicala C, Kehrl JH, Park C, Sereti I, Lederman MM, Fauci AS, Lusso P. IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa. Blood 120:2610-2619, 2012.


Cipriano R, Graham J, Miskimen KL, Bryson BL, Bruntz RC, Scott SA, Brown HA, Stark GRJackson MW. FAM83B mediates EGFR- and RAS-driven oncogenic transformation. J Clin Invest 122:3197-3210, 2012. PMCID: PMC3428078


Clevenger JA, Wang M, Maclennan GT, Montironi R, Lopez-Beltran A, Cheng L. Evidence for clonal fibroblast proliferation and autoimmune process in idiopathic retroperitoneal fibrosis. Hum Pathol 43:1875-1880, 2012.


Cohen J, Bosworth BP, Chak A, Dunkin BJ, Early DS, Gerson LB, Hawes RH, Haycock AV, Hochberger JH, Hwang JH, Martin JA, McNally PR, Sedlack RE, Vassiliou MC. Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) on the use of endoscopy simulators for training and assessing skill. Gastrointest Endosc 76:471-475, 2012.


Cohen PA, Ko JS, Storkus WJ, Spencer CD, Bradley JM, Gorman JE, McCurry DB, Zorro-Manrique S, Dominguez AL, Pathangey LB, Rayman PA, Rini BI, Gendler SJ, Finke JH. Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape. Immunol Invest 41:680-710, 2012.


Coleman RL, Sill MW, Lankes HA, Fader AN, Finkler NJ, Hoffman JS, Rose PG, Sutton GP, Drescher CW, McMeekin DS, Hu W, Deavers M, Godwin AK, Alpaugh RK, Sood AK. A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study. Gynecol Oncol 127:538-543, 2012. PMCID: PMC3568489


Condie AG, Gerson SLMiller RHWang Y. Two-photon fluorescent imaging of myelination in the spinal cord. ChemMedChem 7:2194-2203, 2012.


Cook RJ, Wang Z, Arora M, Lazarus HM, Kasow KA, Champagne MA, Saber W, van Besien KM, Hale GA, Copelan EA, Elmongy M, Ueno NT, Horn BN, Slavin S, Bishop MR, Stadtmauer EA. Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis. Bone Marrow Transplant 47:1455-1458, 2012.


Cooney MM, Nock CBokar JKrishnamurthi SGibbons J, Rodal MB, Ness A, Remick SC, Dreicer RDowlati A. Phase I trial of pomalidomide given for patients with advanced solid tumors. Cancer Chemother Pharmacol 70:755-761, 2012.


Cooper GS, Xu F, Barnholtz-Sloan JSKoroukian SMSchluchter MD. Management of malignant colonic polyps: a population-based analysis of colonoscopic polypectomy versus surgery. Cancer 118:651-659, 2012. PMCID: PMC3193545


Cooper GS, Xu F, Barnholtz-Sloan JSSchluchter MDKoroukian SM. Prevalence and predictors of interval colorectal cancers in Medicare beneficiaries. Cancer 118:3044-3052, 2012. PMCID: PMC3258472


Coskun SA, Qi X, Cakmak A, Cheng E, Cicek AE, Yang L, Jadeja R, Dash RK, Lai N, Ozsoyoglu G, Ozsoyoglu ZM. PathCase-SB: integrating data sources and providing tools for systems biology research. BMC Syst Biol 6:67, 2012. PMCID: PMC3410775


Cousino MK, Zyzanski SJ, Yamokoski AD, Hazen RA, Baker JN, Noll RB, Rheingold SR, Geyer JR, Alexander SC, Drotar D, Kodish ED. Communicating and understanding the purpose of pediatric phase I cancer trials. J Clin Oncol 30:4367-4372, 2012. PMCID: PMC3515769


Craig S, Gao L, Lee I, Gray T, Berdis AJ. Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation. J Med Chem 55:2437-2451, 2012. PMCID: PMC3326641


Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE. ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Science 335:1503-1506, 2012.


Crespo M, Martinez DG, Cerissi A, Rivera-Reyes B, Bernstein HB, Lederman MM, Sieg SF, Luciano AA. Neonatal T-cell maturation and homing receptor responses to Toll-like receptor ligands differ from those of adult naive T cells: relationship to prematurity. Pediatr Res 71:136-143, 2012. PMCID: PMC3394681


Cross BC, Bond PJ, Sadowski PG, Jha BK, Zak J, Goodman JM, Silverman RH, Neubert TA, Baxendale IR, Ron D, Harding HP. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc Natl Acad Sci U S A 109:E869-E878, 2012. PMCID: PMC3326519


Cummings KC 3rd, Xu F, Cummings LCCooper GS. A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study. Anesthesiology 116:797-806, 2012.


Cummings LC, Delaney CP, Cooper GS. Laparoscopic versus open colectomy for colon cancer in an older population: a cohort study. World J Surg Oncol 10:31, 2012. PMCID: PMC3296595


Cutter JL, Cohen NT, Wang J, Sloan AE, Cohen AR, Panneerselvam A, Schluchter M, Blum G, Bogyo M, Basilion JP. Topical application of activity-based probes for visualization of brain tumor tissue. PLoS One 7:e33060, 2012. PMCID: PMC3302795


Czuczman MS, Leonard JP, Jung S, Johnson JL, Hsi ED, Byrd JC, Cheson BD. Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness. Ann Oncol 23:2356-2362, 2012.

D'Amico R, Lei L, Kennedy BC, Sisti J, Ebiana V, Crisman C, Christensen JG, Gil O, Rosenfeld SS, Canoll P, Bruce JN. The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastoma. Neurol Res 34:252-261, 2012.


Das Gupta J, Luk KC, Tang N, Gaughan C, Klein EA, Kandel ES, Hackett J Jr, Silverman RH. Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1. PLoS One 7:e36072, 2012. PMCID: PMC3353988


Daud AI, Krishnamurthi SS, Saleh MN, Gitlitz BJ, Borad MJ, Gold PJ, Chiorean EG, Springett GM, Abbas R, Agarwal S, Bardy-Bouxin N, Hsyu PH, Leip E, Turnbull K, Zacharchuk C, Messersmith WA. Phase I study of bosutinib, a Src/Abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors. Clin Cancer Res 18:1092-1100, 2012.


Davis M, Lasheen W, Walsh D, Mahmoud F, Bicanovsky L, Lagman R. A phase II dose titration study of thalidomide for cancer-associated anorexia. J Pain Symptom Manage 43:78-86, 2012.


Davis MP, Mitchell G. Reconstructing analgesic trials: reasons for following the lead of oncologists. Curr Opin Support Palliat Care 6:490-493, 2012.


Davis MP, Mitchell GK. Topics in research: structuring studies in palliative care. Curr Opin Support Palliat Care 6:483-489, 2012.


Davis MP. Are there cost benefits to fentanyl for breakthrough pain? J Pain Symptom Manage 44:e1-e2, 2012.


Davis MP. Drug management of visceral pain: concepts from basic research. Pain Res Treat 2012:265605, 2012. PMCID: PMC3348642


Davis MP. Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain. J Support Oncol 10:209-219, 2012.


Dazard JE, Rao JS, Markowitz S. Local sparse bump hunting reveals molecular heterogeneity of colon tumors. Stat Med 31:1203-1220, 2012.


Dazard JE, Rao JS. Joint adaptive mean-variance regularization and variance stabilization of high dimensional data. Comput Stat Data Anal 56:2317-2333, 2012. PMCID: PMC3375876


Dazard JE, Saha S, Ewing RM. ROCS: a reproducibility index and confidence score for interaction proteomics. BMC Bioinformatics 13:128, 2012. PMCID: PMC3568013


de Herder WW, Eng C. Obesity, diabetes mellitus, and cancer. Endocr Relat Cancer 19:E5-E7, 2012.


de Lima M, McNiece I, Robinson SN, Munsell M, Eapen M, Horowitz M, Alousi A, Saliba R, McMannis JD, Kaur I, Kebriaei P, Parmar S, Popat U, Hosing C, Champlin R, Bollard C, Molldrem JJ, Jones RB, Nieto Y, Andersson BS, Shah N, Oran B, Cooper LJ, Worth L, Qazilbash MH, Korbling M, Rondon G, Ciurea S, Bosque D, Maewal I, Simmons PJ, Shpall EJ. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med 367:2305-2315, 2012.


De Los Angeles A, Loh YH, Tesar PJ, Daley GQ. Accessing naïve human pluripotency. Curr Opin Genet Dev 22:272-282, 2012.


de Souza HS, West GA, Rebert N, de la Motte C, Drazba J, Fiocchi C. Increased levels of survivin, via association with heat shock protein 90, in mucosal T cells from patients with Crohn's disease. Gastroenterology 143:1017-1026.e9, 2012. PMCID: PMC3578578


de Souza JA, Polite B, Perkins M, Meropol NJ, Ratain MJ, Newcomer LN, Alexander GC. Unsupported off-label chemotherapy in metastatic colon cancer. BMC Health Serv Res 12:481, 2012. PMCID: PMC3544564


Dean D, Jonathan W, Siblani A, Wang MO, Kim K, Mikos AG, Fisher JP. Continuous digital light processing (cDLP): highly accurate additive manufacturing of tissue engineered bone scaffolds. Virtual Phys Prototyp 7:13-24, 2012. PMCID: PMC3466612


Derakhshan JJ, Nour SG, Sunshine JL, Griswold MA, Duerk JL. Resolution enhanced T(1) -insensitive steady-state imaging. Magn Reson Med 68:421-429, 2012. PMCID: PMC3307911


Deschamps AM, Eng C. Engaging basic scientists in translational research. Endocr Relat Cancer 19:E1-E3, 2012.


Deshmane A, Gulani V, Griswold MA, Seiberlich N. Parallel MR imaging. J Magn Reson Imaging 36:55-72, 2012.


Dewal N, Hu Y, Freedman ML, Laframboise T, Pe'er I. Calling amplified haplotypes in next generation tumor sequence data. Genome Res 22:362-374, 2012. PMCID: PMC3266043


DiDonato JA, Mercurio F, Karin M. NF-κB and the link between inflammation and cancer. Immunol Rev 246:379-400, 2012.


Digiorgio MJ, Fatica C, Oden M, Bolwell BSekeres MKalaycio M, Akins P, Shane C, Bako J, Gordon SM, Fraser TG. Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies. Infect Control Hosp Epidemiol 33:865-868, 2012.


Djemil T, Angelov L, Chao S. SU-E-T-423: dosimetric effect of rotation on stereotactic body radiotherapy (SBRT) of the spine. Med Phys 39:3802, 2012.


Do JS, Foucras G, Kamada N, Schenk AF, Shaw M, Nuñez G, Paul WE, Min B. Both exogenous commensal and endogenous self antigens stimulate T cell proliferation under lymphopenic conditions. Cell Immunol 272:117-123, 2012. PMCID: PMC3244518


Do JS, Valujskikh A, Vignali DA, Fairchild RLMin B. Unexpected role for MHC II-peptide complexes in shaping CD8 T-cell expansion and differentiation in vivo. Proc Natl Acad Sci U S A 109:12698-12703, 2012. PMCID: PMC3411949


Do JS, Visperas A, O'Brien RL, Min B. CD4 T cells play important roles in maintaining IL-17-producing γδT-cell subsets in naive animals. Immunol Cell Biol 90:396-403, 2012. PMCID: PMC3170686


Do JS, Visperas A, Oh K, Stohlman SA, Min B. Memory CD4 T cells induce selective expression of IL-27 in CD8+ dendritic cells and regulate homeostatic naive T cell proliferation. J Immunol 188:230-237, 2012. PMCID: PMC3244513


Doane TL, Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev 41:2885-2911, 2012.


Doane TL, Chuang CH, Hill RJ, Burda C. Nanoparticle ζ -potentials. Acc Chem Res 45:317-326, 2012.


Doerr M, Eng C. Personalised care and the genome. BMJ 344:e3174, 2012.


Dong F, Caplan AI. Cell transplantation as an initiator of endogenous stem cell-based tissue repair. Curr Opin Organ Transplant 17:670-674, 2012.


Dor A, Koroukian S, Xu F, Stulberg J, Delaney C, Cooper G. Pricing of surgeries for colon cancer: patient severity and market factors. Cancer 118:5741-5748, 2012. PMCID: PMC3416953


Doray B, Misra S, Qian Y, Brett TJ, Kornfeld S. Do GGA adaptors bind internal DXXLL motifs? Traffic 13:1315-1325, 2012. PMCID: PMC3443260


Dotan E, Meropol NJ, Burtness B, Denlinger CS, Lee J, Mintzer D, Zhu F, Ruth K, Tuttle H, Sylvester J, Cohen SJ. A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study. J Gastrointest Cancer 43:562-569, 2012. PMCID: PMC3400721


Dotan E, Meropol NJ, Zhu F, Zambito F, Bove B, Cai KQ, Godwin AK, Golemis EA, Astsaturov I, Cohen SJ. Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer. Br J Cancer 106:748-755, 2012. PMCID: PMC3322945


Douglas SL, Daly BJ. The impact of patient quality of life and spirituality upon caregiver depression for those with advanced cancer. Palliat Support Care. 2012 Nov 27:1-8.


Douglas SL, Daly BJ, Lipson AR. Neglect of quality-of-life considerations in intensive care unit family meetings for long-stay intensive care unit patients. Crit Care Med 40:461-467, 2012.


Dreicer R. Sequencing of therapies in advanced prostate cancer. Oncology (Williston Park) 26:82, 84, 2012.


Dreicer R. Systemic therapy for advanced adrenal cancer. J Surg Oncol 106:643-646, 2012.


Dreicer R. The future of drug development in urothelial cancer. J Clin Oncol 30:473-475, 2012.


Du J, Chen Y, Li Q, Han X, Cheng C, Wang Z, Danielpour D, Dunwoodie SL, Bunting KD, Yang YC. HIF-1α deletion partially rescues defects of hematopoietic stem cell quiescence caused by Cited2 deficiency. Blood 119:2789-2798, 2012. PMCID: PMC3327457


Du J, Yang YC. HIF-1 and its antagonist Cited2: regulators of HSC quiescence. Cell Cycle 11:2413-2414, 2012. PMCID: PMC3404867


Dumont AG, Rink L, Godwin AK, Miettinen M, Joensuu H, Strosberg JR, Gronchi A, Corless CL, Goldstein D, Rubin BP, Maki RG, Lazar AJ, Lev D, Trent JC, von Mehren M. A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients. Ann Oncol 23:1335-1340, 2012. PMCID: PMC3493136

Eads JR, Meropol NJ. A new era for the systemic therapy of neuroendocrine tumors. Oncologist 17:326-338, 2012. PMCID: PMC3316918


Ebrahem Q, Mahfouz RZ, Ng KP, Saunthararajah Y. High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects. Oncotarget 3:1137-1145, 2012.


Einstein DB, Wessels B, Bangert B, Fu P, Nelson AD, Cohen M, Sagar S, Lewin J, Sloan A, Zheng Y, Williams J, Colussi V, Vinkler R, Maciunas R. Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 84:668-674, 2012.


El-Meanawy A, Schelling JR, Iyengar SK, Hayden P, Barathan S, Goddard K, Pozuelo F, Elashi E, Nair V, Kretzler M, Sedor JR. Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes. BMC Nephrol 13:61, 2012. PMCID: PMC3502501


Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosler P, Higgins PD, Hayward RA, Romagnuolo J, Elta GH, Sherman S, Waljee AK, Repaka A, Atkinson MR, Cote GA, Kwon RS, McHenry L, Piraka CR, Wamsteker EJ, Watkins JL, Korsnes SJ, Schmidt SE, Turner SM, Nicholson S, Fogel EL; U.S. Cooperative for Outcomes Research in Endoscopy (USCORE). A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 366:1414-1422, 2012. PMCID: PMC3339271


Elston RC, Satagopan JM, Sun S. Genetic terminology. Methods Mol Biol 850:1-9, 2012.


El-Telbany A, Ma PC. Cancer genes in lung cancer: racial disparities: are there any? Genes Cancer 3:467-480, 2012. PMCID: PMC3527990


Erten S, Chowdhury SA, Guan X, Nibbe RK, Barnholtz-Sloan JSChance MRKoyutürk M. Identifying stage-specific protein subnetworks for colorectal cancer. BMC Proc 6(Suppl 7):S1, 2012. PMCID: PMC3504924


Eyler CE, Rich JN. Looking in the miR-ror: TGF-β-mediated activation of NF-κB in glioma. J Clin Invest 122:3473-3475, 2012. PMCID: PMC3461933

Fader AN, Seamon LG, Escobar PF, Frasure HE, Havrilesky LA, Zanotti KM, Secord AA, Boggess JF, Cohn DE, Fowler JM, Skafianos G, Rossi E, Gehrig PA. Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers. Gynecol Oncol 126:180-185, 2012.


Fahed E, Hansel DE, Raghavan D, Quinn DI, Dorff TB. Small cell bladder cancer: biology and management. Semin Oncol 39:615-618, 2012.


Fairman-Williams ME, Jankowsky E. Unwinding initiation by the viral RNA helicase NPH-II. J Mol Biol 415:819-832, 2012. PMCID: PMC3267895


Falahati R, Zhang J, Flebbe-Rehwaldt L, Shi Y, Gerson SL, Gaensler KM. Chemoselection of allogeneic HSC after murine neonatal transplantation without myeloablation or post-transplant immunosuppression. Mol Ther 20:2180-2189, 2012. PMCID: PMC3498795


Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, Marcon NE, Schnell T, Corley DA, Sharma P, Cruz-Correa MR, Hur C, Fleischer DE,Chak A, Devault KR, Weinberg DS, Della'zanna G, Richmond E, Smyrk TC, Mandrekar SJ, Limburg PJ; Cancer Prevention Network. A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's Esophagus. Gastroenterology 143:917-926.e1, 2012. PMCID: PMC3458136


Fan C, Gaivin RJ, Marth TA, Willard B, Levine MA, Lietman SA. Cloning and characterization of the human SH3BP2 promoter. Biochem Biophys Res Commun 425:25-32, 2012. PMCID: PMC3423545


Fan Y, Arif A, Gong Y, Jia J, Eswarappa SM, Willard B, Horowitz A, Graham LM, Penn MS, Fox PL. Stimulus-dependent phosphorylation of profilin-1 in angiogenesis. Nat Cell Biol 14:1046-1056 2012.


Fan Y, Eswarappa SM, Hitomi M, Fox PL. Myo1c facilitates G-actin transport to the leading edge of migrating endothelial cells. J Cell Biol 198:47-55, 2012. PMCID: PMC3392929


Fang X, Wang C, Balgley BM, Zhao K, Wang W, He F, Weil RJ, Lee CS. Targeted tissue proteomic analysis of human astrocytomas. J Proteome Res 11:3937-4946, 2012. PMCID: PMC3413268


Fealy CE, Haus JM, Solomon TP, Pagadala M, Flask CA, McCullough AJ, Kirwan JP. Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease. J Appl Physiol 113:1-6, 2012. PMCID: PMC3404833


Feng Y, Thiagarajan PS, Ma PC. MET signaling: novel targeted inhibition and its clinical development in lung cancer. J Thorac Oncol 7:459-467, 2012.


Feng Z, Zhang J. A dual role of BRCA1 in two distinct homologous recombination mediated repair in response to replication arrest. Nucleic Acids Res 40:726-738, 2012. PMCID: PMC3258139


Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, Diamond MS, Virgin HW, Sen GC. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog 8:e1002712, 2012. PMCID: PMC3355090


Ferjani S, Huang G, Shang Q, Xia P. SU-E-J-30: using shifting planned dose matrix to evaluate daily dose changes for IMRT prostate treatment. Med Phys 39:3659, 2012.


Ferjani S, Huang G, Shang Q, Xia P. TU-C-213CD-10: shifting MLC to follow the prostate movements while concurrently treating pelvic lymph nodes. Med Phys 39:3904, 2012.


Fine SW, Amin MB, Berney DM, Bjartell A, Egevad L, Epstein JI, Humphrey PA, Magi-Galluzzi C, Montironi R, Stief C. A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens. Eur Urol 62:20-39, 2012.


Fiocchi C. Genes and 'in-vironment': how will our concepts on the pathophysiology of inflammatory bowel disease develop in the future? Dig Dis 30(Suppl 3):2-11, 2012.


Fishman M, Jacono FJ, Park S, Jamasebi R, Thungtong A, Loparo KA, Dick TE. A method for analyzing temporal patterns of variability of a time series from Poincare plots. J Appl Physiol 113:297-306, 2012. PMCID: PMC3404703


Flechner SM, Campbell SC. The use of kidneys with small renal tumors for transplantation: who is taking the risk? Am J Transplant 12:48-54, 2012.


Fleming VA, Geng C, Ladd AN, Lou H. Alternative splicing of the neurofibromatosis type 1 pre-mRNA is regulated by the muscleblind-like proteins and the CUG-BP and ELAV-like factors. BMC Mol Biol 13:35, 2012. PMCID: PMC3558374


Flocke SA, Antognoli E, Step MM, Marsh S, Parran T, Mason MJ. A teachable moment communication process for smoking cessation talk: description of a group randomized clinician-focused intervention. BMC Health Serv Res 12:109, 2012. PMCID: PMC3529679


Fogh SE, Kubicek GJ, Champ C, Intenzo C, Axelrod R, Keane WM, Machtay MM. Value of fluoro-2-deoxy-d-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer. Am J Clin Oncol 35:311-315, 2012.


Fontes AM, Melo FU, Greene LJ, Faça VM, Lin Y, Gerson SL, Covas DT. Production of human factor VIII-FL in 293T cells using the bicistronic MGMT(P140K)-retroviral vector. Genet Mol Res 11:775-789, 2012.


Forero-Torres A, de Vos S, Pohlman BL, Pashkevich M, Cronier DM, Dang NH, Carpenter SP, Allan BW, Nelson JG, Slapak CA, Smith MR, Link BK, Wooldridge JE, Ganjoo KN. Results of a Phase 1 study of AME-133v (LY2469298), an Fc-engineered humanized monoclonal anti-CD20 antibody, in FcγRIIIa-genotyped patients with previously treated follicular lymphoma. Clin Cancer Res 18:1395-1403, 2012.


Freire M, Rubin B, Lietman S, Sundaram M. Solitary glomus tumor recurring as multiple glomus tumors. Skeletal Radiol 41:1333-1337, 2012.


Freytes CO, Zhang MJ, Carreras J, Burns LJ, Gale RP, Isola L, Perales MA, Seftel M, Vose JM, Miller AM, Gibson J, Gross TG, Rowlings PA, Inwards DJ, Pavlovsky S, Martino R, Marks DI, Hale GA, Smith SM, Schouten HC, Slavin S, Klumpp TR, Lazarus HM, van Besien K, Hari PN. Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure. Biol Blood Marrow Transplant 18:1255-1264, 2012. PMCID: PMC3376237


Fridley BL, Chalise P, Tsai YY, Sun Z, Vierkant RA, Larson MC, Cunningham JM, Iversen ES, Fenstermacher D, Barnholtz-Sloan J, Asmann Y, Risch HA, Schildkraut JM, Phelan CM, Sutphen R, Sellers TA, Goode EL. Germline copy number variation and ovarian cancer survival. Front Genet 3:142, 2012. PMCID: PMC3413872


Fritchie KJ, Carver P, Sun Y, Batiouchko G, Billings SD, Rubin BP, Tubbs RR, Goldblum JR. Solitary fibrous tumor: is there a molecular relationship with cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma? Am J Clin Pathol 137:963-970, 2012.


Fritchie KJ, Goldblum JR, Tubbs RR, Sun Y, Carver P, Billings SD, Rubin BP. The expanded histologic spectrum of myxoid liposarcoma with an emphasis on newly described patterns: implications for diagnosis on small biopsy specimens. Am J Clin Pathol 137:229-239, 2012.


Frullano L, Zhu J, Wang C, Wu C, Miller RHWang Y. Myelin imaging compound (MIC) enhanced magnetic resonance imaging of myelination. J Med Chem 55:94-105, 2012.

Galanter JM, Fernandez-Lopez JC, Gignoux CR, Barnholtz-Sloan J, Fernandez-Rozadilla C, Via M, Hidalgo-Miranda A, Contreras AV, Figueroa LU, Raska P, Jimenez-Sanchez G, Zolezzi IS, Torres M, Ponte CR, Ruiz Y, Salas A, Nguyen E, Eng C, Borjas L, Zabala W, Barreto G, González FR, Ibarra A, Taboada P, Porras L, Moreno F, Bigham A, Gutierrez G, Brutsaert T, León-Velarde F, Moore LG, Vargas E, Cruz M, Escobedo J, Rodriguez-Santana J, Rodriguez-Cintrón W, Chapela R, Ford JG, Bustamante C, Seminara D, Shriver M, Ziv E, Burchard EG, Haile R, Parra E, Carracedo A; LACE Consortium. Development of a panel of genome-wide ancestry informative markers to study admixture throughout the Americas. PLoS Genet 8:e1002554, 2012. PMCID: PMC3297575


Galsky MD, Chen GJ, Oh WK, Bellmunt J, Roth BJ, Petrioli R, Dogliotti L, Dreicer R, Sonpavde G. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma. Ann Oncol 23:406-410, 2012.


Ganti S, Taylor SL, Kim K, Hoppel CL, Guo L, Yang J, Evans C, Weiss RH. Urinary acylcarnitines are altered in human kidney cancer. Int J Cancer 130:2791-2800, 2012. PMCID: PMC3258465


Garcia JA, Mekhail T, Elson P, Wood L, Bukowski RM, Dreicer RRini BI. Phase I/II trial of subcutaneous interleukin-2, granulocyte-macrophage colony-stimulating factor and interferon-α in patients with metastatic renal cell carcinoma. BJU Int 109:63-69, 2012.


Garcia JARini BI. Castration-resistant prostate cancer: many treatments, many options, many challenges ahead. Cancer 118:2583-2593, 2012.


Gartner EM, Silverman P, Simon M, Flaherty L, Abrams J, Ivy P, Lorusso PM. A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer. Breast Cancer Res Treat 131:933-937, 2012.


Gatbonton-Schwager TN, Letterio JJTochtrop GP. Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo. J Nat Prod 75:591-598, 2012.


Geng H, Brennan S, Milne TA, Chen WY, Li Y, Hurtz C, Kweon SM, Zickl L, Shojaee S, Neuberg D, Huang C, Biswas D, Xin Y, Racevskis J, Ketterling RP, Luger SM, Lazarus H, Tallman MS, Rowe JM, Litzow MR, Guzman ML, Allis CD, Roeder RG, Müschen M, Paietta E, Elemento O, Melnick AM. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia. Cancer Discov 2:1004-1023, 2012. PMCID: PMC3516186


Germing U, Lauseker M, Hildebrandt B, Symeonidis A, Cermak J, Fenaux P, Kelaidi C, Pfeilstöcker M, Nösslinger T, Sekeres M, Maciejewski J, Haase D, Schanz J, Seymour J, Kenealy M, Weide R, Lübbert M, Platzbecker U, Valent P, Götze K, Stauder R, Blum S, Kreuzer KA, Schlenk R, Ganser A, Hofmann WK, Aul C, Krieger O, Kündgen A, Haas R, Hasford J, Giagounidis A. Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study. Leukemia 26:1286-1292, 2012.


Gerstenblith MR, Rajaraman P, Khaykin E, Doody MM, Alexander BH, Linet MS, Freedman DM. Basal cell carcinoma and anthropometric factors in the U.S. radiologic technologists cohort study. Int J Cancer 131:E149-E155, 2012.


Ghosh SK, Yohannes E, Bebek G, Weinberg A, Jiang B, Willard BChance MR, Kinter MT, McCormick TS. Proteomic and bioinformatic profile of primary human oral epithelial cells. J Proteome Res 11:5492-5502, 2012. PMCID: PMC3508721


Giovinazzi S, Lindsay CR, Morozov VM, Escobar-Cabrera E, Summers MK, Han HS, McIntosh LP, Ishov AM. Regulation of mitosis and taxane response by Daxx and Rassf1. Oncogene 31:13-26, 2012.


Glasgow RE, Green LW, Taylor MV, Stange KC. An evidence integration triangle for aligning science with policy and practice. Am J Prev Med 42:646-654, 2012.


Goc A, Liu J, Byzova TV, Somanath PR. Akt1 mediates prostate cancer cell microinvasion and chemotaxis to metastatic stimuli via integrin β₃ affinity modulation. Br J Cancer 107:713-723, 2012. PMCID: PMC3419951


Gold MA, Brady WE, Lankes HA, Rose PG, Kelley JL, De Geest K, Crispens MA, Resnick KE, Howell SB. A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 125:635-639, 2012.


Gould N, Sill MW, Mannel RS, Thaker PH, Disilvestro P, Waggoner S, Yamada SD, Armstrong DK, Wenzel L, Huang H, Fracasso PM, Walker JL. A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 125:54-58, 2012.


N, Sill MW, Mannel RS, Thaker PH, Disilvestro PA, Waggoner SE, Yamada SD, Armstrong DK, Fracasso PM, Walker JL. A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 127:506-510, 2012.


Goulet A, Behnke-Parks WM, Sindelar CV, Major J, Rosenfeld SS, Moores C. The structural basis of force generation by the mitotic motor kinesin-5. J Biol Chem 287:44654-44666, 2012. PMCID: PMC3531780


Goyal K, Einstein D, Ibarra RA, Yao MKunos CEllis R, Brindle J, Singh D, Hardacre J, Zhang Y, Fabians J, Funkhouser G, Machtay M, Sanabria JR. Stereotactic body radiation therapy for nonresectable tumors of the pancreas. J Surg Res 174:319-325, 2012.


Grant PM, Komarow L, Lederman MM, Pahwa S, Zolopa AR, Andersen J, Asmuth DM, Devaraj S, Pollard RB, Richterman A, Kanthikeel S, Sereti I. Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164. J Infect Dis 206:1715-1723, 2012. PMCID: PMC3488199


Granzin J, Huang Y, Topbas C, Huang W, Wu Z, Misra S, Hazen SL, Blanton RE, Lee X, Weiergräber OH. Three-dimensional structure of a schistosome serpin revealing an unusual configuration of the helical subdomain. Acta Crystallogr D Biol Crystallogr 68:686-694, 2012. PMCID: PMC3370883


Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M,Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D. Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes. Blood 120:2454-2465, 2012.


Greer KB, Cooper GS. Receipt of colonoscopy is key to reduction of colorectal cancer mortality. Gastrointest Endosc 76:365-366, 2012.


Greer KB, Thompson CL, Brenner L, Bednarchik B, Dawson DWillis J, Grady WM, Falk GW, Cooper GS, Li LChak A. Association of insulin and insulin-like growth factors with Barrett's oesophagus. Gut 61:665-672, 2012.


Gromova P, Rubin BP, Thys A, Cullus P, Erneux C, Vanderwinden JM. ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumors. J Cell Mol Med 16:306-317, 2012.


Grossman SA, Ye X, Peereboom D, Rosenfeld MR, Mikkelsen T, Supko JG, Desideri S; Adult Brain Tumor Consortium. Phase I study of terameprocol in patients with recurrent high-grade glioma. Neuro Oncol 14:511-517, 2012. PMCID: PMC3309850


Gruver AM, Amin MB, Luthringer DJ, Westfall D, Arora K, Farver CF, Osunkoya AO, McKenney JK, Hansel DE. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. Arch Pathol Lab Med 136:1339-1346, 2012.


Gruver AM, Huba MA, Dogan A, Hsi ED. Fibrin-associated large B-cell lymphoma: part of the spectrum of cardiac lymphomas. Am J Surg Pathol 36:1527-1537, 2012.


Guan X, Chance MRBarnholtz-Sloan JS. Splitting random forest (SRF) for determining compact sets of genes that distinguish between cancer subtypes. J Clin Bioinforma 2:13, 2012. PMCID: PMC3444418


Guenthoer J, Diede SJ, Tanaka H, Chai X, Hsu L, Tapscott SJ, Porter PL. Assessment of palindromes as platforms for DNA amplification in breast cancer. Genome Res 22:232-245, 2012. PMCID: PMC3266031


Gulen MF, Bulek K, Xiao H, Yu M, Gao J, Sun L, Beurel E, Kaidanovich-Beilin O, Fox PL, Dicorleto PE, Wang JA, Qin JWald DN, Woodgett JR, Jope RS, Carman J, Dongre A, Li X. Inactivation of the enzyme GSK3α by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenance. Immunity 37:800-812, 2012. PMCID: PMC3512562


Guo S, Reddy CA, Chao STSuh JHBarnett GHVogelbaum MA, Videtic GM. Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases. Lung Cancer 77:389-393, 2012.


Guo S, Reddy CA, Kolar M, Woody N, Mahadevan A, Deibel FC, Dietz DW, Remzi FH, Suh JH. Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland Clinic experience. Radiat Oncol 7:110, 2012. PMCID: PMC3430560


Guo Y, Fu P, Zhu H, Reed E, Remick SC, Petros W, Mueller MD, Yu JJ. Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer. Oncol Rep 27:286-292, 2012.


Gupta K, Gulen F, Sun L, Aguilera R, Chakrabarti A, Kiselar J, Agarwal MK, Wald DN. GSK3 is a regulator of RAR-mediated differentiation. Leukemia 26:1277-1285, 2012.


Gupta K, Thakur VS, Bhaskaran N, Nawab A, Babcook MA, Jackson MWGupta S. Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms. PLoS One 7:e52572, 2012. PMCID: PMC3527608


Gupta R, Billis A, Shah RB, Moch H, Osunkoya AO, Jochum W, Hes O, Bacchi CE, de Castro MG, Hansel DE, Zhou M, Vankalakunti M, Salles PG, Cabrera RA, Gown AM, Amin MB. Carcinoma of the collecting ducts of bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. Am J Surg Pathol 36:1265-1278, 2012.

Haddad H, Garcia JA. Novel agents for the management of castration-resistant prostate cancer. Curr Opin Urol 22:175-182, 2012.


Haddad H, Rini BI. Current treatment considerations in metastatic renal cell carcinoma. Curr Treat Options Oncol 13:212-229, 2012.


Hakimi AA, Agalliu I, Ho GY, Ghavamian R, Yu C, Kattan MW, Rabbani F. Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy. J Urol 187:1234-1240, 2012.


Haldar SM, Jeyaraj D, Anand P, Zhu H, Lu Y, Prosdocimo DA, Eapen B, Kawanami D, Okutsu M, Brotto L, Fujioka H, Kerner J, Rosca MG, McGuinness OP, Snow RJ, Russell AP, Gerber AN, Bai X, Yan Z, Nosek TM, Brotto M, Hoppel CLJain MK. Kruppel-like factor 15 regulates skeletal muscle lipid flux and exercise adaptation. Proc Natl Acad Sci U S A 109:6739-6744, 2012. PMCID: PMC3340075


Hale GA, Shrestha S, Le-Rademacher J, Burns LJ, Gibson J, Inwards DJ, Freytes CO, Bolwell BJ, Hsu JW, Slavin S, Isola L, Rizzieri DA, Gale RP, Laport GG, Montoto S, Lazarus HM, Hari PN. Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR. Biol Blood Marrow Transplant 18:1036-1043.e1, 2012.


Hale JS, Li M, Lathia JD. The malignant social network: cell-cell adhesion and communication in cancer stem cells. Cell Adh Migr 6:346-355, 2012. PMCID: PMC3478257


Hale JS, Li M, Sinyuk M, Jahnen-Dechent W, Lathia JD, Silverstein RL. Context dependent role of the CD36 - thrombospondin - histidine-rich glycoprotein axis in tumor angiogenesis and growth. PLoS One 7:e40033, 2012. PMCID: PMC3393734


Hama A, Muramatsu H, Makishima H, Sugimoto Y, Szpurka H, Jasek M, O'Keefe C, Takahashi Y, Sakaguchi H, Doisaki S, Shimada A, Watanabe N, Kato K, Kiyoi H, Naoe T, Kojima S, Maciejewski JP. Molecular lesions in childhood and adult acute megakaryoblastic leukemia. Br J Haematol 156:316-325, 2012.


Hamerlik P, Lathia JD, Rasmussen R, Wu Q, Bartkova J, Lee M, Moudry P, Bartek J Jr, Fischer W, Lukas J, Rich JN, Bartek J. Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth. J Exp Med 209:507-520, 2012. PMCID: PMC3302235


Hamilton BK, Copelan EA. The role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia. Stem Cells 30:1581-1586, 2012.


Hamilton T, Li X, Novotny M, Pavicic PG Jr, Datta S, Zhao C, Hartupee J, Sun D. Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression. J Leukoc Biol 91:377-383, 2012. PMCID: PMC3409633


Han Y, Yang K, Proweller A, Zhou G, Jain MKRamirez-Bergeron DL. Inhibition of ARNT severely compromises endothelial cell viability and function in response to moderate hypoxia. Angiogenesis 15:409-420, 2012.


Harrison KL, Geller G, Marshall P, Tilburt J, Mercer M, Brinich MA, Highland J, Farrell RM, Sharp RR. Ethical discourse about the modification of food for therapeutic purposes: how patients with gastrointestinal diseases view the good, the bad, and the healthy. AJOB Prim Res 3:12-20, 2012. PMCID: PMC3389757


Harshman LC, Xie W, Bjarnason GA, Knox JJ, Mackenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK. Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study. Lancet Oncol 13:927-935, 2012.


Hartung DM, Guise JM, Fagnan LJ, Davis MM, Stange KC. Role of practice-based research networks in comparative effectiveness research. J Comp Eff Res 1:45-55, 2012. PMCID: PMC3478766


Hartz A, He T, Rimm A. Comparison of adiposity measures as risk factors in postmenopausal women. J Clin Endocrinol Metab 97:227-233, 2012. PMCID: PMC3251939


Hashemi-Sadraei N, Pennell NA. Advanced non-small cell lung cancer (NSCLC): maintenance therapy for all? Curr Treat Options Oncol 13:478-490, 2012.


Hassan C, Rex DK, Cooper GS, Benamouzig R. Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis. Endoscopy 44:456-464, 2012.


Hassan C, Rex DK, Cooper GS, Zullo A, Launois R, Benamouzig R. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis. Gut 61:1172-1179, 2012.


Hassan C, Rex DK, Zullo A, Cooper GS. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists. Cancer 118:4404-4411, 2012.


Haugstad KE, Gerken TA, Stokke BT, Dam TK, Brewer CF, Sletmoen M. Enhanced self-association of mucins possessing the T and Tn carbohydrate cancer antigens at the single-molecule level. Biomacromolecules 13:1400-1409, 2012. PMCID: PMC3364602


Hayashi H, Sakai T. Biological significance of local TGF-β activation in liver diseases. Front Physiol 3:12, 2012. PMCID: PMC3277268


Hayes M, Pyon YS, Li J. A model-based clustering method for genomic structural variant prediction and genotyping using paired-end sequencing data. PLoS One 7:e52881, 2012. PMCID: PMC3531386


Hdeib A, Sloan A. Targeted radioimmunotherapy: the role of 131I-chTNT-1/B mAb (Cotara) for treatment of high-grade gliomas. Future Oncol 8:659-669, 2012.


He H, Osunkoya AO, Carver P, Falzarano S, Klein EMagi-Galluzzi C, Zhou M. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN. BJU Int 110:E751–E755, 2012.


He X, Saji M, Radhakrishnan D, Romigh T, Ngeow J, Yu Q, Wang Y, Ringel MD, Eng C. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome. J Clin Endocrinol Metab 97:E2179-E2187, 2012. PMCID: PMC3485596


Heald B, Edelman E, Eng C. Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. Eur J Hum Genet 20:547-551, 2012. PMCID: PMC3330209


Hecht JR, Farrell JJ, Senzer N, Nemunaitis J, Rosemurgy A, Chung T, Hanna N, Chang KJ, Javle M, Posner M, Waxman I, Reid A, Erickson R, Canto M,Chak A, Blatner G, Kovacevic M, Thornton M. EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc 75:332-338, 2012.


Hector RE, Ray A, Chen BR, Shtofman R, Berkner KL, Runge KW. Mec1p associates with functionally compromised telomeres. Chromosoma 121:277-290, 2012. PMCID: PMC3350766


Heddleston JM, Wu Q, Rivera M, Minhas S, Lathia JDSloan AE, Iliopoulos O, Hjelmeland ABRich JN. Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential. Cell Death Differ 19:428-439, 2012. PMCID: PMC3229666M


Heilman JA, Derakhshan JD, Riffe MJ, Gudino N, Tkach J, Flask CADuerk JL, Griswold MA. Parallel excitation for B-field insensitive fat-saturation preparation. Magn Reson Med 68:631-638, 2012.


Heindl M, Händel N, Ngeow J, Kionke J, Wittekind C, Kamprad M, Rensing-Ehl A, Ehl S, Reifenberger J, Loddenkemper C, Maul J, Hoffmeister A, Aretz S, Kiess W, Eng C, Uhlig HH. Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome. Gastroenterology 142:1093-1096.e6, 2012.


Hekelman F, Werner JJZyzanski SJ. Implications of demographic shifts for the future of family medicine education. Fam Med 44:501-503, 2012.


Heng DY, Mackenzie MJ, Vaishampayan UN, Bjarnason GA, Knox JJ, Tan MH, Wood L, Wang Y, Kollmannsberger C, North S, Donskov F, Rini BI, Choueiri TK. Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy. Ann Oncol 23:1549-1555, 2012.


Henze J, Mühlenberg T, Simon S, Grabellus F, Rubin B, Taeger G, Schuler M, Treckmann J, Debiec-Rychter M, Taguchi T, Fletcher JA, Bauer S. p53 modulation as a therapeutic strategy in gastrointestinal stromal tumors. PLoS One 7:e37776, 2012. PMCID: PMC3360609


Hesson LB, Packham D, Pontzer E, Funchain P, Eng C, Ward RL. A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines. Biol Proced Online 14:5, 2012. PMCID: PMC3342897


Hickman RL Jr, Daly BJ, Douglas SL, Burant CJ. Evaluating the critical care family satisfaction survey for chronic critical illness. West J Nurs Res 34:377-395, 2012.


Hickman RL Jr, Daly BJ, Lee E. Decisional conflict and regret: consequences of surrogate decision making for the chronically critically ill. Appl Nurs Res 25:271-275, 2012. PMCID: PMC3171580


Hill BTSweetenham J. Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma. Leuk Lymphoma 53:763-769, 2012.


Hill BT, Weil AC, Kalaycio M, Cook JR. Pulmonary involvement by chronic lymphocytic leukemia/small lymphocytic lymphoma is a specific pathologic finding independent of inflammatory infiltration. Leuk Lymphoma 53:589-595, 2012.


Hjelmeland ABRich JN. The quest for self-identity: not all cancer stem cells are the same. Clin Cancer Res 18:3495-3498, 2012. PMCID: PMC3389128


Hobert JA, Mester JL, Moline J, Eng C. Elevated plasma succinate in PTEN, SDHB, and SDHD mutation-positive individuals. Genet Med 14:616-619, 2012.


Hofmann CM, Anderson JM, Marchant RE. Targeted delivery of vancomycin to Staphylococcus epidermidis biofilms using a fibrinogen-derived peptide. J Biomed Mater Res A 100:2517-2525, 2012. PMCID: PMC3461832


Hofmann CM, Bednar KJ, Anderson JM, Marchant RE. Disruption of Staphylococcus epidermidis biofilm formation using a targeted cationic peptide. J Biomed Mater Res A 100:1061-1067, 2012.


Holt B, Gupta AS. Streptokinase loading in liposomes for vascular targeted nanomedicine applications: encapsulation efficiency and effects of processing. J Biomater Appl 26:509-527, 2012.


Homer CR, Kabi A, Marina-García N, Sreekumar A, Nesvizhskii AI, Nickerson KP, Chinnaiyan AM, Nuñez G, McDonald C. A dual role for receptor-interacting protein kinase 2 (RIP2) kinase activity in nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy. J Biol Chem 287:25565-25576, 2012. PMCID: PMC3408141


Hong DS, Kurzrock R, Supko JG, He X, Naing A, Wheler J, Lawrence D, Eder JP, Meyer CJ, Ferguson DA, Mier J, Konopleva M, Konoplev S, Andreeff M, Kufe D, Lazarus H, Shapiro GI, Dezube BJ. A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas. Clin Cancer Res 18:3396-3406, 2012.


Hopman SM, Van Rijn RR, Eng C, Bras J, Alders M, van der Horst CM, Hennekam RC, Merks JH. PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon. Am J Med Genet A 158A:1719-1723, 2012.


Hornberger J, Lyman GH, Chien R, Meropol NJ. A multigene prognostic assay for selection of adjuvant chemotherapy in patients with T3, Stage II colon cancer: Impact on quality-adjusted life expectancy and costs. Value Health 15:1014-1021, 2012.


Hota PK, Buck M. Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions. Cell Mol Life Sci 69:3765-3805, 2012.


Houlston RS; members of COGENT (Aaltonen LA, Brenner H, Buch S, Campbell H, Carracedo A, Carvajal-Carmona L, Castells A, Castellví-Bel S, Cheadle JP, Devilee P, Dunlop M, Echeverry MM, Gallinger S, Galvan A, Hampe J, Hemminki K, Ho JW, Hofstra RM, Hudson TJ, Kirac I, Lerch MM, Li L, et al). COGENT (COlorectal cancer GENeTics) revisited. Mutagenesis 27:143-151, 2012. PMCID: PMC3269000


Hovlid ML, Steinmetz NF, Laufer B, Lau JL, Kuzelka J, Wang Q, Hyypiä T, Nemerow GR, Kessler H, Manchester M, Finn MG. Guiding plant virus particles to integrin-displaying cells. Nanoscale 4:3698-3705, 2012. PMCID: PMC3567620


Hsiao W, Goldstein M, Rosoff JS, Piccorelli A, Kattan MW, Greenwood EA, Mulhall JP. Nomograms to predict patency after microsurgical vasectomy reversal. J Urol 187:607-612, 2012.


Hu Z, Saunthararajah Y. CEBPE activation in PML-RARA cells by arsenic. Blood 119:2177-2179, 2012.


Huang AY, Myers JT, Barkauskas D, Howell SJ, Oleinick NL, McCormick TS, Cooper KDBaron EDLam M. Cutaneous penetration of the topically applied photosensitizer Pc 4 as detected by intravital 2-photon laser scanning microscopy. Photodiagnosis Photodyn Ther 9:225-231, 2012. PMCID: PMC3438456


Huang HM, Chandramouli V, Ismail-Beigi F, Muzic RF. Hyperglycemia-induced stimulation of glucose transport in skeletal muscle measured by PET-[18F]6FDG and [18F]2FDG. Physiol Meas 33:1661-1673, 2012. PMCID: PMC3486741


Huang P, Rani MR, Ahluwalia MS, Bae E, Prayson RA, Weil RJ, Nowacki AS, Hedayat H, Sloan AELathia JDRich JN, Tipps R, Gladson CL. Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin α6β1 in glioblastoma. Cancer Res 72:1428-1437, 2012. PMCID: PMC3428239


Huang Z, Bao S. Ubiquitination and deubiquitination of REST and its roles in cancers. FEBS Lett 586:1602-1605, 2012. PMCID: PMC3361610


Hubbard MO, Fu P, Margevicius S, Dowlati A, Linden PA. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival. J Thorac Cardiovasc Surg 143:1307-1313, 2012.


Hunter GK, Reddy CA, Klein EA, Kupelian P, Angermeier K, Ulchaker J, Chehade N, Altman A, Ciezki JP. Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer. Prostate Cancer 2012:853487, 2012. PMCID: PMC3345236


Hunter GK, Suh JH, Reuther AM, Vogelbaum MA, Barnett GH, Angelov L, Weil RJ, Neyman G, Chao ST. Treatment of five or more brain metastases with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83:1394-1398, 2012.


Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark-Wahnefried W, Kakarala M, Brodie A, Berger NA. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (Phila) 5:1260-1272, 2012.


Ibarra RA, Rojas D, Snyder L, Yao M, Fabien J, Milano M, Katz A, Goodman K, Stephans K, El-Gazzaz G, Aucejo F, Miller C, Fung J, Lo S, Machtay M, Sanabria JR. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol 51:575-583, 2012.


Isariyawongse BK, Kattan MW. Prediction tools in surgical oncology. Surg Oncol Clin N Am 21:439-447, viii-ix, 2012.


Ishii A, Fyffe-Maricich SL, Furusho M, Miller RH, Bansal R. ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination. J Neurosci 32:8855-8864, 2012. PMCID: PMC3521511


Ivkovic S, Beadle C, Noticewala S, Massey SC, Swanson KR, Toro LN, Bresnick AR, Canoll P, Rosenfeld SS. Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens. Mol Biol Cell 23:533-542, 2012. PMCID: PMC3279383


Iwafuchi-Doi M, Matsuda K, Murakami K, Niwa H, Tesar PJ, Aruga J, Matsuo I, Kondoh H. Transcriptional regulatory networks in epiblast cells and during anterior neural plate development as modeled in epiblast stem cells. Development 139:3926-3937, 2012.

Jabbour MN, Zaatari GS, Tfayli AH, Abdul-Karim FW. Testicular fibroma. J Urol 188:1944-1945, 2012.


Jacobberger JW, Avva J, Sreenath SN, Weis MC, Stefan T. Dynamic epitope expression from static cytometry data: principles and reproducibility. PLoS One 7:e30870, 2012. PMCID: PMC3275612


Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang MJ, Antin JH, Bolwell BJ, Bredeson C, Cahn JY, Cairo M, Gale RP, Gupta V, Lee SJ, Litzow M, Weisdorf DJ, Horowitz MM, Hahn T. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 119:296-307, 2012. PMCID: PMC3251233


Jagasia MH, Abonour R, Long GD, Bolwell BJ, Laport GG, Shore TB, Durrant S, Szer J, Chen MG, Lizambri R, Waller EK. Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial. Bone Marrow Transplant 47:1350-1355, 2012.


Jayapandian CP, Zhao M, Ewing RM, Zhang GQ, Sahoo SS. A semantic proteomics dashboard (SemPoD) for data management in translational research. BMC Syst Biol 6(Suppl 3):S20, 2012. PMCID: PMC3524316


Jeon O, Alt DS, Ahmed SM, Alsberg E. The effect of oxidation on the degradation of photocrosslinkable alginate hydrogels. Biomaterials 33:3503-3514, 2012.


Jeong SI, Jeon O, Krebs MD, Hill MC, Alsberg E. Biodegradable photo-crosslinked alginate nanofibre scaffolds with tuneable physical properties, cell adhesivity and growth factor release. Eur Cell Mater 24:331-343, 2012. PMCID: PMC3538854


Jerez A, Clemente MJ, Makishima H, Koskela H, Leblanc F, Ng KP, Olson T, Przychodzen B, Afable M, Gomez-Segui I, Guinta K, Durkin L, Hsi ED, McGraw K, Zhang D, Wlodarski MW, Porkka K, Sekeres MA, List A, Mustjoki S, Loughran TP, Maciejewski JP. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood 120:3048-3057, 2012. PMCID: PMC3471515


Jerez A, Gondek LP, Jankowska AM, Makishima H, Przychodzen B, Tiu RV, O'Keefe CL, Mohamedali AM, Batista D, Sekeres MA, McDevitt MA, Mufti GJ,Maciejewski JP. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited. J Clin Oncol 30:1343-1349, 2012. PMCID: PMC3341146


Jerez A, Sugimoto Y, Makishima H, Verma A, Jankowska AM, Przychodzen B, Visconte V, Tiu RV, O'Keefe CL, Mohamedali AM, Kulasekararaj AG, Pellagatti A, McGraw K, Muramatsu H, Moliterno AR, Sekeres MA, McDevitt MA, Kojima S, List A, Boultwood J, Mufti GJ, Maciejewski JP. Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood 119:6109-6117, 2012. PMCID: PMC3383019


Ji J, Sun HK, Smith JS, Wang H, Esser MT, Hu S, Pretorius RG, Chen W, Belinson JL, Qiao YL. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women. BMC Infect Dis 12:137, 2012. PMCID: PMC3482566


Ji Y, Nordgren KK, Chai Y, Hebbring SJ, Jenkins GD, Abo RP, Peng Y, Pelleymounter LL, Moon I, Eckloff BW, Chai X, Zhang J, Fridley BL, Yee VC, Wieben ED, Weinshilboum RM. Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlation. Drug Metab Dispos 40:1984-1992, 2012. PMCID: PMC3463826


Jia H, Wang X, Anderson JT, Jankowsky E. RNA unwinding by the Trf4/Air2/Mtr4 polyadenylation (TRAMP) complex. Proc Natl Acad Sci U S A 109:7292-7297, 2012. PMCID: PMC3358879


Jia J, Arif A, Willard B, Smith JD, Stuehr DJ, Hazen SL, Fox PL. Protection of extraribosomal RPL13a by GAPDH and dysregulation by S-nitrosylation. Mol Cell 47:656-663, 2012.


Jin X, Abbot S, Zhang X, Kang L, Voskinarian-Berse V, Zhao R, Kameneva MV, Moore LR, Chalmers JJ, Zborowski M. Erythrocyte enrichment in hematopoietic progenitor cell cultures based on magnetic susceptibility of the hemoglobin. PLoS One 7:e39491, 2012. PMCID: PMC3428333


Jin X, Chalmers JJ, Zborowski M. Iron transport in cancer cell culture suspensions measured by cell magnetophoresis. Anal Chem 84:4520-4526, 2012. PMCID: PMC3556788


Johnson AC, Davison LM, Giltiay NV, Vareechon C, Li X, Jørgensen TN. Lack of T cells in Act1-deficient mice results in elevated IgM-specific autoantibodies but reduced lupus-like disease. Eur J Immunol 42:1695-1705, 2012.


Johnson DH, Narayan S, Wilson DLFlask CA. Body composition analysis of obesity and hepatic steatosis in mice by relaxation compensated fat fraction (RCFF) MRI. J Magn Reson Imaging 35:837-843, 2012. PMCID: PMC3288219


Jonasch E, Futreal PA, Davis IJ, Bailey ST, Kim WY, Brugarolas J, Giaccia AJ, Kurban G, Pause A, Frydman J, Zurita AJ, Rini BI, Sharma P, Atkins MB, Walker CL, Rathmell WK. State of the science: an update on renal cell carcinoma. Mol Cancer Res 10:859-880, 2012. PMCID: PMC3399969


Jones S, Li M, Parsons DW, Zhang X, Wesseling J, Kristel P, Schmidt MK, Markowitz S, Yan H, Bigner D, Hruban RH, Eshleman JR, Iacobuzio-Donahue CA, Goggins M, Maitra A, Malek SN, Powell S, Vogelstein B, Kinzler KW, Velculescu VE, Papadopoulos N. Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat 33:100-103, 2012. PMCID: PMC3240719


Joo KM, Jin J, Kim E, Ho Kim K, Kim Y, Gu Kang B, Kang YJ, Lathia JD, Ho Cheong K, Song PH, Kim H, Seol HJ, Kong DS, Lee JI, Rich JNLee J, Nam DH. MET signaling regulates glioblastoma stem cells. Cancer Res 72:3828-3838, 2012.

Kabi A, McDonald C. FRMBP2 directs NOD2 to the membrane. Proc Natl Acad Sci U S A 109:21188-21189, 2012. PMCID: PMC3535667


Kabi A, Nickerson KP, Homer CR, McDonald C. Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes. Inflamm Bowel Dis 18:782-792, 2012. PMCID: PMC3245781


Kahana E, Kelley-Moore J, Kahana B. Proactive aging: a longitudinal study of stress, resources, agency, and well-being in late life. Aging Ment Health 16:438-451, 2012.


Kang Z, Swaidani S, Yin W, Wang C, Barlow JL, Gulen MF, Bulek K, Do JS, Aronica M, McKenzie AN, Min B, Li X. Epithelial cell-specific Act1 adaptor mediates interleukin-25-dependent helminth expulsion through expansion of Lin(-)c-Kit(+) innate cell population. Immunity 36:821-833, 2012. PMCID: PMC3376903


Kannan S, Staugaitis SM, Weil RJ, Hatipoglu B. A rare corticotroph-secreting tumor with coexisting prolactin and growth hormone staining cells. Case Report Endocrinol 2012:529730, 2012. PMCID: PMC3534206


Kantarjian H, Thomas D, Jorgensen J, Jabbour E, Kebriaei P, Rytting M, York S, Ravandi F, Kwari M, Faderl S, Rios MB, Cortes J, Fayad L, Tarnai R, Wang SA, Champlin R, Advani A, O'Brien S. Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukemia: a phase 2 study. Lancet Oncol 13:403-411, 2012.


Kanwal R, Gupta S. Epigenetic modifications in cancer. Clin Genet 81:303-311, 2012. PMCID: PMC3590802


Kattan MW, Gerds TA. Stages of prediction model comparison. Eur Urol 62:597-600, 2012.


Kattan MW, Potters L. Validation and comparison of the two Kattan nomograms in patients with prostate cancer treated with (125) iodine brachytherapy. BJU Int 109:1665, 2012.


Kaur H, Burden-Gulley SM, Phillips-Mason PJ, Basilion JPSloan AEBrady-Kalnay SM. Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo. Neuro Oncol 14:561-573, 2012. PMCID: PMC3337312


Kaur H, Phillips-Mason PJ, Burden-Gulley SM, Kerstetter-Fogle AE, Basilion JPSloan AEBrady-Kalnay SM. Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo. Mol Cancer Res 10:293-304, 2012. PMCID: PMC3307867


Kaur P, Schlatzer D, Cooke KChance MR. Pairwise protein expression classifier for candidate biomarker discovery for early detection of human disease prognosis. BMC Bioinformatics 13:191, 2012. PMCID: PMC3468399


Kaye J, Meslin EM, Knoppers BM, Juengst ET, Deschênes M, Cambon-Thomsen A, Chalmers D, De Vries J, Edwards K, Hoppe N, Kent A, Adebamowo C, Marshall P, Kato K. Research priorities. ELSI 2.0 for genomics and society. Science 336:673-674, 2012.


Kaz AM, Luo Y, Dzieciatkowski S, Chak AWillis JE, Upton MP, Leidner RS, Grady WM. Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma. Genes Chromosomes Cancer 51:384-393, 2012. PMCID: PMC3292431


Keever-Taylor CA, Devine SM, Soiffer RJ, Mendizabal A, Carter S, Pasquini MC, Hari PN, Stein A, Lazarus HM, Linker C, Goldstein SC, Stadtmauer EA, O'Reilly RJ. Characteristics of CliniMACS® system CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303. Biol Blood Marrow Transplant 18:690-697, 2012.


Kenyon J, Fu P, Lingas K, Thomas E, Saurastri A, Santos Guasch G, Wald DGerson SL. Humans accumulate microsatellite instability with acquired loss of MLH1 protein in hematopoietic stem and progenitor cells as a function of age. Blood 120:3229-3236, 2012. PMCID: PMC3476537


Kerr BA, Byzova TV. The dark side of the oxidative force in angiogenesis. Nat Med 18:1184-1185, 2012.


Kersey-Barrett T, Glick A, Wald DMeyerson H, Tcheurekdjian H. Hypereosinophilic syndrome associated with regulatory T-cell disruption as a complication of stem cell transplantation. J Investig Allergol Clin Immunol 22:453-455, 2012.


Kesaraju P, Jaini R, Johnson JM, Altuntas CZ, Gruden JJ, Sakalar C, Tuohy VK. Experimental autoimmune breast failure: a model for lactation insufficiency, postnatal nutritional deprivation, and prophylactic breast cancer vaccination. Am J Pathol 181:775-784, 2012. PMCID: PMC3432428


Ketchart W, Smith KM, Krupka T, Wittmann BM, Hu Y, Rayman PA, Doughman YQ, Albert JM, Bai X, Finke JHXu YExner AAMontano MM. Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis. Oncogene (10 September 2012) doi:10.1038/onc. 2012.405. PMCID: PMC3525740


Khairallah RJ, Kim J, O'Shea KM, O'Connell KA, Brown BH, Galvao T, Daneault C, Des Rosiers C, Polster BM, Hoppel CL, Stanley WC. Improved mitochondrial function with diet-induced increase in either docosahexaenoic acid or arachidonic acid in membrane phospholipids. PLoS One 7:e34402, 2012. PMCID: PMC3316678


Khan N, Khan MK, Bena J, Macklis R, Singh AD. Plaque brachytherapy for uveal melanoma: a vision prognostication model. Int J Radiat Oncol Biol Phys 84:e285-e290, 2012.


Khurana S, Bruggeman LA, Kao HY. Nuclear hormone receptors in podocytes. Cell Biosci 2:33, 2012. PMCID: PMC3543367


Khurana S, Chakraborty S, Lam M, Liu Y, Su YT, Zhao X, Saleem MA, Mathieson PW, Bruggeman LA, Kao HY. Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors. J Biol Chem 287:12027-12035, 2012. PMCID: PMC3320949


Khurana S, Chakraborty S, Zhao X, Liu Y, Guan D, Lam M, Huang W, Yang SKao HY. Identification of a novel LXXLL motif in α-actinin 4-spliced isoform that is critical for its interaction with estrogen receptor α and co-activators. J Biol Chem 287:35418-35429, 2012. PMCID: PMC3471738


Kibel AS, Ciezki JPKlein EA, Reddy CA, Lubahn JD, Haslag-Minoff J, Deasy JO, Michalski JM, Kallogjeri D, Piccirillo JF, Rabah DM, Yu C, Kattan MW,Stephenson AJ. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol 187:1259-1265, 2012.


Kim H, Park S, Lo S, Monroe J, Sohn J. SU-E-J-113: a new quantification measure of the difference between two organ contours. Med Phys 39:3678, 2012.


Kim HS, Park SB, Lo SS, Monroe JI, Sohn JW. Bidirectional local distance measure for comparing segmentations. Med Phys 39:6779-6790, 2012.


Kim JJ, Vaziri SA, Rini BIElson PGarcia JA, Wirka R, Dreicer R, Ganapathi MK, Ganapathi R. Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib. Cancer 118:1946-1954, 2012.


Kim TW, Yu M, Zhou H, Cui W, Wang J, DiCorleto P, Fox P, Xiao H, Li X. Pellino 2 is critical for Toll-like receptor/interleukin-1 receptor (TLR/IL-1R)-mediated post-transcriptional control. J Biol Chem 287:25686-25695, 2012. PMCID: PMC3408172


Kim Y, Kim E, Wu Q, Guryanova O, Hitomi M, Lathia JD, Serwanski D, Sloan AEWeil RJLee J, Nishiyama A, Bao SHjelmeland ABRich JN. Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity. Genes Dev 26:1247-1262, 2012. PMCID: PMC3371412


Kim Y, Kim KH, Lee J, Lee YA, Kim M, Lee SJ, Park K, Yang H, Jin J, Joo KM, Lee J, Nam DH. Wnt activation is implicated in glioblastoma radioresistance. Lab Invest 92:466-473, 2012.


Kindwall-Keller TL, Hegerfeldt Y, Meyerson HJ, Margevicius S, Fu P, van Heeckeren W, Lazarus HM, Cooper BWGerson SL, Barr P, Tse WW, Curtis C, Fanning LR, Creger RJ, Carlson-Barko JM, Laughlin MJ. Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies. Bone Marrow Transplant 47:924-933, 2012. PMCID: PMC3262108


Kiser PD, Farquhar ER, Shi W, Sui X, Chance MR, Palczewski K. Structure of RPE65 isomerase in a lipidic matrix reveals roles for phospholipids and iron in catalysis. Proc Natl Acad Sci U S A 109:E2747-E2756, 2012. PMCID: PMC3478654


Kish DD, Gorbachev AV, Fairchild RL. IL-1 receptor signaling is required at multiple stages of sensitization and elicitation of the contact hypersensitivity response. J Immunol 188:1761-1771, 2012. PMCID: PMC3273663


Kish DD, Gorbachev AV, Parameswaran N, Gupta NFairchild RL. Neutrophil expression of Fas ligand and perforin directs effector CD8 T cell infiltration into antigen-challenged skin. J Immunol 189:2191-2202 2012. PMCID: PMC3424302


Kisiel-Sajewicz K, Davis MP, Siemionow V, Seyidova-Khoshknabi D, Wyant A, Walsh D, Hou J, Yue GH. Lack of muscle contractile property changes at the time of perceived physical exhaustion suggests central mechanisms contributing to early motor task failure in patients with cancer-related fatigue. J Pain Symptom Manage 44:351-361 2012.


Klayton T, Li T, Yu JQ, Keller L, Cheng J, Cohen SJ, Meropol NJ, Scott W, Xu-Welliver M, Konski A. The role of qualitative and quantitative analysis of F18-FDG Positron Emission Tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma. J Gastrointest Cancer 43:612-618, 2012.


Klein EA. What is the best way to treat high-risk prostate cancer? Cancer 118:12-14, 2012.


Klink JC, Miocinovic R, Magi-Galluzzi CKlein EA. High-grade prostatic intraepithelial neoplasia. Korean J Urol 53:297-303, 2012. PMCID: PMC3364467


Klionsky DJ,…Almasan A,…Carlin CR,…Distelhorst CW,…McDonald C,…Oleinick NL,…Rubin BP,…Welford SM, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8:445-544, 2012. PMCID: PMC3404883


Kondalsamy-Chennakesavan S, Yu C, Kattan MW, Leung Y, Sykes P, Nascimento M, Nicklin J, Perrin L, Crandon A, Chetty N, Land R, Garrett A, Obermair A. Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer. Gynecol Oncol 125:520-525, 2012.


Konski A, Li T, Christensen M, Cheng JD, Yu JQ, Crawford K, Haluszka O, Tokar J, Scott W, Meropol NJ, Cohen SJ, Maurer A, Freedman GM. Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in (18)F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer. Radiother Oncol 104:72-77, 2012. PMCID: PMC3389132


Koroukian SM, Bakaki PM, Golchin N, Tyler C, Loue S. Mental illness and use of screening mammography among medicaid beneficiaries. Am J Prev Med 42:606-609, 2012.


Koroukian SM, Bakaki PM, Owusu C, Earle CC, Cooper GS. Cancer outcomes in low-income elders: is there an advantage to being on Medicaid? Medicare Medicaid Res Rev 2:E1-E22, 2012.


Koroukian SM, Bakaki PM, Raghavan D. Survival disparities by Medicaid status: an analysis of 8 cancers. Cancer 118:4271-4279, 2012. PMCID: PMC3323683


Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmäki H, Andersson EI, Lagström S, Clemente MJ, Olson T, Jalkanen SE, Majumder MM, Almusa H, Edgren H, Lepistö M, Mattila P, Guinta K, Koistinen P, Kuittinen T, Penttinen K, Parsons A, Knowles J, Saarela J, Wennerberg K, Kallioniemi O, Porkka K, Loughran TP Jr, Heckman CA, Maciejewski JP, Mustjoki S. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 366:1905-1913, 2012.


Kotsopoulos J, Lubinski J, Lynch HT, Kim-Sing C, Neuhausen S, Demsky R, Foulkes WD, Ghadirian P, Tung N, Ainsworth P, Senter L, Karlan B, Eisen A,Eng C, Weitzel J, Gilchrist DM, Blum JL, Zakalik D, Singer C, Fallen T, Ginsburg O, Huzarski T, Sun P, Narod SA. Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 21:1089-1096, 2012. PMCID: PMC3593267


Kotsopoulos J, Lubinski J, Salmena L, Lynch HT, Kim-Sing C, Foulkes WD, Ghadirian P, Neuhausen SL, Demsky R, Tung N, Ainsworth P, Senter L, Eisen A, Eng C, Singer C, Ginsburg O, Blum J, Huzarski T, Poll A, Sun P, Narod SA; the Hereditary Breast Cancer Clinical Study Group. Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 14:R42, 2012. PMCID: PMC3446376


Koyfman SA, Adelstein DJ. Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: a critical review. Int J Radiat Oncol Biol Phys 84:581-589, 2012.


Koyfman SA, Djemil T, Burdick MJ, Woody N, Balagamwala EH, Reddy CA, Angelov L, Suh JH, Chao ST. Marginal recurrence requiring salvage radiotherapy after stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys 83:297-302, 2012.


Kremer ME, Downs-Holmes C, Novak RD, Lyons JASilverman P, Pham RM, Plecha DM. Neglecting to screen women between the ages of 40 and 49 years with mammography: what is the impact on breast cancer diagnosis? AJR Am J Roentgenol 198:1218-1222, 2012.


Krishnamurthy N, Hu Y, Siedlak S, Doughman YQ, Watanabe M, Montano MM. Induction of quinone reductase by tamoxifen or DPN protects against mammary tumorigenesis. FASEB J 26:3993-4002, 2012.


Kshettry VR, Hardy S, Weil RJ, Angelov L, Barnett GH. Immediate titanium cranioplasty after debridement and craniectomy for postcraniotomy surgical site infection. Neurosurgery 70(1 Suppl Operative):8-15, 2012.


Kubicek GJ, Axelrod RS, Machtay M, Ahn PH, Anne PR, Fogh S, Cognetti D, Myers TJ, Curran WJ Jr, Dicker AP. Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies. Int J Radiat Oncol Biol Phys 83:1192-1197, 2012.


Kudo W, Lee HP, Smith MA, Zhu X, Matsuyama S, Lee HG. Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity. Cell Death Dis 3:e309, 2012. PMCID: PMC3366077


Kulkarni S, Augoff K, Rivera L, McCue B, Khoury T, Groman A, Zhang L, Tian L, Sossey-Alaoui K. Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer. PLoS One 7:e42895, 2012. PMCID: PMC3428347


Kummitha CM, Malamas AS, Lu ZR. Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles. Int J Nanomedicine 7:5205-5214, 2012. PMCID: PMC3464083


Kumon RE, Repaka A, Atkinson M, Faulx AL, Wong RC, Isenberg GA, Hsiao YS, Gudur MS, Deng CX, Chak A. Characterization of the pancreas in vivo using EUS spectrum analysis with electronic array echoendoscopes. Gastrointest Endosc 75:1175-1183, 2012.


Kumon RE, Repaka A, Atkinson M, Faulx AL, Wong RC, Isenberg GA, Hsiao YS, Gudur MS, Deng CX, Chak A. Lymph node characterization in vivo using endoscopic ultrasound spectrum analysis with electronic array echo endoscopes. Endoscopy 44:618-621, 2012.


Kunos C, Brindle JM, Debernardo R. Stereotactic radiosurgery for gynecologic cancer. J Vis Exp 62:3793, 2012. PMCID: PMC3466654


Kunos CRadivoyevitch TAbdul-Karim FW, Fanning J, Abulafia O, Bonebrake AJ, Usha L. Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group study. J Transl Med 10:79, 2012. PMCID: PMC3403898


Kunos CA, Brindle J, Waggoner SZanotti KResnick K, Fusco N, Adams R, Debernardo R. Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies. Front Oncol 2:181, 2012. PMCID: PMC3514687


Kunos CA, Debernardo R, Radivoyevitch T, Fabien J, Dobbins DC, Zhang Y, Brindle J. Hematological toxicity after robotic stereotactic body radiosurgery for treatment of metastatic gynecologic malignancies. Int J Radiat Oncol Biol Phys 84:e35-e41, 2012.


Kunos CARadivoyevitch T, Ingalls ST, Hoppel CL. Management of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone-induced methemoglobinemia. Future Oncol 8:145-150, 2012. PMCID: PMC3292053


Kunos CARadivoyevitch T, Kresak A, Dawson DJacobberger J, Yang B, Abdul-Karim FW. Elevated ribonucleotide reductase levels associate with suppressed radiochemotherapy response in human cervical cancers. Int J Gynecol Cancer 22:1463-1469, 2012. PMCID: PMC3481180


Kunos CA. Therapeutic mechanisms of treatment in cervical and vaginal cancer. Oncol Hematol Rev 8:55-60, 2012. PMCID: PMC3429879


Kurek KC, Howard E, Tennant LB, Upton J, Alomari AI, Burrows PE, Chalache K, Harris DJ, Trenor CC 3rd, Eng C, Fishman SJ, Mulliken JB, Perez-Atayde AR, Kozakewich HP. PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes. Am J Surg Pathol 36:671-687, 2012. PMCID: PMC3367317


Kwan WH, Hashimoto D, Paz-Artal E, Ostrow K, Greter M, Raedler H, Medof ME, Merad M, Heeger PS. Antigen-presenting cell-derived complement modulates graft-versus-host disease. J Clin Invest 122:2234-2238, 2012. PMCID: PMC3366405


Kyono A, Avishai N, Ouyang Z, Landreth GE, Murakami S. FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation. J Bone Miner Metab 30:19-30, 2012. PMCID: PMC3192226

Lamarre ED, Batra PS, Lorenz RR, Citardi MJ, Adelstein DJ, Srinivas SM, Scharpf J. Role of positron emission tomography in management of sinonasal neoplasms-a single institution's experience. Am J Otolaryngol 33:289-295, 2012.


Lamarre ED, Seth R, Lorenz RR, Esclamado R, Adelstein DJ, Rodriguez CP, Saxton J, Scharpf J. Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution. Am J Otolaryngol 33:98-103, 2012.


Lamers E, Walboomers XF, Domanski M, Prodanov L, Melis J, Luttge R, Winnubst L, Anderson JM, Gardeniers HJ, Jansen JA. In vitro and in vivo evaluation of the inflammatory response to nanoscale grooved substrates. Nanomedicine 8:308-317, 2012.


Lathia JD, Li M, Hall PE, Gallagher J, Hale JS, Wu Q, Venere M, Levy E, Rani MR, Huang P, Bae E, Selfridge J, Cheng L, Guvenc H, McLendon RE, Nakano I, Sloan AE, Phillips HS, Lai A, Gladson CL, Bredel M, Bao SHjelmeland ABRich JN. Laminin alpha 2 enables glioblastoma stem cell growth. Ann Neurol 72:766-778, 2012.


Lathia JDRich JN. Holding on to stemness. Nat Cell Biol 14:450-452, 2012.


Lavelle D, Vaitkus K, Ling Y, Ruiz MA, Mahfouz R, Ng KP, Negrotto S, Smith N, Terse P, Engelke KJ, Covey J, Chan KK, Desimone J, Saunthararajah Y. Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine. Blood 119:1240-1247, 2012. PMCID: PMC3277356


Lazarus HMAdvani AS. When, how, and what cell source for hematopoietic cell transplantation in first complete remission adult acute lymphoblastic leukemia? Hematology Am Soc Hematol Educ Program 2012:382-388, 2012.


Lazarus HM, Litzow MR. AML cytogenetics: the complex just got simpler. Blood 120:2357-2358, 2012.


Lazarus HM. Acute leukemia in adults: novel allogeneic transplant strategies. Hematology 17(Suppl 1):S47-S51, 2012.


Lee D, Das Gupta J, Gaughan C, Steffen I, Tang N, Luk KC, Qiu X, Urisman A, Fischer N, Molinaro R, Broz M, Schochetman G, Klein EA, Ganem D, Derisi JL, Simmons G, Hackett J Jr, Silverman RH, Chiu CY. In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer. PLoS One 7:e44954, 2012. PMCID: PMC3445615


Lee H, Zhang P, Herrmann A, Yang C, Xin H, Wang Z, Hoon DS, Forman SJ, Jove R, Riggs AD, Yu H. Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. Proc Natl Acad Sci U S A 109:7765-7769, 2012. PMCID: PMC3356652


Lee HJ, Hota PK, Chugha P, Guo H, Miao H, Zhang L, Kim SJ, Stetzik L, Wang BCBuck M. NMR structure of a heterodimeric SAM:SAM complex: characterization and manipulation of EphA2 binding reveal new cellular functions of SHIP2. Structure 20:41-55, 2012. PMCID: PMC3516615


Lee M, Cooper B, Becker D. Keeping abreast of axillary masses. Lancet 380:1530, 2012.


Lee Z, Dennis J, Welter J, Caplan A. Imaging stem cell differentiation for cell-based tissue repair. Methods Enzymol 506:247-263, 2012.


Leidner RS, Ravi L, Leahy P, Chen Y, Bednarchik B, Streppel M, Canto M, Wang JS, Maitra A, Willis JMarkowitz SDBarnholtz-Sloan J, Adams MD,Chak A, Guda K. The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis. Genes Chromosomes Cancer 51:473-479, 2012. PMCID: PMC3547654


Lennon DP, Schluchter MDCaplan AI. The effect of extended first passage culture on the proliferation and differentiation of human marrow-derived mesenchymal stem cells. Stem Cells Transl Med 1:279-288, 2012.


Leslie KK, Sill MW, Lankes HA, Fischer EG, Godwin AK, Gray H, Schilder RJ, Walker JL, Tewari K, Hanjani P, Abulafia O, Rose PG. Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer. Gynecol Oncol 127:345-350, 2012. PMCID: PMC3518448


Lewis CM, Bu D, Sarode V, Robinson L, Wilson KS, Viscusi RK, Eng C, Euhus DM. The clinical consequences of hemizygosity across 2 MB of 10q23 are restricted to Cowden syndrome. Breast Cancer Res Treat 136:911-918, 2012.


Li B. Telomere components as potential therapeutic targets for treating microbial pathogen infections. Front Oncol 2:156, 2012. PMCID: PMC3485576


Li H, Snow-Lisy D, Klein EA. Hepatic splenosis diagnosed after inappropriate metastatic evaluation in patient with low-risk prostate cancer. Urology 79:e73-e74, 2012.


Li M, Hale JS, Rich JN, Ransohoff RM, Lathia JD. Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair. Trends Neurosci 35:619-628, 2012. PMCID: PMC3461091


Li Q, Ramirez-Bergeron DL, Dunwoodie SL, Yang YC. Cited2 gene controls pluripotency and cardiomyocyte differentiation of murine embryonic stem cells through Oct4 gene. J Biol Chem 287:29088-29100, 2012. PMCID: PMC3436543


Li W, Zhong Y, Vassil A, Xia P. SU-E-J-104: evaluation of atlas-based auto-segmentation on daily in-room CT for prostate cancer. Med Phys 39:3676-3976, 2012.


Li X, Li J. Haplotype inference. Methods Mol Biol 850:411-421, 2012.


Lim JW, Baik OM, Ashing-Giwa KT. Cultural health beliefs and health behaviors in asian american breast cancer survivors: a mixed-methods approach. Oncol Nurs Forum 39:388-397, 2012.


Lim S, Bae E, Kim HS, Kim TA, Byun K, Kim B, Hong S, Im JP, Yun C, Lee B, Lee B, Park SH, Letterio J, Kim SJ. TRAF6 mediates IL-1β/LPS-induced suppression of TGF-β signaling through its interaction with the type III TGF-β receptor. PLoS One 7:e32705, 2012. PMCID: PMC3299683


Lin S, Wang B, Getsios S. Eph/ephrin signaling in epidermal differentiation and disease. Semin Cell Dev Biol 23:92-101, 2012. PMCID: PMC3378995


Linderman GC, Chance MR, Bebek G. MAGNET: MicroArray Gene expression and Network Evaluation Toolkit. Nucleic Acids Res 40(Web Server issue):W152-W156, 2012. PMCID: PMC3394302


Lioi AB, Rodriguez AL, Funderburg NT, Feng Z, Weinberg A, Sieg SF. Membrane damage and repair in primary monocytes exposed to human β-defensin-3. J Leukoc Biol 92:1083-1091, 2012.


Liou HL, Myers JT, Barkauskas DS, Huang AY. Intravital imaging of the mouse popliteal lymph node. J Vis Exp 60:3720, 2012. PMCID: PMC3369637


Liu AM, Qu WW, Liu X, Qu CK. Chromosomal instability in in vitro cultured mouse hematopoietic cells associated with oxidative stress. Am J Blood Res 2:71-76, 2012. PMCID: PMC3301439


Liu H, Greskovich J, Koyfman S, Xia P. SU-E-T-342: evaluation of volumetric change and dosimetric discrepancy with daily cone-beam CT for patients with head-and-neck cancer. Med Phys 39:3782, 2012.


Liu H, Johnson JL, Koval G, Malnassy G, Sher D, Damon LE, Hsi ED, Bucci DM, Linker CA, Cheson BD, Stock W. Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909. Haematologica 97:579-585, 2012. PMCID: PMC3347669


Liu H, Magnelli A, Xia P. SU-E-J-173: can a metal artifact reduction algorithm affect accuracy of dose calculation? Med Phys 39:3692, 2012.


Liu X, Sabnis H, Bunting KD, Qu CK. Molecular targets for the treatment of juvenile myelomonocytic leukemia. Adv Hematol 2012:308252, 2012. PMCID: PMC3226315


Liu X, Zheng H, Qu CK. Protein tyrosine phosphatase Shp2 (Ptpn11) plays an important role in maintenance of chromosome stability. Cancer Res 72:5296-5306, 2012. PMCID: PMC3473170


Liu Y, Koyuturk MBarnholtz-Sloan JSChance MR. Gene interaction enrichment and network analysis to identify dysregulated pathways and their interactions in complex diseases. BMC Syst Biol 6:65, 2012. PMCID: PMC3426489


Liu Y, Koyutürk M, Maxwell S, Zhao Z, Chance MR. Integrative analysis of common neurodegenerative diseases using gene association, interaction networks and mRNA expression data. AMIA Summits Transl Sci Proc 2012:62-71, 2012. PMCID: PMC3392058


Liu Y, Maxwell S, Feng T, Zhu X, Elston RC, Koyutürk M, Chance MR. Gene, pathway and network frameworks to identify epistatic interactions of single nucleotide polymorphisms derived from GWAS data. BMC Syst Biol 6(Suppl 3):S15, 2012. PMCID: PMC3524014


Liu Y, Melin BS, Rajaraman P, Wang Z, Linet M, Shete S, Amos CI, Lau CC, Scheurer ME, Tsavachidis S, Armstrong GN, Houlston RS, Hosking FJ, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, Lachance D, Vick NA, Wrensch M, Davis F, McCarthy BJ, Andersson U, Thompson PA, Chanock S; The Gliogene Consortium, Bondy ML. Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Hum Genet 131:1507-1517, 2012.


Liu YC, Simmons DP, Li XAbbott DW, Boom WH, Harding CV. TLR2 signaling depletes IRAK1 and inhibits induction of type I IFN by TLR7/9. J Immunol 188:1019-1026, 2012. PMCID: PMC3262948


Liu Z, Lanford R, Mueller S, Gerhard GS, Luscieti S, Sanchez M, Devireddy L. Siderophore-mediated iron trafficking in humans is regulated by iron. J Mol Med (Berl) 90:1209-1221, 2012. PMCID: PMC3567482


Lopez-Chavez A, Young T, Fages S, Leon L, Schiller JH, Dowlati A, Brahmer JR, Johnson DH, Sandler A. Bevacizumab maintenance in patients with advanced non-small-cell lung cancer, clinical patterns, and outcomes in the eastern cooperative oncology group 4599 study: results of an exploratory analysis. J Thorac Oncol 7:1707-1712, 2012.


Lorusso PM, Venkatakrishnan K, Ramanathan RK, Sarantopoulos J, Mulkerin D, Shibata SI, Hamilton A, Dowlati A, Mani S, Rudek MA, Takimoto CH, Neuwirth R, Esseltine DL, Ivy P. Pharmacokinetics and safety of Bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: Phase I NCI Organ Dysfunction Working Group Study NCI-6432. Clin Cancer Res 18:2954-2963, 2012.


Lotan Y, Goodman PJ, Youssef RF, Svatek RS, Shariat SF, Tangen CM, Thompson IM Jr, Klein EA. Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT. J Urol 187:2005-2010, 2012.


Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WW, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 44:1321-1325, 2012.


Lu J, Ksendzovsky A, Yang C, Mehta GU, Yong RL, Weil RJ, Park DM, Mushlin HM, Fang X, Balgley BM, Lee DH, Lee CS, Lonser RR, Zhuang Z. CNTF receptor subunit α as a marker for glioma tumor-initiating cells and tumor grade. J Neurosurg 117:1022-1031, 2012.


Lu L, Erokwu B, Lee G, Gulani V, Griswold MA, Dell KM, Flask CA. Diffusion-prepared fast imaging with steady-state free precession (DP-FISP): a rapid diffusion MRI technique at 7 T. Magn Reson Med 68:868-873, 2012. PMCID: PMC3297727


Lu ZR. pH-sensitive siRNA delivery systems. J Drug Deliv Sci Technol 22:55-63, 2012.


Lue N, Kang JW, Yu CC, Barman I, Dingari NC, Feld MS, Dasari RR, Fitzmaurice M. Portable optical fiber probe-based spectroscopic scanner for rapid cancer diagnosis: a new tool for intraoperative margin assessment. PLoS One 7:e30887, 2012. PMCID: PMC3267755


Luger SM, Ringdén O, Zhang MJ, Pérez WS, Bishop MR, Bornhauser M, Bredeson CN, Cairo MS, Copelan EA, Gale RP, Giralt SA, Gulbas Z, Gupta V, Hale GA, Lazarus HM, Lewis VA, Lill MC, McCarthy PL, Weisdorf DJ, Pulsipher MA. Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplant 47:203-211, 2012. PMCID: PMC3134582

Ma J, Altomare A, Guarino M, Cicala M, Rieder F, Fiocchi C, Li D, Cao W, Behar J, Biancani P, Harnett KM. HCl-induced and ATP-dependent upregulation of TRPV1 receptor expression and cytokine production by human esophageal epithelial cells. Am J Physiol Gastrointest Liver Physiol 303:G635-G645, 2012. PMCID: PMC3468560


Ma PC. Personalized targeted therapy in advanced non-small cell lung cancer. Cleve Clin J Med 79(Electronic Suppl 1):eS56-eS60, 2012. PMID: 22614968


Macfarlane R, Heng DY, Xie W, Knox JJ, McDermott DF, Rini BI, Kollmannsberger C, Choueiri TK. The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy. Cancer 118:365-370, 2012.


Machtay M, Bae K, Movsas B, Paulus R, Gore EM, Komaki R, Albain K, Sause WT, Curran WJ. Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 82:425-434, 2012.


Machtay M, Moughan J, Farach A, Martin-O'Meara E, Galvin J, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK. Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis. Int J Radiat Oncol Biol Phys 84:983-989, 2012. PMCID: PMC3479676


Machtay M, Paulus R, Moughan J, Komaki R, Bradley JE, Choy H, Albain K, Movsas B, Sause WT, Curran WJ. Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma. A Radiation Therapy Oncology Group Analysis. J Thorac Oncol 7:716-722, 2012. PMCID: PMC3335930


Maciejewski JP, Padgett RA. Defects in spliceosomal machinery: a new pathway of leukaemogenesis. Br J Haematol 158:165-173, 2012. PMCID: PMC3507475


Macklis R. Finally, a substantial role for radiotherapy in melanoma. Lancet Oncol 13:561-562, 2012.


Macklis RM, Conti PS, Bourland D. Image-guided radiation therapy in lymphoma management. The increasing role of functional imaging. Med Phys 39:564, 2012.


Maggiore RJ, Gross CP, Togawa K, Tew WP, Mohile SG, Owusu C, Klepin HD, Lichtman SM, Gajra A, Ramani R, Katheria V, Klapper SM, Hansen K, Hurria A; on behalf of the Cancer and Aging Research Group. Use of complementary medications among older adults with cancer. Cancer 118:4815-4823, 2012. PMCID: PMC3366170


Magnelli A, Tendulkar R, Macklis RXia P. SU-E-J-77: clinical evaluation of a three-dimensional optical surface based imaging device for breast treatment setup. Med Phys 39:3670, 2012.


Mahabeleshwar GH, Qureshi MA, Takami Y, Sharma N, Lingrel JB, Jain MK. A myeloid hypoxia-inducible factor 1α-Kruppel-like factor 2 pathway regulates Gram-positive endotoxin-mediated sepsis. J Biol Chem 287:1448-1457, 2012. PMCID: PMC3256857


Mahindra A, Bolwell BJ, Rybicki L, Elder P, Kalaycio M, Dean R, Avalos B, Sobecks R, Tench S, Andresen S, Pohlman BSweetenham J, Devine S,Copelan E. Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia. Bone Marrow Transplant 47:231-235, 2012.


Mahindra A, Kalaycio ME, Vela-Ojeda J, Vesole DH, Zhang MJ, Li P, Berenson JR, Bird JM, Dispenzieri A, Gajewski JL, Gale RP, Holmberg L, Kumar S, Kyle RA, Lazarus HM, Lonial S, Mikhael J, Milone GA, Munker R, Nath R, Saccaro S, To LB, Vogl DT, Wirk B, Hari P. Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research. Leukemia 26:1091-1097, 2012. PMCID: PMC3274611


Mailloux AW, Sugimori C, Komrokji RS, Yang L, Maciejewski JPSekeres MA, Paquette R, Loughran TP Jr, List AF, Epling-Burnette PK. Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome. J Immunol 189:3198-3208, 2012. PMCID: PMC3436939


Majhail NS, Brazauskas R, Hassebroek A, Bredeson CN, Hahn T, Hale GA, Horowitz MM, Lazarus HM, Maziarz RT, Wood WA, Parsons SK, Joffe S, Rizzo JD, Lee SJ, Hayes-Lattin BM. Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. Biol Blood Marrow Transplant 18:861-873, 2012. PMCID: PMC3288160


Makishima H, Sugimoto Y, Szpurka H, Clemente MJ, Ng KP, Muramatsu H, O'Keefe C, Saunthararajah Y, Maciejewski JP. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors. Leukemia 26:1547-1554, 2012.


Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A, Przychodzen B, Bupathi M, Guinta K, Afable MG, Sekeres MA, Padgett RA, Tiu RVMaciejewski JP. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 119:3203-3210, 2012. PMCID: PMC3321850


Malinoc A, Sullivan M, Wiech T, Kurt Werner S, Jilg C, Straeter J, Deger S, Hoffmann MM, Bosse A, Rasp G, Eng C, Neumann HP. Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3. Endocr Relat Cancer 19:283-290, 2012.


Mallipattu SK, Liu R, Zheng F, Narla G, Ma'ayan A, Dikman S, Jain MK, Saleem M, D'Agati V, Klotman P, Chuang PY, He JC. Kruppel-Like factor 15 (KLF15) is a key regulator of podocyte differentiation. J Biol Chem 287:19122-19135, 2012. PMCID: PMC3365945


Mandl JN, Liou R, Klauschen F, Vrisekoop N, Monteiro JP, Yates AJ, Huang AY, Germain RN. Quantification of lymph node transit times reveals differences in antigen surveillance strategies of naive CD4+ and CD8+ T cells. Proc Natl Acad Sci U S A 109:18036-18041, 2012. PMCID: PMC3497782


Manson GV, Campagnaro E, Balog A, Kaplan D, Sommers SR, Fu P, Rajkumar SV, Lazarus HM. Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance. Bone Marrow Transplant 47:1212-1216, 2012.


Mansoori B, Erhard KK, Sunshine JL. Picture Archiving and Communication System (PACS) implementation, integration & benefits in an integrated health system. Acad Radiol 19:229-235, 2012.


Marcelain K, Armisen R, Aguirre A, Ueki N, Toro J, Colmenares C, Hayman MJ. Chromosomal instability in mouse embryonic fibroblasts null for the transcriptional co-repressor Ski. J Cell Physiol 227:278-287, 2012. PMCID: PMC3138863


Marinis JM, Hutti JE, Homer CR, Cobb BA, Cantley LC, McDonald CAbbott DW. IκB kinase α phosphorylation of TRAF4 downregulates innate immune signaling. Mol Cell Biol 32:2479-2489, 2012. PMCID: PMC3434482


Marko NF, Coughlan C, Weil RJ. Towards an integrated molecular and clinical strategy to predict early recurrence in surgically resected non-functional pituitary adenomas. J Clin Neurosci 19:1535-1540, 2012.


Marko NF, Lasota E, Hamrahian AH, Weil RJ. Comparative effectiveness review of treatment options for pituitary microadenomas in acromegaly. J Neurosurg 117:522-538, 2012.


Marko NF, Weil RJ. A case for reclassifying infiltrating gliomas in adults. J Neurooncol 109:587-591, 2012.


Marko NF, Weil RJ. Non-gaussian distributions affect identification of expression patterns, functional annotation, and prospective classification in human cancer genomes. PLoS One 7:e46935, 2012. PMCID: PMC3485292


Marko NF, Weil RJ. Pituitary gland: new pathways in the pathogenesis of pituitary adenomas. Nat Rev Endocrinol 8:572-573, 2012.


Marko NF, Weil RJ. The molecular biology of WHO grade I astrocytomas. Neuro Oncol 14:1424-1431, 2012. PMCID: PMC3499013


Marko NF, Xu Z, Gao T, Kattan MWWeil RJ. Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models. Cancer 118:3749-3757, 2012.


Marotta M, Chen X, Inoshita A, Stephens R, Budd GT, Crowe J, Lyons J, Kondratova A, Tubbs R, Tanaka H. A common copy number breakpoint of ERBB2 amplification in breast cancer co-localizes with a complex block of segmental duplications. Breast Cancer Res 14:R150, 2012.


Marotta M, Piontkivska H, Tanaka H. Molecular trajectories leading to the alternative fates of duplicate genes. PLoS One 7:e38958, 2012. PMCID: PMC3375281


Marshall PA, Magtanong RV, Leek AC, Hizlan S, Yamokoski AD, Kodish ED. Negotiating decisions during informed consent for pediatric phase I oncology trials. J Empir Res Hum Res Ethics 7:51-59, 2012. PMCID: PMC3472642


Martires KJ, Barnholtz-Sloan JSBordeaux JS. A call for consistent reporting of regression in melanoma. Arch Dermatol 148:1081-1083, 2012.


Marwaha G, Wilkinson A, Bena J, Macklis R, Singh AD. Dosimetric benefit of a new ophthalmic radiation plaque. Int J Radiat Oncol Biol Phys 84:1226-1230, 2012.


Master AM, Livingston M, Oleinick NL, Sen Gupta A. Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers. Mol Pharm 9:2331-2338, 2012. PMCID: PMC3498539


Master AM, Qi Y, Oleinick NLGupta AS. EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies. Nanomedicine 8:655-664, 2012. PMCID: PMC3312049


Master AM, Sen Gupta A. EGF receptor-targeted nanocarriers for enhanced cancer treatment. Nanomedicine (Lond) 7:1895-1906, 2012.


Maurice MJ, Vricella GJ, Maclennan G, Buehner P, Ponsky LE. Endoscopic snare resection of bladder tumors: evaluation of an alternative technique for bladder tumor resection. J Endourol 26:614-617, 2012.


Mayne E, Funderburg NT, Sieg SF, Asaad R, Kalinowska M, Rodriguez B, Schmaier AH, Stevens W, Lederman MM. Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression. J Acquir Immune Defic Syndr 59:340-346, 2012. PMCID: PMC3299881


Mazanec S, Daly BMeropol NJStep M. Facilitating enrollment in a cancer registry through modified consent procedures: a pilot study. J Empir Res Hum Res Ethics 7:71-75, 2012.


Mazumder S, Choudhary GS, Al-Harbi S, Almasan A. Mcl-1 phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B-cells. Cancer Res 72:3069-3079, 2012. PMCID: PMC3377792


McLennan G, Bennett SL, Ju S, Babsky A, Bansal N, Shorten ML, Levitin S, Bonnac L, Panciewicz KW, Jayaram HN. Tumor response and apoptosis of N1-S1 rodent hepatomas in response to intra-arterial and intravenous benzamide riboside. Cardiovasc Intervent Radiol 35:645-652, 2012.


McMeekin DS, Sill MW, Darcy KM, Abulafia O, Hanjani P, Pearl ML, Rubin SC, Rose PG, Small L, Benbrook DM. A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study. Gynecol Oncol 127:356-361, 2012.


McNamara MJ, Adelstein DJ. Current developments in the management of locally advanced esophageal cancer. Curr Oncol Rep 14:342-349, 2012.


Meller J, Malinin NL, Panigrahi S, Kerr BA, Patil A, Ma Y, Venkateswaran L, Rogozin IB, Mohandas N, Ehlayel MS, Podrez EA, Chinen J, Byzova TV. Novel aspects of Kindlin-3 function in humans based on a new case of leukocyte adhesion deficiency III. J Thromb Haemost 10:1397-1408, 2012. PMCID: PMC3583563


Mendoza R, Silverman RHKlein EA, Miller AD. No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients. PLoS One 7:e36073, 2012. PMCID: PMC3353987


Meropol NJBerger NA. Colon cancer recurrence: insights from the interface between epidemiology, laboratory science, and clinical medicine. J Natl Cancer Inst 104:1697-1698, 2012. PMCID: PMC3502198


Meropol NJ, Kris MG, Winer EP. The American Society of Clinical Oncology's blueprint for transforming clinical and translational cancer research. J Clin Oncol 30:690-691, 2012.


Meropol NJ. Comparative effectiveness research to inform medical decisions: the need for common language. J Clin Oncol 30:4192-4193, 2012.


Merritt SR, Exner AALee Zvon Recum HA. Electrospinning and imaging. Adv Eng Mater 14:B266-B278, 2012.


Messerschmitt PJ, Rettew AN, Schroeder NO, Brookover RE, Jakatdar AP, Getty PJ, Greenfield EM. Osteosarcoma phenotype is inhibited by 3,4-methylenedioxy-β-nitrostyrene. Sarcoma 2012:479712, 2012. PMCID: PMC3371351


Messing EM, Albertsen P, Andriole GL Jr, Carroll PR, Klein EA. The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing. Urol Oncol 30:117-119, 2012.


Mester J, Eng C. Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome. Genet Med 14:819-822, 2012.


Mester JL, Zhou M, Prescott N, Eng C. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome. Urology 79:1187.e1-1187.e7, 2012. PMCID: PMC3341468


Meyerson HJ, Blidaru G, Edinger A, Osei E, Schweitzer K, Fu P, Ho L. NRP-1/CD304 expression in acute leukemia: a potential marker for minimal residual disease detection in precursor B-cell acute lymphoblastic leukemia. Am J Clin Pathol 137:39-50, 2012.


Michal SA, Adelstein DJ, Rybicki LA, Rodriguez CP, Saxton JP, Wood BG, Scharpf J, Ives DI. Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly. Head Neck 34:1147-1152, 2012.


Mieyal JJ, Chock PB. Posttranslational modification of cysteine in redox signaling and oxidative stress: focus on S-glutathionylation. Antioxid Redox Signal 16:471-475, 2012. PMCID: PMC3270050


Milas M, Mester J, Metzger R, Shin J, Mitchell J, Berber E, Siperstein AE, Eng C. Should patients with Cowden syndrome undergo prophylactic thyroidectomy? Surgery 152:1201-1210, 2012.


Miles LA, Plow EF, Waisman DM, Parmer RJ. Plasminogen receptors. J Biomed Biotechnol 2012:130735, 2012. PMCID: PMC3511834


Miller GW, Ulatowski L, Labut EM, Lebold KM, Manor D, Atkinson J, Barton CL, Tanguay RL, Traber MG. The α-tocopherol transfer protein is essential for vertebrate embryogenesis. PLoS One 7:e47402, 2012. PMCID: PMC3471827


Miller RH, Bai L. Translating stem cell therapies to the clinic. Neurosci Lett 519:87-92, 2012.


Mitra AP, Hansel DE, Cote RJ. Prognostic value of cell-cycle regulation biomarkers in bladder cancer. Semin Oncol 39:524-533, 2012. PMCID: PMC3478886


Mohammadi AM, Recinos PF, Barnett GHWeil RJVogelbaum MA, Chao STSuh JH, Marko NF, Elson P, Neyman G, Angelov L. Role of Gamma Knife surgery in patients with 5 or more brain metastases. J Neurosurg 117(Suppl):5-12, 2012.


Moinova H, Leidner RS, Ravi L, Lutterbaugh J, Barnholtz-Sloan JS, Chen Y, Chak AMarkowitz SDWillis JE. Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies. Cancer Epidemiol Biomarkers Prev 21:594-600, 2012. PMCID: PMC3454489


Monaco G, Decrock E, Akl H, Ponsaerts R, Vervliet T, Luyten T, De Maeyer M, Missiaen L, Distelhorst CW, De Smedt H, Parys JB, Leybaert L, Bultynck G. Selective regulation of IP(3)-receptor-mediated Ca(2+) signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl. Cell Death Differ 19:295-309, 2012. PMCID: PMC3263504


Moore KN, Sill MW, Miller DS, McCourt C, De Geest K, Rose PG, Cardenes HR, Mannel RS, Farley JH, Schilder RJ, Fracasso PM. A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: a gynecologic oncology group study. Gynecol Oncol 127:456-461, 2012.


Moriya K, Sakai K, Yan MH, Sakai T. Fibronectin is essential for survival but is dispensable for proliferation of hepatocytes in acute liver injury in mice. Hepatology 56:311-321, 2012. PMCID: PMC3355232


Motea EA, Lee I, Berdis AJ. A non-natural nucleoside with combined therapeutic and diagnostic activities against leukemia. ACS Chem Biol 7:988-998, 2012. PMCID: PMC3376215


Motea EA, Lee I, Berdis AJ. Development of a 'clickable' non-natural nucleotide to visualize the replication of non-instructional DNA lesions. Nucleic Acids Res 40:2357-2367, 2012. PMCID: PMC3300027


Mu L, Tuck D, Katsaros D, Lu L, Schulz V, Perincheri S, Menato G, Scarampi L, Harris L, Yu H. Favorable outcome associated with an IGF-1 ligand signature in breast cancer. Breast Cancer Res Treat 133:321-331, 2012.


Mukherjee S, Sekeres MA. What's all the fuss about? Facts and figures about bone marrow failure and conditions. Curr Hematol Malig Rep 7:300-309, 2012.


Mukherjee S, Tiu RV, Sekeres MA. Blood consult: treating del(5q) myelodysplastic syndromes. Blood 119:342-344, 2012.


Mulligan GB, Faiman C, Gupta M, Kennedy L, Hatipoglu B, Hui F, Weil RJ, Hamrahian AH. Prolactin measurement during inferior petrosal sinus sampling improves the localization of pituitary adenomas in Cushing's disease. Clin Endocrinol (Oxf) 77:268-274, 2012.


Murphy WJ, Steiber A, Connery GC, Carder J, Spry L, Hoppel C. Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation. Nephrol Dial Transplant 27:304-310, 2012.


Muzny DM, et al…Willis JE… 326 collaborators-(Cancer Genome Atlas Network). Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330-337, 2012. PMCID: PMC3401966

Nabors LB, Mikkelsen T, Hegi ME, Ye X, Batchelor T, Lesser G, Peereboom D, Rosenfeld MR, Olsen J, Brem S, Fisher JD, Grossman SA; for the New Approaches to Brain Tumor Therapy (NABTT) Central Nervous System Consortium. A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306). Cancer 118:5601-5607, 2012. PMCID: PMC3423527


Nademanee AP, Dipersio JF, Maziarz RT, Stadtmauer EA, Micallef IN, Stiff PJ, Hsu FJ, Bridger G, Bolwell BJ. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial. Biol Blood Marrow Transplant 18:1564-1572, 2012.


Naguib M, Bie B, Ting AH. Fundamental concepts of epigenetics for consideration in anesthesiology. Curr Opin Anaesthesiol 25:434-443, 2012.


Najjar YG, Rini BI. Novel agents in renal carcinoma: a reality check. Ther Adv Med Oncol 4:183-194, 2012. PMCID: PMC3384093


Nawab A, Thakur VS, Yunus M, Ali Mahdi A, Gupta S. Selective cell cycle arrest and induction of apoptosis in human prostate cancer cells by a polyphenol-rich extract of Solanum nigrum. Int J Mol Med 29:277-284, 2012.


Nayak L, Schmaier AH. A platelet acquired storage pool disorder associated with tamoxifen therapy. Case Rep Hematol 2012:948351, 2012. PMCID: PMC3541551


Negrotto S, Ng KP, Jankowska AM, Bodo J, Gopalan B, Guinta K, Mulloy JC, Hsi EMaciejewski JSaunthararajah Y. CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors. Leukemia 26:244-254, 2012. PMCID: PMC3217177


Nelson VR, Heaney JD, Tesar PJ, Davidson NO, Nadeau JH. Transgenerational epigenetic effects of the Apobec1 cytidine deaminase deficiency on testicular germ cell tumor susceptibility and embryonic viability. Proc Natl Acad Sci U S A 109:E2766-E2773, 2012. PMCID: PMC3478648


Neumeister VM, Sullivan CA, Lindner R, Lezon-Geyda K, Li J, Zavada J, Martel M, Glazer PM, Tuck DP, Rimm DL, Harris L. Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer. Breast Cancer Res Treat 136:67-75, 2012.


Neuner EA, Ahrens CL, Groszek JJ, Isada C, Vogelbaum MA, Fissell WH, Bhimraj A. Use of therapeutic drug monitoring to treat Elizabethkingia meningoseptica meningitis and bacteraemia in an adult. J Antimicrob Chemother 67:1558-1560, 2012. PMCID: PMC3350328


Ngeow J, He X, Mester JL, Lei J, Romigh T, Orloff MS, Milas M, Eng C. Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes. J Clin Endocrinol Metab 97:E2320-E2327, 2012. PMCID: PMC3513537


Nguyen CT, Isariyawongse B, Yu C, Kattan MW. The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer. Front Oncol 2:138, 2012. PMCID: PMC3468831


Nguyen PL, Chen MH, Hoffman KE, Chen RC, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int 110:201-205, 2012.


Ni Y, Eng C. Vitamin E protects against lipid peroxidation and rescues tumorigenic phenotypes in Cowden/Cowden-like patient-derived lymphoblast cells with germline SDHx variants. Clin Cancer Res 18:4954-4961, 2012. PMCID: PMC3445717


Ni Y, He X, Chen J, Moline J, Mester J, Orloff MS, Ringel MD, Eng C. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53. Hum Mol Genet 21:300-310, 2012. PMCID: PMC3250252


Niazi F, Valadkhan S. Computational analysis of functional long noncoding RNAs reveals lack of peptide-coding capacity and parallels with 3' UTRs. RNA 18:825-843, 2012. PMCID: PMC3312569


Nickel GC, Barnholtz-Sloan J, Gould MP, McMahon S, Cohen A, Adams MD, Guda K, Cohen M, Sloan AELaframboise T. Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence. PLoS One 7:e35262, 2012. PMCID: PMC3335059


Nikfarjam M, Frias-Kletecka C, Hardacre J. Gastrointestinal: duodenal tumour and cutaneous skin lesions. J Gastroenterol Hepatol 27:414, 2012.


Nilsen TW, Rio DC. In vitro transcription of labeled RNA: synthesis, capping, and substitution. Cold Spring Harb Protoc 2012:1181-1186, 2012.


Nilsen TW. Removing rRNA from deproteinized, phenol-extracted total RNA by enzymatic digestion. Cold Spring Harb Protoc 2012:1187-1188, 2012.


Nilsen TW. Selective precipitation of large RNAs. Cold Spring Harb Protoc 2012:pdb.prot072322, 2012.


Niu X, Zhang T, Liao L, Zhou L, Lindner DJ, Zhou M, Rini B, Yan Q, Yang H. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C. Oncogene 31:776-786, 2012.


Nock NL, Dimitropolous A, Tkach J, Frasure H, Vongruenigen V. Reduction in neural activation to high-calorie food cues in obese endometrial cancer survivors after a behavioral lifestyle intervention: a pilot study. BMC Neurosci 13:74, 2012. PMCID: PMC3426465


Novoa RA, Honda KKoon HBGerstenblith MR. Vasculitis and panniculitis associated with vemurafenib. J Am Acad Dermatol 67:e271-e272, 2012.


Nyberg E, Sandhu GS, Jesberger J, Blackham KA, Hsu DP, Griswold MA, Sunshine JL. Comparison of brain MR images at 1.5T using BLADE and rectilinear techniques for patients who move during data acquisition. AJNR Am J Neuroradiol 33:77-82, 2012.


Nyland SB, Krissinger DJ, Clemente MJ, Irby RB, Baab KT, Jarbadan NR, Sokol L, Schaefer E, Liao J, Cuthbertson D, Epling-Burnette P, Paquette R, List AF, Maciejewski JP, Loughran TP Jr. Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study. Leuk Res 36:581-587, 2012. PMCID: PMC3312981

O'Brien S, Rizzieri DA, Vey N, Ravandi F, Krug UO, Sekeres MA, Dennis M, Venditti A, Berry DA, Jacobsen TF, Staudacher K, Bergeland T, Giles FJ. Elacytarabine has single-agent activity in patients with advanced acute myeloid leukemia. Br J Haematol 158:581-588, 2012.


Ohshima-Hosoyama S, Davare MA, Prajapati SI, Abraham J, Lal S, Nelon LD, Kilcoyne A, Giles FJ, Hanes MA, Rubin BP, Keller C. Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model. J Pediatr Hematol Oncol 34:116-121, 2012.


O'Malley M, Laguardia L, Kalady MF, Parambil J, Heald B, Eng C, Church J, Burke CA. The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome. Dis Colon Rectum 55:886-892, 2012.


Orban T, Jastrzebska B, Gupta S, Wang B, Miyagi M, Chance MR, Palczewski K. Conformational dynamics of activation for the pentameric complex of dimeric g protein-coupled receptor and heterotrimeric g protein. Structure 20:826-840, 2012. PMCID: PMC3351692


Orloff MS, Zhang L, Bebek G, Eng C. Integrative genomic analysis reveals extended germline homozygosity with lung cancer risk in the PLCO cohort. PLoS One 7:e31975, 2012. PMCID: PMC3288062


Ortiz AP, Thompson CLChak ABerger NA, Li L. Insulin resistance, central obesity, and risk of colorectal adenomas. Cancer 118:1774-1781, 2012. PMCID: PMC3262947


Ostrom QT, McCulloh C, Chen Y, Devine K, Wolinsky Y, Davitkov P, Robbins S, Cherukuri R, Patel A, Gupta R, Cohen M, Barrios JV, Brewer C, Schilero C, Smolenski K, McGraw M, Denk B, Naska T, Laube F, Steele R, Greene D, Kastl A, Bell S, Aziz D, Chiocca EA, McPherson C, Warnick R, Barnett GHSloan AEBarnholtz-Sloan JS. Family history of cancer in benign brain tumor subtypes versus gliomas. Front Oncol 2:19, 2012. PMCID: PMC3355899


Ousema PH, Moutos FT, Estes BT, Caplan AI, Lennon DP, Guilak F, Weinberg JB. The inhibition by interleukin 1 of MSC chondrogenesis and the development of biomechanical properties in biomimetic 3D woven PCL scaffolds. Biomaterials 33:8967-8974, 2012. PMCID: PMC3466362


Oyetakinwhite P, Tribout H, Baron E. Protective mechanisms of green tea polyphenols in skin. Oxid Med Cell Longev 2012:560682, 2012. PMCID: PMC3390139

Padgett RA. New connections between splicing and human disease. Trends Genet 28:147-154, 2012. PMCID: PMC3319163


Page RC, Pruneda JN, Amick J, Klevit RE, Misra S. Structural insights into the conformation and oligomerization of E2~ubiquitin conjugates. Biochemistry 51:4175-4187, 2012. PMCID: PMC3366460


Page RC, Xu Z, Amick J, Nix JC, Misra S. Crystallization and preliminary X-ray crystallographic analysis of the Bag2 amino-terminal domain from Mus musculus. Acta Crystallogr Sect F Struct Biol Cryst Commun 68:647-651, 2012. PMCID: PMC3370901


Pan B, Ren H, Lv X, Zhao Y, Yu B, He Y, Ma Y, Niu C, Kong J, Yu F, Sun WB, Zhang Y, Willard B, Zheng L. Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis. J Transl Med 10:65, 2012. PMCID: PMC3342142


Pan B, Ren H, Ma Y, Liu D, Yu B, Ji L, Pan L, Li J, Yang L, Lv X, Shen X, Chen B, Zhang Y, Willard B, He Y, Zheng L. High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells. Int J Cancer 131:70-82, 2012.


Pandey M, Kaur P, Shukla S, Abbas A, Fu PGupta S. Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study. Mol Carcinog 51:952-962, 2012.


Paner GP, Aron M, Hansel DE, Amin MB. Non-epithelial neoplasms of the prostate. Histopathology 60:166-186, 2012.


Pantopoulos K, Porwal SK, Tartakoff A, Devireddy L. Mechanisms of mammalian iron homeostasis. Biochemistry 51:5705-5724, 2012. PMCID: PMC3572738


Papp-Wallace KM, Taracila MA, Smith KM, Xu Y, Bonomo RA. Understanding the molecular determinants of substrate and inhibitor specificity in the carbapenemase KPC-2: exploring the roles of Arg220 and Glu276. Antimicrob Agents Chemother 56:4428-4438, 2012. PMCID: PMC3421566


Park S, Kim H, Yao MEllis RMachtay M, Sohn J. SU-E-J-87: building deformation error histogram and quality assurance of deformable image registration. Med Phys 39:3672, 2012.


Park SB, Monroe JI, Yao MMachtay MSohn JW. Composite radiation dose representation using Fuzzy Set theory. Inf Sci (Ny) 187:204-215, 2012.


Park YM, Drazba JA, Vasanji A, Egelhoff T, Febbraio M, Silverstein RL. Oxidized LDL/CD36 interaction induces loss of cell polarity and inhibits macrophage locomotion. Mol Biol Cell 23:3057-3068, 2012. PMCID: PMC3418302


Pasquini MC, Devine S, Mendizabal A, Baden LR, Wingard JR, Lazarus HM, Appelbaum FR, Keever-Taylor CA, Horowitz MM, Carter S, O'Reilly RJ, Soiffer RJ. Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission Undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. J Clin Oncol 30:3194-3201, 2012. PMCID: PMC3434978


Patel JP, Gönen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, Van Vlierberghe P, Dolgalev I, Thomas S, Aminova O, Huberman K, Cheng J, Viale A, Socci ND, Heguy A, Cherry A, Vance G, Higgins RR, Ketterling RP, Gallagher RE, Litzow M, van den Brink MR, Lazarus HM, Rowe JM, Luger S, Ferrando A, Paietta E, Tallman MS, Melnick A, Abdel-Wahab O, Levine RL. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 366:1079-1089, 2012. PMCID: PMC3545649


Patel M, Vogelbaum MABarnett GH, Jalali R, Ahluwalia MS. Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions. Expert Opin Investig Drugs 21:1247-1266, 2012.


Patil S, Manola J, Elson P, Negrier S, Escudier B, Eisen T, Atkins M, Bukowski R, Motzer RJ. Improvement in overall survival of patients with advanced renal cell carcinoma: prognostic factor trend analysis from an international data set of clinical trials. J Urol 188:2095-2100, 2012.


Pauli EM, Schomisch SJ, Furlan JP, Marks AS, Chak A, Lash RH, Ponsky JL, Marks JM. Biodegradable esophageal stent placement does not prevent high-grade stricture formation after circumferential mucosal resection in a porcine model. Surg Endosc 26:3500-3508, 2012.


Peereboom DM. Clinical trial design in brain metastasis: approaches for a unique patient population. Curr Oncol Rep 14:91-96, 2012.


Peery AF, Hoppo T, Garman KS, Dellon ES, Daugherty N, Bream S, Sanz AF, Davison J, Spacek M, Connors D, Faulx AL, Chak A, Luketich JD, Shaheen NJ, Jobe BA; Barrett's Esophagus Risk Consortium. Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc 75:945-953.e2, 2012.


Peiris PM, Bauer L, Toy R, Tran E, Pansky J, Doolittle E, Schmidt E, Hayden E, Mayer A, Keri RA, Griswold MA, Karathanasis E. Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release. ACS Nano 6:4157-4168, 2012. PMCID: PMC3358486


Peiris PM, Toy R, Doolittle E, Pansky J, Abramowski A, Tam M, Vicente P, Tran E, Hayden E, Camann A, Mayer A, Erokwu BO, Berman Z, Wilson D, Baskaran H, Flask CA, Keri RAKarathanasis E. Imaging metastasis using an integrin-targeting chain-shaped nanoparticle. ACS Nano 6:8783-8795, 2012. PMCID: PMC3487383


Pennell NA, Yin L, Keshtgarpour M, Ma PC. Two generations of light/never-smokers with advanced adenocarcinoma of the lung with durable responses to erlotinib. J Thorac Oncol 7:1200-1201, 2012.


Pennell NA. Selection of chemotherapy for patients with advanced non-small cell lung cancer. Cleve Clin J Med 79(Electronic Suppl 1):eS46-eS50, 2012. PMID: 22614966


Pennell NA. Treating ALK-positive lung cancer in the weeks after the FDA approval of crizotinib. Am J Manag Care 18:SP84-SP87, 2012.


Pennell NA. Treating anaplastic lymphoma kinase-positive lung cancer in the weeks after the US Food and Drug Administration approval of crizotinib. J Oncol Pract 8(3 Suppl):34s-37s, 2012. PMCID: PMC3348597


Petrosiute A, Auletta JJLazarus HM. Achieving graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy. Immunotherapy 4:1139-1151, 2012.


Petty A, Myshkin E, Qin H, Guo H, Miao H, Tochtrop GP, Hsieh JT, Page P, Liu L, Lindner DJ, Acharya C, Mackerell AD Jr, Ficker E, Song J, Wang B. A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo. PLoS One 7:e42120, 2012. PMCID: PMC3419725


Pfannenstiel LW, Demelash A, Gastman BR. Raiding the pharmacy: genomic screening identifies known chemotherapies as negative regulators of MCL1. Genome Med 4:53, 2012.


Pietanza MC, Gadgeel SM, Dowlati A, Lynch TJ, Salgia R, Rowland KM Jr, Wertheim MS, Price KA, Riely GJ, Azzoli CG, Miller VA, Krug LM, Kris MG, Beumer JH, Tonda M, Mitchell B, Rizvi NA. Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer. J Thorac Oncol 7:856-865, 2012.


Pietanza MC, Lynch TJ Jr, Lara PN Jr, Cho J, Yanagihara RH, Vrindavanam N, Chowhan NM, Gadgeel SM, Pennell NA, Funke R, Mitchell B, Wakelee HA, Miller VA. XL647--a multitargeted tyrosine kinase inhibitor: results of a phase II study in subjects with non-small cell lung cancer who have progressed after responding to treatment with either gefitinib or erlotinib. J Thorac Oncol 7:219-226, 2012.


Plow EF, Doeuvre L, Das R. So many plasminogen receptors: why? J Biomed Biotechnol 2012:141806, 2012. PMCID: PMC3479832


Portell CA, Sekeres MA, Rogers HJ, Tiu RV. De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone. Br J Haematol 157:266-267, 2012.


Prabha S, Sharma B, Labhasetwar V. Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice. Cancer Gene Ther 19:530-537, 2012. PMCID: PMC3400709


Pretorius RG, Belinson JL, Azizi F, Peterson PC, Belinson S. Utility of random cervical biopsy and endocervical curettage in a low-risk population. J Low Genit Tract Dis 16:333-338, 2012.


Prithviraj GK, Koroukian S, Margevicius S, Berger NA, Bagai R, Owusu C. Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol 3:228-237, 2012. PMCID: PMC3375830


Prologo JD, Pirasteh A, Tenley N, Yuan L, Corn D, Hart D, Love Z, Lazarus HM, Lee Z. Percutaneous image-guided delivery for the transplantation of mesenchymal stem cells in the setting of degenerated intervertebral discs. J Vasc Interv Radiol 23:1084-1088, 2012.


Pucilowska J, Puzerey PA, Karlo JC, Galán RF, Landreth GE. Disrupted ERK signaling during cortical development leads to abnormal progenitor proliferation, neuronal and network excitability and behavior, modeling human neuro-cardio-facial-cutaneous and related syndromes. J Neurosci 32:8663-8677, 2012.


Pulsipher MA, Skinner R, McDonald GB, Hingorani S, Armenian SH, Cooke KR, Gracia C, Petryk A, Bhatia S, Bunin N, Nieder ML, Dvorak CC, Sung L, Sanders JE, Kurtzberg J, Baker KS. NCI, NHLBI/PBMTC First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines. Biol Blood Marrow Transplant 18:334-347, 2012. PMCID: PMC3281504


Putnam A, Jankowsky E. Analysis of duplex unwinding by RNA helicases using stopped-flow fluorescence spectroscopy. Methods Enzymol 511:1-27, 2012.

Qi P, Xia P. SU-E-T-578: beam energy dependence and intermediate-low dose bath on normal tissue when comparing VMAT with conventional IMRT. Med Phys 39:3838, 2012.


Qin J, Wu C. ILK: a pseudokinase in the center stage of cell-matrix adhesion and signaling. Curr Opin Cell Biol 24:607-613, 2012. PMCID: PMC3467332


Qing Y, Lin Y, Gerson SL. An intrinsic BM hematopoietic niche occupancy defect of HSC in scid mice facilitates exogenous HSC engraftment. Blood 119:1768-1771, 2012. PMCID: PMC3286352


Qiu J, Tsien C, Thapalaya S, Narayanan A, Weihl CC, Ching JK, Eghtesad B, Singh K, Fu X, Dubyak GMcDonald CAlmasan A, Hazen SL, Naga Prasad SV, Dasarathy S. Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis. Am J Physiol Endocrinol Metab 303:E983-E993, 2012. PMCID: PMC3469607


Quon H, Lavertu P. Postradiotherapy neck dissection: an obsolete treatment paradigm? Int J Radiat Oncol Biol Phys 82:502-504, 2012.


Qutaish MQ, Sullivant KE, Burden-Gulley SM, Lu H, Roy D, Wang J, Basilion JPBrady-Kalnay SM, Wilson DL. Cryo-image analysis of tumor cell migration, invasion, and dispersal in a mouse xenograft model of human glioblastoma multiforme. Mol Imaging Biol 14:572-583, 2012. PMCID: PMC3444683

Radivoyevitch T, Hlatky L, Landaw J, Sachs RK. Quantitative modeling of chronic myeloid leukemia: insights from radiobiology. Blood 119:4363-4371, 2012. PMCID: PMC3362357


Radivoyevitch TKunos CA. On model ensemble analyses of nonmonotonic data. Nucleosides Nucleotides Nucleic Acids 31:147-156, 2012. PMCID: PMC3307047


Radivoyevitch TSaunthararajah YPink J, Ferris G, Lent I, Jackson M, Junk D, Kunos CA. dNTP supply gene expression patterns after P53 loss. Cancers (Basel) 4:1212-1224, 2012. PMCID: PMC3509543


Rahmathulla G, Recinos PF, Traul DE, Avitsian R, Yunak M, Harper NT, Barnett GH, Recinos VR. Surgical briefings, checklists, and the creation of an environment of safety in the neurosurgical intraoperative magnetic resonance imaging suite. Neurosurg Focus 33:E12, 2012.


Rahmathulla G, Recinos PF, Valerio JE, Chao SBarnett GH. Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review. Stereotact Funct Neurosurg 90:192-200, 2012.


Rahmathulla G, Toms SA, Weil RJ. The molecular biology of brain metastasis. J Oncol 2012:723541, 2012. PMCID: PMC3317231


Raman J, Guan Y, Perrine CL, Gerken TA, Tabak LA. UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: completion of the family tree. Glycobiology 22:768-777, 2012. PMCID: PMC3336867


Rao M, Mottl AK, Cole SA, Umans JG, Freedman BI, Bowden DW, Langefeld CD, Fox CS, Yang Q, Cupples A, Iyengar SK, Hunt SC, Trikalinos TA. Meta-analysis of genome-wide linkage scans for renal function traits. Nephrol Dial Transplant 27:647-656, 2012. PMCID: PMC3275782


Raska P, Iversen E, Chen A, Chen Z, Fridley BL, Permuth-Wey J, Tsai YY, Vierkant RA, Goode EL, Risch H, Schildkraut JM, Sellers TA, Barnholtz-Sloan J. European American stratification in ovarian cancer case control data: the utility of genome-wide data for inferring ancestry. PLoS One 7:e35235, 2012. PMCID: PMC3348917


Ratajczak J, Kucia M, Mierzejewska K, Liu R, Kim CH, Natarajan N, Sharma V, Miller DM, Maciejewski J, Ratajczak MZ. A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate gradient. Leukemia 26:1722-1725, 2012.


Ravikumar KM, Huang W, Yang S. Coarse-grained simulations of protein-protein association: an energy landscape perspective. Biophys J 103:837-845, 2012. PMCID: PMC3443792


Raza A, Galili N, Mulford D, Smith SE, Brown GL, Steensma DP, Lyons RM, Boccia R, Sekeres MA, Garcia-Manero G, Mesa RA. Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS). J Hematol Oncol 5:18, 2012. PMCID: PMC3416694


Raza A, Galili N, Smith SE, Godwin J, Boccia RV, Myint H, Mahadevan D, Mulford D, Rarick M, Brown GL, Schaar D, Faderl S, Komrokji RS, List AF,Sekeres M. A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome. Cancer 118:2138-2147, 2012.


Reardon DA, Cloughesy T, Rich J, Alfred Yung WK, Yung L, Dilea C, Huang J, Dugan M, Mietlowski W, Maes A, Conrad C. Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma. Cancer Chemother Pharmacol 69:281-287, 2012.


Reardon DA, Desjardins A, Vredenburgh JJ, Herndon JE 2nd, Coan A, Gururangan S, Peters KB, McLendon R, Sathornsumetee S, Rich JN, Lipp ES, Janney D, Friedman HS. Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma. Cancer 118:4759-4767, 2012.


Reardon DA, Herndon JE 2nd, Peters K, Desjardins A, Coan A, Lou E, Sumrall A, Turner S, Sathornsumetee S, Rich JN, Boulton S, Lipp ES, Friedman HS, Vredenburgh JJ. Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients. J Neurooncol 107:213-221, 2012. PMCID: PMC3403724


Reardon DA, Vredenburgh JJ, Desjardins A, Peters KB, Sathornsumetee S, Threatt S, Sampson JH, Herndon JE 2nd, Coan A, McSherry F, Rich JN, McLendon RE, Zhang S, Friedman HS. Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma. J Neurooncol 108:499-506, 2012.


Reardon DA, Wen PY, Alfred Yung WK, Berk L, Narasimhan N, Turner CD, Clackson T, Rivera VM, Vogelbaum MA. Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trial. Cancer Chemother Pharmacol 69:849-860, 2012.


Reikvam H, Tiu RV. Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera. Leukemia 26:563-571, 2012.


Repaka A, Atkinson MR, Faulx AL, Isenberg GA, Cooper GSChak A, Wong RC. Immediate unprepared hydroflush colonoscopy for severe lower GI bleeding: a feasibility study. Gastrointest Endosc 76:367-373, 2012.


Rhodes C, Campbell S, Shields W, Fabien J, Colussi V, Wessels B. SU-E-T-600: utilizing collimator rotation to increase maximum treatable target dimensions using an Elekta Synergy-S with beam modulator multileaf collimator. Med Phys 39:3844, 2012.


Richmond AL, Kabi A, Homer CR, Marina-García N, Nickerson KP, Nesvizhskii AI, Sreekumar A, Chinnaiyan AM, Nuñez G, McDonald C. The nucleotide synthesis enzyme CAD inhibits NOD2 antibacterial function in human intestinal epithelial cells. Gastroenterology 142:1483-1492.e6, 2012. PMCID: PMC3565430


Rieder F, Kessler S, Sans M, Fiocchi C. Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease. Am J Physiol Gastrointest Liver Physiol 303:G786-G801, 2012.


Rini B, Szczylik C, Tannir NM, Koralewski P, Tomczak P, Deptala A, Dirix LY, Fishman M, Ramlau R, Ravaud A, Rogowski W, Kracht K, Sun YN, Bass MB, Puhlmann M, Escudier B. AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 study. Cancer 118:6152-6161, 2012.


Rini B. Dissecting responsive phenotypes through cytokine and angiogenic factor analysis. Ann Oncol 23:6-7, 2012.


Rini BIGarcia J, Elson P, Wood L, Shah S, Stephenson A, Salem M, Gong M, Fergany A, Rabets J, Kaouk J, Krishnamurthi V, Klein EDreicer R,Campbell S. The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery. J Urol 187:1548-1554, 2012.


Robles Irizarry L, Hambardzumyan D, Nakano I, Gladson CLAhluwalia MS. Therapeutic targeting of VEGF in the treatment of glioblastoma. Expert Opin Ther Targets 16:973-984, 2012.


Rodriguez CP, Adelstein DJ, Rybicki LA, Saxton JP, Lorenz RR, Wood BG, Scharpf J, Ives DI. Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck. Head Neck 34:1517-1523, 2012.


Roget K, Ben-Addi A, Mambole-Dema A, Gantke T, Yang HT, Janzen J, Morrice N, Abbott D, Ley SC. IκB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400. Mol Cell Biol 32:4684-4690, 2012. PMCID: PMC3486174


Roobol MJ, Schröder FH, Hugosson J, Jones JS, Kattan MWKlein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Ankerst D, Bartsch G, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Freedland SJ, Moreira DM, Vickers AJ, Lilja H, Steyerberg EW. Importance of prostate volume in the European Randomized Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the Prostate Biopsy Collaborative Group. World J Urol 30:149-155, 2012. PMCID: PMC3321270


Rood MN, Cruz-Knight W, Cunagin J, Zyzanski SJWerner JJ, Mason MJ, Lawson PJ, Stange KCFlocke SA. The effect of insurance-driven medication changes on patient care. J Fam Pract 61:E1-E7, 2012.


Ros PR. Enterprise-wide and multisite imaging and archiving in academic radiology departments: articles based on the 2011 AUR-Carestream Innovations in Academic Radiology course. Acad Radiol 19:129-130, 2012.


Rose PG, Sill MW, McMeekin DS, Ahmed A, Salani R, Yamada SD, Wolfson AH, Fusco N, Fracasso PM. A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol 125:158-162, 2012.


Rose PG. Are the differences in treatment outcome for adenocarcinoma of the cervix different enough to change the treatment paradigm? Gynecol Oncol 125:285-286, 2012.


Rose PG. Which is the best foot to put forward in recurrent ovarian cancer? Cancer 118:3229-3231, 2012.


Rosko A, Lazarus HM. Refining hematopoietic cell transplant: a concise review. Cytometry B Clin Cytom 82:266-267, 2012.


Rosko A, Lazarus HM. Salvage chemotherapy and autologous hematopoietic cell transplant in primary refractory diffuse large B-cell lymphoma: progress or better patient selection? Leuk Lymphoma 53:756-757, 2012.


Roth JC, Ismail M, Reese JS, Lingas KT, Ferrari G, Gerson SL. Cotransduction with MGMT and ubiquitous or erythroid-specific GFP lentiviruses allows enrichment of dual-positive hematopoietic progenitor cells in vivo. ISRN Hematol 2012:212586, 2012. PMCID: PMC3408655


Rubinstein YR, Groft SC, Chandros SH, Kaneshiro J, Karp B, Lockhart NC, Marshall PA, Moxley RT 3rd, Pollen GB, Miller VR, Schwartz J. Informed consent process for patient participation in rare disease registries linked to biorepositories. Contemp Clin Trials 33:5-11, 2012.


Ruffalo M, Koyutürk M, Ray S, Laframboise T. Accurate estimation of short read mapping quality for next-generation genome sequencing. Bioinformatics 28:i349-i355, 2012. PMCID: PMC3436835


Ryder C, McColl K, Zhong F, Distelhorst CW. Acidosis promotes Bcl-2 family mediated evasion of apoptosis: involvement of acid-sensing G protein-coupled receptor GPR65 signaling to MEK/ERK. J Biol Chem 287:27863-27875, 2012. PMCID: PMC3431637

Sadeghi S, Albiges L, Wood LS, Black SL, Gilligan TDDreicer RGarcia JA, Escudier BJ, Rini BI. Cessation of vascular endothelial growth factor-targeted therapy in patients with metastatic renal cell carcinoma: feasibility and clinical outcome. Cancer 118:3277-3282, 2012.


Sadeghi S, Garcia JA. Current status of targeted therapy in metastatic transitional cell carcinoma of the bladder. Semin Oncol 39:608-614, 2012.


Saha A, Barman I, Dingari NC, Galindo LH, Sattar A, Liu W, Plecha D, Klein N, Dasari RR, Fitzmaurice M. Precision of Raman spectroscopy measurements in detection of microcalcifications in breast needle biopsies. Anal Chem 84:6715-6722, 2012. PMCID: PMC3424275


Saha S, Dazard JE, Xu H, Ewing RM. Computational framework for analysis of prey-prey associations in interaction proteomics identifies novel human protein-protein interactions and networks. J Proteome Res 11:4476-4487, 2012.


Saha S, Roman T, Galante A, Koyutürk M, Ewing RM. Network-based approaches for extending the Wnt signaling pathway and identifying context-specific sub-networks. Int J Comput Biol Drug Des 5:185-205, 2012.


Sahgal A, Ma L, Weinberg V, Gibbs IC, Chao S, Chang UK, Werner-Wasik M, Angelov L, Chang EL, Sohn MJ, Soltys SG, Létourneau D, Ryu S, Gerszten PC, Fowler J, Wong CS, Larson DA. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 82:107-116, 2012.


Saito Y, Aoki Y, Muramatsu H, Makishima H, Maciejewski JP, Imaizumi M, Rikiishi T, Sasahara Y, Kure S, Niihori T, Tsuchiya S, Kojima S, Matsubara Y. Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia. Leuk Res 36:1009-1015, 2012.


Sakaguchi H, Makishima H, Muramatsu H, Visconte V, Jerez A, Jankowska AM, Tiu RVMaciejewski JP, Kojima S. Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies. Leuk Res 36:e215-e217, 2012.


Salit RB, Fowler DH, Wilson WH, Dean RM, Pavletic SZ, Dunleavy K, Hakim F, Fry TJ, Steinberg SM, Hughes TE, Odom J, Bryant K, Gress RE, Bishop MR. Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. J Clin Oncol 30:830-836, 2012. PMCID: PMC3295571


Salom D, Cao P, Sun W, Kramp K, Jastrzebska B, Jin H, Feng Z, Palczewski K. Heterologous expression of functional G-protein-coupled receptors in Caenorhabditis elegans. FASEB J 26:492-502, 2012. PMCID: PMC3290431


Sandhu GS, Rezaee RP, Jesberger J, Wright K, Griswold MA, Gulani V. Time-resolved MR angiography of the legs at 3 T using a low dose of gadolinium: initial experience and contrast dynamics. AJR Am J Roentgenol 198:686-691, 2012.


Sangodkar J, Dhawan NS, Melville H, Singh VJ, Yuan E, Rana H, Izadmehr S, Farrington C, Mazhar S, Katz S, Albano T, Arnovitz P, Okrent R, Ohlmeyer M, Galsky M, Burstein D, Zhang D, Politi K, Difeo ANarla G. Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response. J Clin Invest 122:2637-2651, 2012. PMCID: PMC3386822


Saunthararajah YMaciejewski J. Polycomb segment myeloid malignancies. Blood 119:1097-1098, 2012.


Saunthararajah Y, Triozzi PRini B, Singh A, Radivoyevitch TSekeres M, Advani A, Tiu RReu FKalaycio MCopelan EHsi E, Lichtin A, Bolwell B. p53-independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies. Semin Oncol 39:97-108, 2012.


Sava MR, Rubin B, Sundaram M. Subpubic cyst. Skeletal Radiol 41:851-852, 867-868, 2012.


Savdie R, Symons J, Spernat D, Yuen C, Pe Benito RA, Haynes AM, Matthews J, Rasiah KK, Jagavkar RS, Yu C, Fogarty G, Kattan MW, Brenner P, Sutherland RL, Stricker PD. High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse. BJU Int 110(Suppl 4):71-76, 2012.


Savvides PSXu YLiu L, Rogers LBokar JSilverman PDowlati AGerson SL. Phase 1 clinical trial of the base-excision repair inhibitor methoxyamine-HCl (TRC102; MX) in combination with temozolomide (TMZ) in patients with solid tumors. Cancer Res 72:1743, 2012.


Scheppke L, Murphy EA, Zarpellon A, Hofmann JJ, Merkulova A, Shields DJ, Weis SM, Byzova TV, Ruggeri ZM, Iruela-Arispe ML, Cheresh DA. Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane. Blood 119:2149-2158, 2012. PMCID: PMC3311249


Schlatzer D, Maahs DM, Cooke K, Dazard JE, Li X, Hazlett F, Rewers M, Snell-Bergeon JK. Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. Diabetes Care 35:549-555, 2012. PMCID: PMC3322681


Schlatzer DM, Dazard JE, Ewing RM, Ilchenko S, Tomcheko SE, Eid S, Ho V, Yanik G, Cooke K, Cooke KR. Human biomarker discovery and predictive models for disease progression for idiopathic pneumonia syndrome following allogeneic stem cell transplantation. Mol Cell Proteomics 11:M111.015479, 2012. PMCID: PMC3433920


Schlatzer DM, Sugalski J, Dazard JEChance MR, Anthony DD. A quantitative proteomic approach for detecting protein profiles of activated human myeloid dendritic cells. J Immunol Methods 375:39-45, 2012. PMCID: PMC3253886


Schonberg DL, Bao SRich JN. TRP-ing up brain tumors. Nat Med 18:1175-1176, 2012.


Schwandt A, Mekhail T, Halmos B, O'Brien TMa PCFu P, Ivy P, Dowlati A. Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer. J Thorac Oncol 7:751-754, 2012. PMCID: PMC3310884


Schwele S, Fischer AM, Brestrich G, Wlodarski MW, Wagner L, Schmueck M, Roemhild A, Thomas S, Hammer MH, Babel N, Kurtz A, Maciejewski JP, Reinke P, Volk HD. Cytomegalovirus-specific regulatory and effector T cells share TCR clonality-possible relation to repetitive CMV infections. Am J Transplant 12:669-681, 2012.


Scott JG, Bauchet L, Fraum TJ, Nayak L, Cooper AR, Chao STSuh JHVogelbaum MAPeereboom DM, Zouaoui S, Mathieu-Daudé H, Fabbro-Peray P, Rigau V, Taillandier L, Abrey LE, Deangelis LM, Shih JH, Iwamoto FM. Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer 118:5595-5600, 2012. PMCID: PMC3402652


Seicean A, Schiltz NK, Seicean S, Alan N, Neuhauser D, Weil RJ. Use and utility of preoperative hemostatic screening and patient history in adult neurosurgical patients. J Neurosurg 116:1097-1105, 2012.


Seicean S, Seicean A, Plana JC, Budd GT, Marwick TH. Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study. J Am Coll Cardiol 60:2384-2390, 2012.


Sekeres MA, Steensma DP. Boulevard of broken dreams: drug approval for older adults with acute myeloid leukemia. J Clin Oncol 30:4061-4063, 2012.


Sekeres MATiu RV, Komrokji R, Lancet J, Advani AS, Afable M, Englehaupt R, Juersivich J, Cuthbertson D, Paleveda J, Tabarroki A, Visconte V, Makishima H, Jerez A, Paquette R, List AF, Maciejewski JP. Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes. Blood 120:4945-4951, 2012. PMCID: PMC3525020


Sekeres MA. How to manage lower-risk myelodysplastic syndromes. Leukemia 26:390-394, 2012.


Sen GC, Fensterl V. Crystal structure of IFIT2 (ISG54) predicts functional properties of IFITs. Cell Res 22:1407-1409, 2012. PMCID: PMC3463260


Shah L, Samala RV, Davis MP. Posterior reversible encephalopathy syndrome: an unexpected finding in a palliative care unit. J Pain Symptom Manage 44:e3-e6, 2012.


Shamay M, Hand N, Lemas MV, Koon HB, Krown SE, Wrangle J, Desai P, Ramos JC, Ambinder RF. CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA. J Infect Dis 205:1095-1099, 2012. PMCID: PMC3295606


Shanbhogue AK, Vikram R, Paspulati RM, Maclennan G, Verma S, Sandrasegaran K, Prasad SR. Rare (<1%) histological subtypes of renal cell carcinoma: an update. Abdom Imaging 37:861-872, 2012.


Shang Q, Qi P, Vassil A, Huang G, Xia P. SU-E-J-22: effect of MLC leaf width on MLC leaf shifting algorithm for concurrent treatment of prostate and pelvic lymph nodes. Med Phys 39:3657, 2012.


Shankar E, Vykhovanets EV, Vykhovanets OV, Maclennan GT, Singh R, Bhaskaran N, Shukla S, Gupta S. High-fat diet activates pro-inflammatory response in the prostate through association of Stat-3 and NF-κB. Prostate 72:233-243, 2012. PMCID: PMC3161175


Sharma A, Singh K, Almasan A. Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol Biol 920:613-626, 2012.


Shay LA, Dumenci L, Siminoff LA, Flocke SA, Lafata JE. Factors associated with patient reports of positive physician relational communication. Patient Educ Couns 89:96-101, 2012. PMCID: PMC3431455


Shen B, Yu C, Lian L, Remzi FH, Kiran RP, Fazio VW, Kattan MW. Prediction of late-onset pouch failure in patients with restorative proctocolectomy with a nomogram. J Crohns Colitis 6:198-206, 2012.


Shen GQ, Li L, Wang QK. Genetic variant R952Q in LRP8 is associated with increased plasma triglyceride levels in patients with early-onset CAD and MI. Ann Hum Genet 76:193-199, 2012.


Shen X, Andrews DW, Sergott RC, Evans JJ, Curran WJ, Machtay M, Fragoso R, Eldredge H, Champ CE, Witek M, Mishra MV, Dicker AP, Werner-Wasik M. Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study. Radiat Oncol 7:225, 2012. PMCID: PMC3551726


Shepard DRCooney MMElson P, Bukowski RM, Dreicer RRini BIGarcia JA. A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma. Invest New Drugs 30:364-367, 2012.


Sheplan Olsen LJ, Robles Irizarry L, Chao STWeil RJ, Hamrahian AH, Hatipoglu B, Suh JH. Radiotherapy for prolactin-secreting pituitary tumors. Pituitary 15:135-145, 2012.


Sheth VR, Li Y, Chen LQ, Howison CM, Flask CA, Pagel MD. Measuring in vivo tumor pHe with CEST-FISP MRI. Magn Reson Med 67:760-768, 2012. PMCID: PMC3572795


Shires DA, Stange KC, Divine G, Ratliff S, Vashi R, Tai-Seale M, Lafata JE. Prioritization of evidence-based preventive health services during periodic health examinations. Am J Prev Med 42:164-173, 2012. PMCID: PMC3262983


Shiue K, Song A, Teh BS, Ellis RJYao M, Mayr NA, Huang Z, Sohn JMachtay M, Lo SS. Stereotactic body radiation therapy for metastasis to the adrenal glands. Expert Rev Anticancer Ther 12:1613-1620, 2012.


Shoemaker LK, Aktas A, Walsh D, Hullihen B, Khan MI, Russell KM, Davis MP, Lagman R, Legrand S. A pilot study of palliative medicine fellows' hospice home visits. Am J Hosp Palliat Care 29:591-598, 2012.


Shola DT, Wang H, Wahdan-Alaswad R, Danielpour D. Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8. Oncogene 31:2480-2490, 2012. PMCID: PMC3340512


Shukla S, Maclennan GTFu PGupta S. Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model. Pharm Res 29:1506-1517, 2012.


Shukla-Dave A, Hricak H, Akin O, Yu C, Zakian KL, Udo K, Scardino PT, Eastham J, Kattan MW. Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. BJU Int 109:1315-1322, 2012. PMCID: PMC3270152


Siegel DS, Martin T, Wang M, Vij R, Jakubowiak AJ, Lonial S, Trudel S, Kukreti V, Bahlis N, Alsina M, Chanan-Khan A, Buadi F, Reu FJ, Somlo G, Zonder J, Song K, Stewart AK, Stadtmauer E, Kunkel L, Wear S, Wong AF, Orlowski RZ, Jagannath S. A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma. Blood 120:2817-2825, 2012.


Sikand K, Singh J, Ebron JS, Shukla GC. Housekeeping gene selection advisory: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin are targets of miR-644a. PLoS One 7:e47510, 2012. PMCID: PMC3472982


Simmons DP, Wearsch PA, Canaday DH, Meyerson HJ, Liu YC, Wang Y, Boom WH, Harding CV. Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing. J Immunol 188:3116-3126, 2012. PMCID: PMC3311734


Simmons MN, Hillyer SP, Lee BH, Fergany AF, Kaouk J, Campbell SC. Diameter-axial-polar nephrometry: integration and optimization of R.E.N.A.L. and centrality index scoring systems. J Urol 188:384-390, 2012.


Simmons MN, Hillyer SP, Lee BH, Fergany AF, Kaouk J, Campbell SC. Functional recovery after partial nephrectomy: effects of volume loss and ischemic injury. J Urol 187:1667-173, 2012.


Simmons MN, Hillyer SP, Lee BH, Fergany AF, Kaouk J, Campbell SC. Nephrometry score is associated with volume loss and functional recovery after partial nephrectomy. J Urol 188:39-44, 2012.


Singh AD, Aronow ME, Sun Y, Bebek G, Saunthararajah Y, Schoenfield LR, Biscotti CV, Tubbs RR, Triozzi PLEng C. Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array. Invest Ophthalmol Vis Sci 53:3331-3339, 2012.


Singh K, Matsuyama S, Drazba JA, Almasan A. Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress. Autophagy 8:236-251, 2012. PMCID: PMC3336077


Sinnott M, Falzarano SM, Hernandez AV, Jones JS, Klein EA, Zhou M, Magi-Galluzzi C. Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: implications for focal therapy. Prostate 72:1179-1186, 2012.


Sive JI, Buck G, Fielding A, Lazarus HM, Litzow MR, Luger S, Marks DI, McMillan A, Moorman AV, Richards SM, Rowe JM, Tallman MS, Goldstone AH. Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial. Br J Haematol 157:463-471, 2012.


Sizemore ST, Keri RA. The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression. J Biol Chem 287:24631-24640, 2012. PMCID: PMC3397891


Slyfield CR, Tkachenko EV, Wilson DL, Hernandez CJ. Three-dimensional dynamic bone histomorphometry. J Bone Miner Res 27:486-495, 2012. PMCID: PMC3288521


Smith JS, Lewkowitz AK, Qiao YL, Ji J, Hu S, Chen W, Zhang R, Liaw KL, Esser M, Taddeo FJ, Pretorius RG, Belinson JL. Population-based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women. Int J Cancer 131:1388-1395, 2012.


Sobecks RM, Rybicki L, Yurch M, Kalaycio MDean R, Andresen S, Pohlman B, Duong HBolwell BCopelan E. Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS. Bone Marrow Transplant 47:633-638, 2012.


Solinas P, Fujioka H, Tandler B, Hoppel CL. Isolation of rat adrenocortical mitochondria. Biochem Biophys Res Commun 427:96-99, 2012.


Solorio L, Olear AM, Hamilton JI, Patel RB, Beiswenger AC, Wallace JE, Zhou H, Exner AA. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging. Theranostics 2:1064-1077, 2012. PMCID: PMC3516837


Solorio L, Olear AM, Zhou H, Beiswenger AC, Exner AA. Effect of cargo properties on in situ forming implant behavior determined by noninvasive ultrasound imaging. Drug Deliv Transl Res 2:45-55, 2012. PMCID: PMC3375723


Solorio LD, Vieregge EL, Dhami CD, Dang PN, Alsberg E. Engineered cartilage via self-assembled hMSC sheets with incorporated biodegradable gelatin microspheres releasing transforming growth factor-β1. J Control Release 158:224-232, 2012. PMCID: PMC3294133


Song J, Hao Y, Du Z, Wang Z, Ewing RM. Identifying novel protein complexes in cancer cells using epitope-tagging of endogenous human genes and affinity-purification mass spectrometry. J Proteome Res 11:5630-5641, 2012.


Song J, Saha S, Gokulrangan G, Tesar PJ, Ewing RM. DNA and chromatin modification networks distinguish stem cell pluripotent ground states. Mol Cell Proteomics 11:1036-1047, 2012. PMCID: PMC3494154


Song MJ, Brady-Kalnay SM, McBride SH, Phillips-Mason P, Dean D, Knothe Tate ML. Mapping the mechanome of live stem cells using a novel method to measure local strain fields in situ at the fluid-cell interface. PLoS One 7:e43601, 2012. PMCID: PMC3438189


Song X, Yang J, Hirbawi J, Ye S, Perera HD, Goksoy E, Dwivedi P, Plow EF, Zhang R, Qin J. A novel membrane-dependent on/off switch mechanism of talin FERM domain at sites of cell adhesion. Cell Res 22:1533-1545, 2012. PMCID: PMC3494399


Song Y, Fang G, Shen H, Li H, Yang W, Pan B, Huang G, Lin G, Ma L, Willard B, Gu J, Zheng L, Wang Y. Human surfactant protein A2 gene mutations impair dimmer/trimer assembly leading to deficiency in protein sialylation and secretion. PLoS One 7:e46559, 2012. PMCID: PMC3463533


Sonpavde G, Choueiri TK, Escudier B, Ficarra V, Hutson TE, Mulders PF, Patard JJ, Rini BI, Staehler M, Sternberg CN, Stief CG. Sequencing of agents for metastatic renal cell carcinoma: can we customize therapy? Eur Urol 61:307-316, 2012.


Spain SL, Carvajal-Carmona LG, Howarth KM, Jones AM, Su Z, Cazier JB, Williams J, Aaltonen LA, Pharoah P, Kerr DJ, Cheadle J, Li L, Casey G, Vodicka P, Sieber O, Lipton L, Gibbs P, Martin NG, Montgomery GW, Young J, Baird PN, Morreau H, van Wezel T, Ruiz-Ponte C, Fernandez-Rozadilla C, Carracedo A, Castells A, Castellvi-Bel S, Dunlop M, Houlston RS, Tomlinson IP. Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13. Hum Mol Genet 21:934-946, 2012. PMCID: PMC3263985


Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao STWeil RJSuh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys 82:2111-2117, 2012. PMCID: PMC3172400


Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao STWeil RJSuh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M. Summary report on the Graded Prognostic Assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419-425, 2012. PMCID: PMC3269967


Stange KC, Breslau ES, Dietrich AJ, Glasgow RE. State-of-the-art and future directions in multilevel interventions across the cancer control continuum. J Natl Cancer Inst Monogr 2012:20-31, 2012. PMCID: PMC3482971


Stark GR, Darnell JE Jr. The JAK-STAT pathway at twenty. Immunity 36:503-514, 2012.


Starnes AM, Jou PC, Molitoris JK, Lam MBaron ED, Garcia-Zuazaga J. Acute effects of fractional laser on photo-aged skin. Dermatol Surg 38:51-57, 2012.


Starnes AM, Kast DR, Lu K, Honda K. Leukemia cutis amidst a psoriatic flare: a case report. Am J Dermatopathol 34:292-294, 2012.


Steele E, Umar SA, Bomeisl P, Miedler J, Zanotti KM, Wasman JK, Hunt DC, Abdul-Karim FW. Glandular cells in vaginal cytology Papanicolaou tests in patients with hysterectomy for endometrial adenocarcinoma. Diagn Cytopathol 40:138-140, 2012.


Stein CM, Morris NJ, Nock NL. Structural equation modeling. Methods Mol Biol 850:495-512, 2012.


Stepanik VA, Harte PJ. A mutation in the E(Z) methyltransferase that increases trimethylation of histone H3 lysine 27 and causes inappropriate silencing of active Polycomb target genes. Dev Biol 364:249-258, 2012.


Stephenson AJ, Bolla M, Briganti A, Cozzarini C, Moul JW, Roach Iii M, van Poppel H, Zietman A. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur Urol 61:443-451, 2012.


Steyer GJ, Dong F, Kanodia L, Roy D, Penn M, Wilson DL. Detection and quantification of fluorescent cell clusters in cryo-imaging. Int J Biomed Imaging 2012:698413, 2012. PMCID: PMC3317210


Steyerberg EW, Pencina MJ, Lingsma HF, Kattan MW, Vickers AJ, Van Calster B. Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. Eur J Clin Invest 42:216-228, 2012. PMCID: PMC3587963


Stockham AL, Suh JH, Chao STBarnett GH. Management of recurrent brain metastasis after radiosurgery. Prog Neurol Surg 25:273-286, 2012.


Stockham AL, Tievsky AL, Koyfman SA, Reddy CA, Suh JHVogelbaum MABarnett GHChao ST. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery. J Neurooncol 109:149-158, 2012.


Strainic MG, Shevach EM, An F, Lin F, Medof ME. Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3(+) regulatory T cells. Nat Immunol 14:162-171, 2012.


Strong SA. Inflammatory bowel disease surgery in the biologic therapy era. Curr Opin Gastroenterol 28:349-353, 2012.


Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbalý V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer 48:2192-2202, 2012.


Suarez C, Rini BI. Determining the optimal dose and schedule of sunitinib: some answers, more questions. Cancer 118:1178-1180, 2012.


Subbarayan SK, Fleseriu M, Gordon MB, Brzana JA, Kennedy L, Faiman C, Hatipoglu BA, Prayson RA, Delashaw JB, Weil RJ, Hamrahian AH. Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone. Endocr Pract 18:817-825, 2012.


Sugimori C, Padron E, Caceres G, Shain K, Sokol L, Zhang L, Tiu R, O'Keefe CL, Afable M, Clemente M, Lee JM, Maciejewski JP, List AF, Epling-Burnette PK, Araten DJ. Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation. Blood Cancer J 2:e63, 2012. PMCID: PMC3317526


Sugimoto Y, Sekeres MA, Makishima H, Traina F, Visconte V, Jankowska A, Jerez A, Szpurka H, O'Keefe CL, Guinta K, Afable M, Tiu R, McGraw KL, List AF, Maciejewski J. Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide. J Hematol Oncol 5:4, 2012. PMCID: PMC3323440


Sun D, Elson P, Liedtke M, Medeiros BC, Earl M, Alizadeh A, Bates J, Sekeres MA, Coutre S, Kalaycio MSobecks RCopelan EAdvani AS. Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia. Am J Hematol 87:957-960, 2012.


Sun X, Vengoechea J, Elston R, Chen Y, Amos CI, Armstrong G, Bernstein JL, Claus E, Davis F, Houlston RS, Il'yasova D, Jenkins RB, Johansen C, Lai R, Lau CC, Liu Y, McCarthy BJ, Olson SH, Sadetzki S, Schildkraut J, Shete S, Yu R, Vick NA, Merrell R, Wrensch M, Yang P, Melin B, Bondy ML, Barnholtz-Sloan JS; on behalf of the Gliogene Consortium. A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma. Cancer Epidemiol Biomarkers Prev 21:2242-2251, 2012. PMCID: PMC3518573


Sunder S, Greeson-Lott NT, Runge KWSanders SL. A new method to efficiently induce a site-specific double-strand break in the fission yeast Schizosaccharomyces pombe. Yeast 29:275-291, 2012. PMCID: PMC3389596


Suppiah S, Linden P, Robke J, Schroeder C, Yao MMachtay M, Lo SS. Sublobar/wedge resection or stereotactic body radiation therapy for stage I marginally operable non-small-cell lung cancer. Expert Rev Anticancer Ther 12:1375-1377, 2012.


Sweeney SA, Bazemore A, Phillips RL Jr, Etz RS, Stange KC. A re-emerging political space for linking person and community through primary health care. Am J Prev Med 42(6 Suppl 2):S184-S190, 2012.


Sweeney SA, Bazemore A, Phillips RL Jr, Etz RS, Stange KC. A reemerging political space for linking person and community through primary health care. Am J Public Health 102(Suppl 3):S336-S341, 2012.

Tabarroki A, Tiu RV. Immunomodulatory agents in myelofibrosis. Expert Opin Investig Drugs 21:1141-1154, 2012.


Tan M, Burden-Gulley SM, Li W, Wu X, Lindner DBrady-Kalnay SMGulani VLu ZR. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model. Pharm Res 29:953-960, 2012.


Tan MH, De S, Bebek G, Orloff MS, Wesolowski R, Downs-Kelly E, Budd GTStark GREng C. Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer. Breast Cancer Res Treat 131:849-858, 2012.


Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 18:400-407, 2012. PMCID: PMC3261579


Taylor D, Unbehaun A, Li W, Das S, Lei J, Liao HY, Grassucci RA, Pestova TV, Frank J. Cryo-EM structure of the mammalian eukaryotic release factor eRF1-eRF3-associated termination complex. Proc Natl Acad Sci U S A 109:18413-18418, 2012. PMCID: PMC3494903


Tendulkar RD, Reddy CA, Stephans KL, Ciezki JPKlein EA, Mahadevan A, Kupelian PA. Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy. Int J Radiat Oncol Biol Phys 82:1397-1404, 2012.


Tendulkar RD, Rehman S, Shukla ME, Reddy CA, Moore HBudd GT, Dietz J, Crowe JP, Macklis R. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy. Int J Radiat Oncol Biol Phys 83:e577-e581, 2012.


Teng K, Eng C, Hess CA, Holt MA, Moran RT, Sharp RR, Traboulsi EI. Building an innovative model for personalized healthcare. Cleve Clin J Med 79(Suppl 1):S1-S9, 2012. PMID: 22492701


Teng KA, Eng C. Personalizing patient care. Cleve Clin J Med 79:329-330, 2012. PMID: 22550074


Thakkar VV, Chao STBarnett GH, LeGrand S, Rasmussen P, Vogelbaum MA, Reddy CA, Jamison B, Suh J. Quality of life after Gamma Knife radiosurgery for benign lesions: a prospective study. J Radiosurg Stereotact Body Radiat Ther 1:281-286, 2012.


Thakur VS, Gupta K, Gupta S. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. Carcinogenesis 33:377-384, 2012. PMCID: PMC3499108


Thakur VS, Gupta K, Gupta S. Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases. Int J Oncol 41:353-361, 2012. PMCID: PMC3580388


Thompson CLBerger NAChak ALi L. Racial differences in measures of obesity and risk of colon adenoma. Obesity (Silver Spring) 20:673-677, 2012.


Thompson CLLi L. Association of sleep duration and breast cancer OncotypeDX recurrence score. Breast Cancer Res Treat 134:1291-1295, 2012. PMCID: PMC3409927


Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 79:356-360, 2012.


Tian H, Lu X, Guo H, Corn D, Molter J, Wang BLuo GLee Z. Radio-deoxynucleoside analogs used for imaging tk expression in a transgenic mouse model of induced hepatocellular carcinoma. Theranostics 2:597-606, 2012. PMCID: PMC3388592


Tie F, Banerjee R, Conrad PA, Scacheri PCHarte PJ. Histone demethylase UTX and chromatin remodeler BRM bind directly to CBP and modulate acetylation of histone H3 lysine 27. Mol Cell Biol 32:2323-2334, 2012. PMCID: PMC3372260


Tigno-Aranjuez JT, Abbott DW. Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease. Biochim Biophys Acta 1823:2022-2028, 2012. PMCID: PMC3404158


Titi M, Overhiser A, Ulusarac O, Falk GW, Chak A, Wang K, Sharma P. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus. Gastroenterology 143:564-566.e1, 2012.


Tiu RKalaycio M. Targeted therapy for patients with chronic myeloid leukemia: clinical trial experience and challenges in inter-trial comparisons. Leuk Lymphoma 53:1263-1272, 2012.


Traber MG, Manor D. Vitamin E. Adv Nutr 3:330-331, 2012.


Traina F, Visconte V, Jankowska AM, Makishima H, O'Keefe CL, Elson P, Han Y, Hsieh FH, Sekeres MA, Mali RS, Kalaycio M, Lichtin AE, Advani AS,Duong HKCopelan E, Kapur R, Olalla Saad ST, Maciejewski JPTiu RV. Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. PLoS One 7:e43090, 2012. PMCID: PMC3419680


Triozzi PL, Achberger S, Aldrich W, Elson PGarcia JDreicer R. Differential immunologic and microRNA effects of 2 dosing regimens of recombinant human granulocyte/macrophage colony stimulating factor. J Immunother 35:587-594, 2012.


Triozzi PL, Achberger S, Aldrich W, Singh AD, Grane R, Borden EC. The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon. J Transl Med 10:241, 2012. PMCID: PMC3573971


Triozzi PL, Aldrich W, Achberger S, Ponnazhagan S, Alcazar O, Saunthararajah Y. Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice. Cancer Immunol Immunother 61:1441-1450 2012.


Trock BJ, Brotzman MJ, Mangold LA, Bigley JW, Epstein JI, McLeod D, Klein EA, Jones JS, Wang S, McAskill T, Mehrotra J, Raghavan B, Partin AW. Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies. BJU Int 110:56-62 2012. PMCID: PMC3397791


Tuupanen S, Yan J, Turunen M, Gylfe AE, Kaasinen E, Li LEng C, Culver DA, Kalady MF, Pennison MJ, Pasche B, Manne U, de la Chapelle A, Hampel H, Henderson BE, Le Marchand L, Hautaniemi S, Askhtorab H, Smoot D, Sandler RS, Keku T, Kupfer SS, Ellis NA, Haiman CA, Taipale J, Aaltonen LA. Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583. Cancer Genet 205:25-33, 2012.

Ulatowski L, Dreussi C, Noy NBarnholtz-Sloan JKlein EManor D. Expression of the α-tocopherol transfer protein gene is regulated by oxidative stress and common single-nucleotide polymorphisms. Free Radic Biol Med 53:2318-2326, 2012.


Umar N, Litaker D, Schaarschmidt ML, Peitsch WK, Schmieder A, Terris DD. Outcomes associated with matching patients' treatment preferences to physicians' recommendations: study methodology. BMC Health Serv Res 12:1, 2012. PMCID: PMC3276415

Valdagni R, Kattan MW, Rancati T, Yu C, Vavassori V, Fellin G, Cagna E, Gabriele P, Mauro FA, Baccolini M, Bianchi C, Menegotti L, Monti AF, Stasi M, Giganti MO, Fiorino C. Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome. Int J Radiat Oncol Biol Phys 82:1957-1966, 2012.


van Weeghel M, Te Brinke H, van Lenthe H, Kulik W, Minkler PE, Stoll MS, Sass JO, Janssen U, Stoffel W, Schwab KO, Wanders RJ, Hoppel CL, Houten SM. Functional redundancy of mitochondrial enoyl-CoA isomerases in the oxidation of unsaturated fatty acids. FASEB J 26:4316-4326, 2012.


Vatolin S, Khan SN, Reu FJ. Direct chromatin PCR (DC-PCR): hypotonic conditions allow differentiation of chromatin states during thermal cycling. PLoS One 7:e44690, 2012. PMCID: PMC3440349


Vaziri SA, Tavares EJ, Golshayan AR, Rini BI, Aydin H, Zhou M, Sercia L, Wood L, Ganapathi MK, Bukowski RM, Ganapathi R. Differing von hippel lindau genotype in paired primary and metastatic tumors in patients with clear cell renal cell carcinoma. Front Oncol 2:51, 2012. PMCID: PMC3361062


Vetter D, Cohen-Naftaly M, Villanueva A, Lee YA, Kocabayoglu P, Hannivoort R, Narla G, M Llovet J, Thung SN, Friedman SL. Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing. Hepatology 56:1361-1370, 2012. PMCID: PMC3412196


Vij R, Wang M, Kaufman JL, Lonial S, Jakubowiak AJ, Stewart AK, Kukreti V, Jagannath S, McDonagh KT, Alsina M, Bahlis NJ, Reu FJ, Gabrail NY, Belch A, Matous JV, Lee P, Rosen P, Sebag M, Vesole DH, Kunkel LA, Wear SM, Wong AF, Orlowski RZ, Siegel DS. An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma. Blood 119:5661-5670, 2012.


Vijayaraghavalu S, Peetla C, Lu S, Labhasetwar V. Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions. Mol Pharm 9:2730-2742, 2012. PMCID: PMC3433581


Vinogradova O, Qin J. NMR as a unique tool in assessment and complex determination of weak protein-protein interactions. Top Curr Chem 326:35-45, 2012.


Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, Tzankov A, Wen W, Liu WM, Kahl BS, d'Amore ES, Montes-Moreno S, Dybkær K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HY, O'Neill S, Dunphy CH, Hsi ED, Zhao XF, Go RS, Choi WW, Zhou F, Czader M, Tong J, Zhao X, van Krieken JH, Huang Q, Ai W, Etzell J, Ponzoni M, Ferreri AJ, Piris MA, Møller MB, Bueso-Ramos CE, Medeiros LJ, Wu L, Young KH. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 26:2103-2113, 2012.


Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A, O'Keefe C, Rogers HJ, Sekeres MA, Maciejewski JPTiu RV. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia 26:542-545, 2012.


Visconte V, Makishima H, Maciejewski JP, Tiu RV. Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders. Leukemia 26:2447-2454, 2012.


Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F, McMahon J, Makishima H, Szpurka H, Jankowska A, Jerez A, Sekeres MA,Saunthararajah YAdvani ASCopelan E, Koseki H, Isono K, Padgett RA, Osman S, Koide K, O'Keefe C, Maciejewski JP, Tiu RV. SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. Blood 120:3173-3186, 2012. PMCID: PMC3476536


Visioni A, Zhang M, Graor H, Kim J. Expansion of melanoma-specific T cells from lymph nodes of patients in stage III: implications for adoptive immunotherapy in treating cancer. Surgery 152:557-566, 2012. PMCID: PMC3462253


Vivar C, Potter MC, Choi J, Lee JY, Stringer TP, Callaway EM, Gage FH, Suh H, van Praag H. Monosynaptic inputs to new neurons in the dentate gyrus. Nat Commun 3:1107, 2012.


von Gruenigen V, Frasure H, Kavanagh MB, Janata J, Waggoner S, Rose P, Lerner E, Courneya KS. Survivors of uterine cancer empowered by exercise and healthy diet (SUCCEED): a randomized controlled trial. Gynecol Oncol 125:699-704, 2012.


von Gruenigen VE, Frasure HE, Smith DA, Fusco NL, Eaton SM, Debernardo RL, Heugel AM, Waggoner SE. Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies: a phase I study. Anticancer Drugs 23:724-730 2012.


von Mehren M, Rankin C, Goldblum JR, Demetri GD, Bramwell V, Ryan CW, Borden E. Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas. Cancer 118:770-776, 2012. PMCID: PMC3576704


Voskens CJ, Sewell D, Hertzano R, Desanto J, Rollins S, Lee M, Taylor R, Wolf J, Suntharalingam M, Gastman B, Papadimitriou JC, Lu C, Tan M, Morales R, Cullen K, Celis E, Mann D, Strome SE. inducTION of mage-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma. Head Neck 34:1734-1746, 2012.


Vykhovanets EV, Maclennan GT, Vykhovanets OV, Cherullo EEPonsky LEGupta S. Molecular imaging of nuclear factor-κB in bladder as a primary regulator of inflammatory response. J Urol 187:330-337, 2012.

Wahdan-Alaswad RS, Bane KL, Song K, Shola DT, Garcia JADanielpour D. Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin. Mol Cancer Res 10:821-833, 2012. PMCID: PMC3557528


Wang C, Sen A, Ruffin MT 4th, Nease DE Jr, Gramling R, Acheson LS, O'Neill SM, Rubinstein WS; Family Healthware™ Impact Trial (FHITr) Group. Family history assessment: impact on disease risk perceptions. Am J Prev Med 43:392-398, 2012. PMCID: PMC3448124


Wang J, Han X, Feng X, Wang Z, Zhang Y. Coupling cellular localization and function of checkpoint kinase 1 (Chk1) in checkpoints and cell viability. J Biol Chem 287:25501-25509, 2012. PMCID: PMC3408180


Wang J, Han X, Zhang Y. Autoregulatory mechanisms of phosphorylation of checkpoint kinase 1. Cancer Res 72:3786-3794, 2012. PMCID: PMC3412312


Wang L, Cvetkov TL, Chance MR, Moiseenkova-Bell VY. Identification of in vivo disulfide conformation of the TRPA1 ion channel. J Biol Chem 287:6169-6176, 2012. PMCID: PMC3307328


Wang LX, Plautz GE. T cells sensitized with breast tumor progenitor cell vaccine have therapeutic activity against spontaneous HER2/neu tumors. Breast Cancer Res Treat 134:61-70, 2012. PMCID: PMC3349011


Wang NX, Bazdar DA, Sieg SF, von Recum HA. Microparticle delivery of interleukin-7 to boost T-cell proliferation and survival. Biotechnol Bioeng 109:1835-1843, 2012.


Wang R, Bosch RJ, Benson CA, Lederman MM. Drug-resistant virus has reduced ability to induce immune activation. J Acquir Immune Defic Syndr 61:e60-e63, 2012. PMCID: PMC3499025


Wang W, Albert JM. Estimation of mediation effects for zero-inflated regression models. Stat Med 31:3118-3132, 2012. PMCID: PMC3469758


Wang WL, Evans HL, Meis JM, Liegl-Atzwanger B, Bovee JV, Goldblum JR, Billings SD, Rubin BP, López-Terrada D, Lazar AJ. FUS rearrangements are rare in 'pure' sclerosing epithelioid fibrosarcoma. Mod Pathol 25:846-853, 2012.


Wang X, Morris NJ, Schaid DJ, Elston RC. Power of single- vs. multi-marker tests of association. Genet Epidemiol 36:480-487 2012.


Wang X, Tian H, Lee ZHeston WD. Structure-activity relationships of 2',5'-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists. Nucleosides Nucleotides Nucleic Acids 31:432-444, 2012.


Wang Y, He X, Ngeow J, Eng C. GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer. Hum Mol Genet 21:569-576, 2012.


Wang Z, Chamie D, Bezerra HG, Yamamoto H, Kanovsky J, Wilson DL, Costa MA, Rollins AM. Volumetric quantification of fibrous caps using intravascular optical coherence tomography. Biomed Opt Express 3:1413-1426, 2012. PMCID: PMC3370980


Wang Z, Lu T, Du L, Hu Z, Zhuang Q, Li Y, Wang CY, Zhu H, Ye Z. Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review. Int J Clin Exp Pathol 5:601-608, 2012. PMCID: PMC3430099


Wang ZH, Li YY, Hu ZQ, Zhu H, Zhuang QY, Qi Y, Ye ZQ. Does urothelial cancer of bladder behave differently in young patients? Chin Med J (Engl) 125:2643-2648, 2012.


Warlick E, Ahn KW, Pedersen TL, Artz A, de Lima M, Pulsipher M, Akpek G, Aljurf M, Cahn JY, Cairo M, Chen YB, Cooper B, Deol A, Giralt S, Gupta V, Khoury HJ, Kohrt H, Lazarus HM, Lewis I, Olsson R, Pidala J, Savani BN, Seftel M, Socié G, Tallman M, Ustun C, Vij R, Vindeløv L, Weisdorf D. Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era. Blood 119:4083-4090, 2012. PMCID: PMC3350369


Waterman J, Rybicki L, Bolwell BCopelan EPohlman BSweetenham JDean R, Sobecks R, Andresen S, Kalaycio M. Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation. Bone Marrow Transplant 47:488-493, 2012.


Watts KE, Montironi R, Mazzucchelli R, van der Kwast T, Osunkoya AO, Stephenson AJ, Hansel DE. Clinicopathologic characteristics of 23 cases of invasive low-grade papillary urothelial carcinoma. Urology 80:361-366, 2012.


Weber DM, Graef T, Hussein M, Sobecks RM, Schiller GJ, Lupinacci L, Hardwick JS, Jagannath S. Phase I trial of vorinostat combined with bortezomib for the treatment of relapsing and/or refractory multiple myeloma. Clin Lymphoma Myeloma Leuk 12:319-324, 2012.


Weinberg AJin G, Sieg S, McCormick TS. The yin and yang of human beta-defensins in health and disease. Front Immunol 3:294, 2012. PMCID: PMC3465815


Weinfurt KP, Seils DM, Lin L, Sulmasy DP, Astrow AB, Hurwitz HI, Cohen RB, Meropol NJ. Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question? J Clin Oncol 30:4396-4400, 2012.


Weinstein MC, Brodell RT, Bordeaux J, Honda K. The art and science of surgical margins for the dermatopathologist. Am J Dermatopathol 34:737-745, 2012.


Wen AM, Lee KL, Yildiz I, Bruckman MA, Shukla S, Steinmetz NF. Viral nanoparticles for in vivo tumor imaging. J Vis Exp 69:e4352, 2012.


Wen AM, Ryan MJ, Yang AC, Breitenkamp K, Pokorski JK, Steinmetz NF. Photodynamic activity of viral nanoparticles conjugated with C60. Chem Commun (Camb) 48:9044-9046, 2012. PMCID: PMC3470913


Wen AM, Shukla S, Saxena P, Aljabali AA, Yildiz I, Dey S, Mealy JE, Yang AC, Evans DJ, Lomonossoff GP, Steinmetz NF. Interior engineering of a viral nanoparticle and its tumor homing properties. Biomacromolecules 13:3990-4001, 2012. PMCID: PMC3525095


Wendt MK, Tian M, Schiemann WP. Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression. Cell Tissue Res 347:85-101, 2012.


Wendtner CM, Hillmen P, Mahadevan D, Bühler A, Uharek L, Coutré S, Frankfurt O, Bloor A, Bosch F, Furman RR, Kimby E, Gribben JG, Gobbi M, Dreisbach L, Hurd DD, Sekeres MA, Ferrajoli A, Shah S, Zhang J, Moutouh-de Parseval L, Hallek M, Heerema NA, Stilgenbauer S, Chanan-Khan AA. Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia. Leuk Lymphoma 53:417-423, 2012.


Werner JJ. Measuring the impact of practice-based research networks (PBRNs). J Am Board Fam Med 25:557-559, 2012.


Wessels D, Lusche DF, Steimle PA, Scherer A, Kuhl S, Wood K, Hanson B, Egelhoff TT, Soll DR. Myosin heavy chain kinases play essential roles in Ca2+, but not cAMP, chemotaxis and the natural aggregation of Dictyostelium discoideum. J Cell Sci 125:4934-4944, 2012.


West XZ, Meller N, Malinin NL, Deshmukh L, Meller J, Mahabeleshwar GH, Weber ME, Kerr BA, Vinogradova O, Byzova TV. Integrin β3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch. PLoS One 7:e31071, 2012. PMCID: PMC3281915


Wilkins LR, Wu H, Haaga JRExner A. Radiofrequency ablation: effect of tumor- and organ-specific pharmacologic modulation of arterial and portal venous blood flow on coagulation diameter in an N1-S1 tumor model. J Vasc Interv Radiol 23:826-832, 2012. PMCID: PMC3360825


Will B, Zhou L, Vogler TO, Ben-Neriah S, Schinke C, Tamari R, Yu Y, Bhagat T, Bhattacharya S, Barreyro L, Heuck C, Mo Y, Parekh S, McMahon C, Pellagatti A, Boultwood J, Montagna C, Silverman L, Maciejewski J, Greally JM, Ye BH, List AF, Steidl C, Steidl U, Verma A. Stem and progenitor cells in myelodysplastic syndromes show aberrant stage specific expansion and harbor genetic and epigenetic alterations. Blood 120:2076-2086, 2012. PMCID: PMC3437595


Willard MD, Lajiness ME, Wulur IH, Feng B, Swearingen ML, Uhlik MT, Kinzler KW, Velculescu VE, Sjöblom T, Markowitz SD, Powell SM, Vogelstein B, Barber TD. Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes. Mol Cancer Res 10:739-749, 2012.


Willett CG, Moughan J, O'Meara E, Galvin JM, Crane CH, Winter K, Manfredi D, Rich TA, Rabinovitch R, Lustig R, Machtay M, Curran WJ. Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials. Radiother Oncol 105:9-13, 2012.


Williams WM, Castellani RJ, Weinberg A, Perry G, Smith MA. Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration? ScientificWorldJournal 2012:905785, 2012. PMCID: PMC3346844


Williamson SR, Halat S, Eble JN, Grignon DJ, Lopez-Beltran A, Montironi R, Tan PH, Wang M, Zhang S, Maclennan GT, Baldridge LA, Cheng L. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma. Am J Surg Pathol 36:1425-1433, 2012.


Wilson WH, Jung SH, Porcu P, Hurd D, Johnson J, Martin SE, Czuczman M, Lai R, Said J, Chadburn A, Jones D, Dunleavy K, Canellos G, Zelenetz AD, Cheson BD, Hsi ED; Cancer Leukemia Group B. A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica 97:758-765, 2012. PMCID: PMC3342980


Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. Radiation Therapy Oncology Group 0247: a randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 82:1367-1375, 2012. PMCID: PMC3208721


Woody NM, Videtic GM, Stephans KL, Djemil T, Kim Y, Xia P. Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes. Int J Radiat Oncol Biol Phys 83:427-434, 2012.


Wu H, Patel RB, Zheng Y, Solorio L, Krupka TM, Ziats NP, Haaga JRExner AA. Differentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model. Ultrasound Med Biol 38:443-453, 2012. PMCID: PMC3280615


Wu L, Zepp J, Li X. Function of Act1 in IL-17 family signaling and autoimmunity. Adv Exp Med Biol 946:223-235, 2012.


Wu R, Du H, Belinson SE, Pretorius RG, Zou J, Yang B, Wang C, Belinson JL. Secondary screening after primary self-sampling for human papillomavirus from SHENCCAST II. J Low Genit Tract Dis 16:416-420, 2012.


Wu X, Burden-Gulley SM, Yu GP, Tan M, Lindner DBrady-Kalnay SMLu ZR. Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer. Bioconjug Chem 23:1548-1556, 2012. PMCID: PMC3552558


Wu Z, Chen K, Yildiz I, Dirksen A, Fischer R, Dawson PE, Steinmetz NF. Development of viral nanoparticles for efficient intracellular delivery. Nanoscale 4:3567-3576, 2012. PMCID: PMC3563001

Xia P, Balter P. WE-F-BRCD-01: transitioning from 3D IMRT to 4D IMRT and role of image guidance. Med Phys 39:3963, 2012.


Xie H, Peereboom DM. Ogilvie's syndrome during chemotherapy with high-dose methotrexate for primary CNS lymphoma. J Clin Oncol 30:e192-e194 2012.


Xu DS, Yang C, Proescholdt M, Bründl E, Brawanski A, Fang X, Lee CS, Weil RJ, Zhuang Z, Lonser RR. Neuronatin in a subset of glioblastoma multiforme tumor progenitor cells is associated with increased cell proliferation and shorter patient survival. PLoS One 7:e37811, 2012. PMCID: PMC3356299


Xu J, Mahajan K, Xue W, Winter JO, Zborowski M, Chalmers JJ. Simultaneous, single particle, magnetization and size measurements of micron sized, magnetic particles. J Magn Magn Mater 324:4189-4199, 2012. PMCID: PMC3433070


Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, Wu X, Stack EC, Loda M, Liu T, Xu H, Cato L, Thornton JE, Gregory RI, Morrissey C, Vessella RL, Montironi R, Magi-Galluzzi C, Kantoff PW, Balk SP, Liu XS, Brown M. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science 338:1465-1469, 2012.


Xu Y, Hu B, Choi AJ, Gopalan B, Lee BH, Kalady MF, Church JM, Ting AH. Unique DNA methylome profiles in CpG island methylator phenotype colon cancers. Genome Res 22:283-291, 2012. PMCID: PMC3266035


Xu Z, Marko NF, Angelov L, Barnett GHChao STVogelbaum MASuh JHWeil RJ. Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast cancer. Cancer 118:1323-1333, 2012.


Xu Z, Marko NF, Chao ST, Angelov L, Vogelbaum MASuh JHBarnett GHWeil RJ. Relationship between HER2 status and prognosis in women with brain metastases from breast cancer. Int J Radiat Oncol Biol Phys 82:e739-e747, 2012.


Xu-Monette ZY, Wu L, Visco C, Tai YC, Tzankov A, Liu WM, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Zhao XF, Choi WW, Zhao X, van Krieken JH, Huang Q, Huh J, Ai W, Ponzoni M, Ferreri AJ, Zhou F, Kahl BS, Winter JN, Xu W, Li J, Go RS, Li Y, Piris MA, Møller MB, Miranda RN, Abruzzo LV, Medeiros LJ, Young KH. Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study. Blood 120:3986-3996, 2012. PMCID: PMC3496956

Yamashita M, Chattopadhyay S, Fensterl V, Saikia P, Wetzel JL, Sen GC. Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling. Sci Signal 5:ra50, 2012. PMCID: PMC3431157


Yamashita M, Chattopadhyay S, Fensterl V, Zhang Y, Sen GC. A TRIF-independent branch of TLR3 signaling. J Immunol 188:2825-2833, 2012. PMCID: PMC3386560


Yang C, Iyer RR, Yu AC, Yong RL, Park DM, Weil RJ, Ikejiri B, Brady RO, Lonser RR, Zhuang Z. β-catenin signaling initiates the activation of astrocytes and its dysregulation contributes to the pathogenesis of astrocytomas. Proc Natl Acad Sci U S A 109:6963-6968, 2012. PMCID: PMC3344971


Yang L, Cheng E, Ozsoyoğlu ZM. Efficient path-based computations on pedigree graphs with compact encodings. BMC Bioinformatics 13(Suppl 3):S14, 2012. PMCID: PMC3311099


Yang S, Savvides PLiu LGerson SL, Xu Y. Development and validation of an LC-MS/MS method for pharmacokinetic study of methoxyamine in phase I clinical trial. J Chromatogr B Analyt Technol Biomed Life Sci 901:25-33, 2012.


Yang Y, Kennedy VO, Updegraph JB 3rd, Samas B, Macikenas D, Chaloux B, Miller JA, Van Goethem EM, Kenney ME. Long directional interactions (LDIs) in oligomeric cofacial silicon phthalocyanines and other oligomeric and polymeric cofacial phthalocyanines. J Phys Chem A 116:8718-8730, 2012.


Yanik GA, Mineishi S, Levine JE, Kitko CL, White ES, Vander Lugt MT, Harris AC, Braun T, Cooke KR. Soluble tumor necrosis factor receptor: Enbrel (etanercept) for sub-acute pulmonary dysfunction following allogeneic stem cell transplantation. Biol Blood Marrow Transplant 18:1044-1054, 2012.


Yaskiv O, Rubin BP, He H, Falzarano S, Magi-Galluzzi C, Zhou M. ERG protein expression in human tumors detected with a rabbit monoclonal antibody. Am J Clin Pathol 138:803-810, 2012.


Yao M, Lu M, Savvides PS, Rezaee R, Zender CA, Lavertu P, Buatti JM, Machtay M. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 83:684-689, 2012.


Yao P, Fox PL. A truncated tRNA synthetase directs a "translational trickle" of gene expression. Cell Cycle 11:1868-1869, 2012.


Yao P, Potdar AA, Arif A, Ray PS, Mukhopadhyay R, Willard B, Xu Y, Yan J, Saidel GMFox PL. Coding region polyadenylation generates a truncated tRNA synthetase that counters translation repression. Cell 149:88-100, 2012.


Ye F, Lattif AA, Xie J, Weinberg A, Gao S. Nutlin-3 induces apoptosis, disrupts viral latency and inhibits expression of angiopoietin-2 in Kaposi sarcoma tumor cells. Cell Cycle 11:1393-1399, 2012. PMCID: PMC3350880


Ye Y, Lee IJ, Runge KW, Wu JQ. Roles of putative Rho-GEF Gef2 in division-site positioning and contractile-ring function in fission yeast cytokinesis. Mol Biol Cell 23:1181-1195, 2012. PMCID: PMC3315812


Ye Z, Jeong EK, Wu X, Tan M, Yin S, Lu ZR. Polydisulfide manganese(II) complexes as non-gadolinium biodegradable macromolecular MRI contrast agents. J Magn Reson Imaging 35:737-744, 2012.


Yi X, Zhong B, Smith KM, Geldenhuys WJ, Feng Y, Pink JJDowlati AXu Y, Zhou A, Su B. Identification of a class of novel tubulin inhibitors. J Med Chem 55:3425-3435, 2012.


Yu N, Xia P. SU-E-J-184: liver dose calculation for 90Y radioembolization with PET/CT. Med Phys 39:3695, 2012.


Yu S, Levi L, Siegel R, Noy N. Retinoic acid induces neurogenesis by activating both retinoic acid receptors (RARs) and peroxisome proliferator-activated receptor β/δ(PPARβ/δ). J Biol Chem 287:42195-42205, 2012. PMCID: PMC3516764


Yu X, Guda KWillis JVeigl MWang ZMarkowitz SAdams MSun S. How do alignment programs perform on sequencing data with varying qualities and from repetitive regions? BioData Min 5:6, 2012. PMCID: PMC3414812


Yuan J, Brindle J, Zheng Y, Sohn J, Geis P, Yao M, Lo S, Wessels B. SU-C-211-02: a fast Monte Carlo dose algorithm for radiotherapy treatment planning based on hybrid adaptive meshes. Med Phys 39:3596-3597, 2012.

Zaytoun OM, Stephenson AJ, Fareed K, El-Shafei A, Gao T, Levy D, Jones JS. When serial prostate biopsy is recommended: most cancers detected are clinically insignificant. BJU Int 110:987-992, 2012.


Zeng W, Fu K, Quintanilla-Fend L, Lim M, Ondrejka S, Hsi ED. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Am J Surg Pathol 36:214-219, 2012.


Zentner GE, Scacheri PC. The chromatin fingerprint of gene enhancer elements. J Biol Chem 287:30888-30896, 2012. PMCID: PMC3438921


Zepp JA, Liu C, Qian W, Wu L, Gulen MF, Kang Z, Li X. Cutting edge: TNF receptor-associated factor 4 restricts IL-17-mediated pathology and signaling processes. J Immunol 189:33-37, 2012. PMCID: PMC3590847


Zhang AY, Gary F, Zhu H. What precipitates depression in African-American cancer patients? Triggers and stressors. Palliat Support Care 10:279- 286, 2012.


Zhang AY, Zyzanski SJ, Siminoff LA. Ethnic differences in the caregiver's attitudes and preferences about the treatment and care of advanced lung cancer patients. Psychooncology 21:1250-1253, 2012.


Zhang J, Liu M, Su Y, Du J, Zhu AJ. A targeted in vivo RNAi screen reveals deubiquitinases as new regulators of Notch signaling. G3 (Bethesda) 2:1563-1575, 2012. PMCID: PMC3516478


Zhang JM, Wang P, Yao JX, Zhao L, Davis MP, Walsh D, Yue GH. Music interventions for psychological and physical outcomes in cancer: a systematic review and meta-analysis. Support Care Cancer 20:3043-3053, 2012.


Zhang K, Wong P, Zhang L, Jacobs B, Borden EC, Aster JC, Bedogni B. A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth. Oncogene 31:4609-4618, 2012.


Zhang L, Bouguet-Bonnet S, Buck M. Combining NMR and molecular dynamics studies for insights into the allostery of small GTPase-protein interactions. Methods Mol Biol 796:235-259, 2012.


Zhang M, Kim JA. Effect of molecular size and modification pattern on the internalization of water soluble β-(1 → 3)-(1 → 4)-glucan by primary murine macrophages. Int J Biochem Cell Biol 44:914-927, 2012.


Zhang Z, Lee JC, Lin L, Olivas V, Au V, Laframboise T, Abdel- Rahman M, Wang X, Levine AD, Rho JK, Choi YJ, Choi CM, Kim SW, Jang SJ, Park YS, Kim WS, Lee DH, Lee JS, Miller VA, Arcila M, Ladanyi M, Moonsamy P, Sawyers C, Boggon TJ, Ma PC, Costa C, Taron M, Rosell R, Halmos B, Bivona TG. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer. Nat Genet 44:852-860, 2012. PMCID: PMC3408577


Zhao FH, Lewkowitz AK, Chen F, Lin MJ, Hu SY, Zhang X, Pan QJ, Ma JF, Niyazi M, Li CQ, Li SM, Smith JS, Belinson JL, Qiao YL, Castle PE. Pooled analysis of a self-sampling HPV DNA test as a cervical cancer primary screening method. J Natl Cancer Inst 104:178-188, 2012. PMCID: PMC3274511


Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, Wu RF, Li CQ, Wei LH, Xu AD, Zhang WH, Pan QJ, Zhang X, Belinson JL, Sellors JW, Smith JS, Qiao YL, Franceschi S. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer 131:2929-2938, 2012. PMCID: PMC3435460


Zhao Y, Malinin NL, Meller J, Ma Y, West XZ, Qin J, Podrez EA, Byzova TV. Regulation of cell adhesion and migration by Kindlin-3 cleavage by calpain. J Biol Chem 287:40012-40020, 2012. PMCID: PMC3501071


Zheng Y, Yuan J, Woods C, Machtay M, Wessels B. SU-E-T-460: isoeffective dose display (EQD2) for composite plan of radiosurgery and conventional 3D radiotherapy. Med Phys 39:3810-3811, 2012.


Zhong B, Cai X, Chennamaneni S, Yi X, Liu LPink JJDowlati A, Xu Y, Zhou A, Su B. From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation. Eur J Med Chem 47:432-444, 2012.


Zhou L. Myeloproliferation and hematopoietic stem cell dysfunction due to defective Notch receptor modification by O-fucose glycans. Semin Immunopathol 34:455-469, 2012.


Zhu J, He P, Lin L, Jones DR, Marchant RE. Biomimetic poly(ethylene glycol)-based hydrogels as scaffolds for inducing endothelial adhesion and capillary- like network formation. Biomacromolecules 13:706-713, 2012. PMCID: PMC3310151


Zhu W, Wu C, Li Y, Somoza E, Liu LGerson SWang Y. In vivo quantification of abasic sites for efficacious evaluation of DNA-targeted chemotherapies. J Cancer Sci Ther S5:006, 2012.


Zhu X, Feng T, Elston RC. Linkage-disequilibrium-based binning misleads the interpretation of genome-wide association studies. Am J Hum Genet 91:965- 968, 2012. PMCID: PMC3487138


Zhuang T, Djemil T, Qi P, Magnelli A, Stephans K, Videtic G, Xia P. SU-E-T-486: volume and location dependence on the difference between Monte Carlo and pencil beam dose calculations for lung stereotactic body radiation therapy. Med Phys 39:3817, 2012.


Zhuang T, Magnelli A, Liu H, Qi P, Djemil T, Stephans K, Videtic G, Xia P. SU-E-J-10: accuracy of image guidance using cone-beam CT with multiple breath hold using active breathing coordination. Med Phys 39:3654, 2012.